id	sid	tid	token	lemma	pos
aiua-10278	1	1	cop+ed+fisse	cop+ed+fisse	NOUN
aiua-10278	1	2	2006	2006	NUM
aiua-10278	1	3	archivio	archivio	NOUN
aiua-10278	1	4	italiano	italiano	X
aiua-10278	1	5	di	di	X
aiua-10278	1	6	urologia	urologia	PROPN
aiua-10278	1	7	e	e	PROPN
aiua-10278	1	8	andrologia	andrologia	PROPN
aiua-10278	1	9	2022	2022	NUM
aiua-10278	1	10	;	;	PUNCT
aiua-10278	1	11	94	94	NUM
aiua-10278	1	12	,	,	PUNCT
aiua-10278	1	13	132	132	NUM
aiua-10278	1	14	original	original	ADJ
aiua-10278	1	15	paper	paper	NOUN
aiua-10278	1	16	no	no	DET
aiua-10278	1	17	conflict	conflict	NOUN
aiua-10278	1	18	of	of	ADP
aiua-10278	1	19	interest	interest	NOUN
aiua-10278	1	20	declared	declare	VERB
aiua-10278	1	21	.	.	PUNCT
aiua-10278	2	1	(	(	PUNCT
aiua-10278	2	2	psa	psa	NOUN
aiua-10278	2	3	)	)	PUNCT
aiua-10278	2	4	and	and	CCONJ
aiua-10278	2	5	digital	digital	ADJ
aiua-10278	2	6	rectal	rectal	ADJ
aiua-10278	2	7	examination	examination	NOUN
aiua-10278	2	8	(	(	PUNCT
aiua-10278	2	9	dre	dre	PROPN
aiua-10278	2	10	)	)	PUNCT
aiua-10278	2	11	are	be	AUX
aiua-10278	2	12	the	the	DET
aiua-10278	2	13	common	common	ADJ
aiua-10278	2	14	initial	initial	ADJ
aiua-10278	2	15	assessments	assessment	NOUN
aiua-10278	2	16	for	for	ADP
aiua-10278	2	17	detection	detection	NOUN
aiua-10278	2	18	.	.	PUNCT
aiua-10278	3	1	a	a	DET
aiua-10278	3	2	suspicious	suspicious	ADJ
aiua-10278	3	3	dre	dre	NOUN
aiua-10278	3	4	or	or	CCONJ
aiua-10278	3	5	a	a	DET
aiua-10278	3	6	psa	psa	NOUN
aiua-10278	3	7	higher	high	ADJ
aiua-10278	3	8	than	than	ADP
aiua-10278	3	9	4	4	NUM
aiua-10278	3	10	ng	ng	NOUN
aiua-10278	3	11	/	/	SYM
aiua-10278	3	12	ml	ml	NOUN
aiua-10278	3	13	are	be	AUX
aiua-10278	3	14	generally	generally	ADV
aiua-10278	3	15	considered	consider	VERB
aiua-10278	3	16	an	an	DET
aiua-10278	3	17	indication	indication	NOUN
aiua-10278	3	18	for	for	ADP
aiua-10278	3	19	prostate	prostate	NOUN
aiua-10278	3	20	biopsy	biopsy	NOUN
aiua-10278	3	21	(	(	PUNCT
aiua-10278	3	22	pb	pb	NOUN
aiua-10278	3	23	)	)	PUNCT
aiua-10278	3	24	(	(	PUNCT
aiua-10278	3	25	2	2	NUM
aiua-10278	3	26	)	)	PUNCT
aiua-10278	3	27	.	.	PUNCT
aiua-10278	4	1	in	in	ADP
aiua-10278	4	2	fact	fact	NOUN
aiua-10278	4	3	,	,	PUNCT
aiua-10278	4	4	a	a	DET
aiua-10278	4	5	suspicious	suspicious	ADJ
aiua-10278	4	6	dre	dre	NOUN
aiua-10278	4	7	is	be	AUX
aiua-10278	4	8	associated	associate	VERB
aiua-10278	4	9	with	with	ADP
aiua-10278	4	10	a	a	DET
aiua-10278	4	11	higher	high	ADJ
aiua-10278	4	12	risk	risk	NOUN
aiua-10278	4	13	of	of	ADP
aiua-10278	4	14	pca	pca	NOUN
aiua-10278	4	15	independently	independently	ADV
aiua-10278	4	16	of	of	ADP
aiua-10278	4	17	the	the	DET
aiua-10278	4	18	psa	psa	NOUN
aiua-10278	4	19	levels	level	NOUN
aiua-10278	4	20	(	(	PUNCT
aiua-10278	4	21	3	3	NUM
aiua-10278	4	22	)	)	PUNCT
aiua-10278	4	23	.	.	PUNCT
aiua-10278	5	1	the	the	DET
aiua-10278	5	2	gold	gold	ADJ
aiua-10278	5	3	standard	standard	NOUN
aiua-10278	5	4	for	for	ADP
aiua-10278	5	5	pca	pca	NOUN
aiua-10278	5	6	diagnosis	diagnosis	NOUN
aiua-10278	5	7	is	be	AUX
aiua-10278	5	8	the	the	DET
aiua-10278	5	9	transrectal	transrectal	ADJ
aiua-10278	5	10	ultrasound	ultrasound	NOUN
aiua-10278	5	11	(	(	PUNCT
aiua-10278	5	12	trus)-guided	trus)-guide	VERB
aiua-10278	5	13	pb	pb	PROPN
aiua-10278	5	14	.	.	PUNCT
aiua-10278	6	1	nonetheless	nonetheless	ADV
aiua-10278	6	2	this	this	DET
aiua-10278	6	3	technique	technique	NOUN
aiua-10278	6	4	has	have	VERB
aiua-10278	6	5	some	some	DET
aiua-10278	6	6	limitations	limitation	NOUN
aiua-10278	6	7	.	.	PUNCT
aiua-10278	7	1	trus	trus	NOUN
aiua-10278	7	2	-	-	PUNCT
aiua-10278	7	3	guided	guide	VERB
aiua-10278	7	4	pb	pb	ADP
aiua-10278	7	5	may	may	AUX
aiua-10278	7	6	miss	miss	VERB
aiua-10278	7	7	up	up	ADP
aiua-10278	7	8	to	to	PART
aiua-10278	7	9	20	20	NUM
aiua-10278	7	10	%	%	NOUN
aiua-10278	7	11	of	of	ADP
aiua-10278	7	12	cancers	cancer	NOUN
aiua-10278	7	13	(	(	PUNCT
aiua-10278	7	14	4	4	NUM
aiua-10278	7	15	)	)	PUNCT
aiua-10278	7	16	.	.	PUNCT
aiua-10278	8	1	additionally	additionally	ADV
aiua-10278	8	2	,	,	PUNCT
aiua-10278	8	3	a	a	DET
aiua-10278	8	4	large	large	ADJ
aiua-10278	8	5	proportion	proportion	NOUN
aiua-10278	8	6	of	of	ADP
aiua-10278	8	7	detected	detect	VERB
aiua-10278	8	8	cancers	cancer	NOUN
aiua-10278	8	9	are	be	AUX
aiua-10278	8	10	clinically	clinically	ADV
aiua-10278	8	11	insignificant	insignificant	ADJ
aiua-10278	8	12	(	(	PUNCT
aiua-10278	8	13	5	5	NUM
aiua-10278	8	14	)	)	PUNCT
aiua-10278	8	15	,	,	PUNCT
aiua-10278	8	16	contributing	contribute	VERB
aiua-10278	8	17	to	to	PART
aiua-10278	8	18	overdiagnosis	overdiagnosis	VERB
aiua-10278	8	19	and	and	CCONJ
aiua-10278	8	20	overtreatment	overtreatment	NOUN
aiua-10278	8	21	of	of	ADP
aiua-10278	8	22	indolent	indolent	ADJ
aiua-10278	8	23	tumors	tumor	NOUN
aiua-10278	8	24	which	which	PRON
aiua-10278	8	25	may	may	AUX
aiua-10278	8	26	adversely	adversely	ADV
aiua-10278	8	27	impact	impact	VERB
aiua-10278	8	28	quality	quality	NOUN
aiua-10278	8	29	of	of	ADP
aiua-10278	8	30	life	life	NOUN
aiua-10278	8	31	without	without	ADP
aiua-10278	8	32	altering	alter	VERB
aiua-10278	8	33	survival	survival	NOUN
aiua-10278	8	34	(	(	PUNCT
aiua-10278	8	35	6	6	NUM
aiua-10278	8	36	)	)	PUNCT
aiua-10278	8	37	.	.	PUNCT
aiua-10278	9	1	multiparametric	multiparametric	PROPN
aiua-10278	9	2	magnetic	magnetic	ADJ
aiua-10278	9	3	resonance	resonance	NOUN
aiua-10278	9	4	imaging	imaging	NOUN
aiua-10278	9	5	(	(	PUNCT
aiua-10278	9	6	mpmri	mpmri	PROPN
aiua-10278	9	7	)	)	PUNCT
aiua-10278	9	8	promises	promise	NOUN
aiua-10278	9	9	to	to	PART
aiua-10278	9	10	overcome	overcome	VERB
aiua-10278	9	11	these	these	DET
aiua-10278	9	12	problems	problem	NOUN
aiua-10278	9	13	,	,	PUNCT
aiua-10278	9	14	distinguishing	distinguish	VERB
aiua-10278	9	15	significant	significant	ADJ
aiua-10278	9	16	from	from	ADP
aiua-10278	9	17	insignificant	insignificant	ADJ
aiua-10278	9	18	disease	disease	NOUN
aiua-10278	9	19	and	and	CCONJ
aiua-10278	9	20	avoiding	avoid	VERB
aiua-10278	9	21	unnecessary	unnecessary	ADJ
aiua-10278	9	22	pb	pb	ADP
aiua-10278	9	23	(	(	PUNCT
aiua-10278	9	24	7	7	NUM
aiua-10278	9	25	,	,	PUNCT
aiua-10278	9	26	8)	8)	NUM
aiua-10278	9	27	.	.	PUNCT
aiua-10278	9	28	compared	compare	VERB
aiua-10278	9	29	with	with	ADP
aiua-10278	9	30	radical	radical	ADJ
aiua-10278	9	31	prostatectomy	prostatectomy	NOUN
aiua-10278	9	32	specimens	specimen	NOUN
aiua-10278	9	33	,	,	PUNCT
aiua-10278	9	34	mpmri	mpmri	PROPN
aiua-10278	9	35	detects	detect	NOUN
aiua-10278	9	36	85	85	NUM
aiua-10278	9	37	-	-	SYM
aiua-10278	9	38	95	95	NUM
aiua-10278	9	39	%	%	NOUN
aiua-10278	9	40	of	of	ADP
aiua-10278	9	41	clinically	clinically	ADV
aiua-10278	9	42	significant	significant	ADJ
aiua-10278	9	43	pca	pca	NOUN
aiua-10278	9	44	(	(	PUNCT
aiua-10278	9	45	cspca	cspca	PROPN
aiua-10278	9	46	)	)	PUNCT
aiua-10278	9	47	(	(	PUNCT
aiua-10278	9	48	9	9	NUM
aiua-10278	9	49	)	)	PUNCT
aiua-10278	9	50	and	and	CCONJ
aiua-10278	9	51	has	have	VERB
aiua-10278	9	52	negative	negative	ADJ
aiua-10278	9	53	predictive	predictive	ADJ
aiua-10278	9	54	values	value	NOUN
aiua-10278	9	55	of	of	ADP
aiua-10278	9	56	8394	8394	NUM
aiua-10278	9	57	%	%	NOUN
aiua-10278	9	58	(	(	PUNCT
aiua-10278	9	59	9	9	NUM
aiua-10278	9	60	,	,	PUNCT
aiua-10278	9	61	10	10	NUM
aiua-10278	9	62	)	)	PUNCT
aiua-10278	9	63	.	.	PUNCT
aiua-10278	10	1	additionally	additionally	ADV
aiua-10278	10	2	,	,	PUNCT
aiua-10278	10	3	mpmri	mpmri	PROPN
aiua-10278	10	4	preferentially	preferentially	ADV
aiua-10278	10	5	detects	detect	VERB
aiua-10278	10	6	cspca	cspca	NOUN
aiua-10278	10	7	and	and	CCONJ
aiua-10278	10	8	thus	thus	ADV
aiua-10278	10	9	may	may	AUX
aiua-10278	10	10	help	help	VERB
aiua-10278	10	11	to	to	PART
aiua-10278	10	12	avoid	avoid	VERB
aiua-10278	10	13	unnecessary	unnecessary	ADJ
aiua-10278	10	14	pb	pb	ADP
aiua-10278	10	15	for	for	ADP
aiua-10278	10	16	benign	benign	ADJ
aiua-10278	10	17	or	or	CCONJ
aiua-10278	10	18	insignificant	insignificant	ADJ
aiua-10278	10	19	lesions	lesion	NOUN
aiua-10278	10	20	,	,	PUNCT
aiua-10278	10	21	reducing	reduce	VERB
aiua-10278	10	22	overtreatment	overtreatment	NOUN
aiua-10278	10	23	(	(	PUNCT
aiua-10278	10	24	8	8	NUM
aiua-10278	10	25	,	,	PUNCT
aiua-10278	10	26	11	11	NUM
aiua-10278	10	27	)	)	PUNCT
aiua-10278	10	28	.	.	PUNCT
aiua-10278	11	1	as	as	ADP
aiua-10278	11	2	a	a	DET
aiua-10278	11	3	result	result	NOUN
aiua-10278	11	4	,	,	PUNCT
aiua-10278	11	5	64	64	NUM
aiua-10278	11	6	%	%	NOUN
aiua-10278	11	7	of	of	ADP
aiua-10278	11	8	urologists	urologist	NOUN
aiua-10278	11	9	consider	consider	VERB
aiua-10278	11	10	mpmri	mpmri	PROPN
aiua-10278	11	11	useful	useful	ADJ
aiua-10278	11	12	to	to	PART
aiua-10278	11	13	detect	detect	VERB
aiua-10278	11	14	pca	pca	PROPN
aiua-10278	11	15	in	in	ADP
aiua-10278	11	16	biopsy	biopsy	NOUN
aiua-10278	11	17	-	-	PUNCT
aiua-10278	11	18	naïve	naïve	ADJ
aiua-10278	11	19	men	man	NOUN
aiua-10278	11	20	,	,	PUNCT
aiua-10278	11	21	while	while	SCONJ
aiua-10278	11	22	97	97	NUM
aiua-10278	11	23	%	%	NOUN
aiua-10278	11	24	consider	consider	VERB
aiua-10278	11	25	it	it	PRON
aiua-10278	11	26	valuable	valuable	ADJ
aiua-10278	11	27	in	in	ADP
aiua-10278	11	28	men	man	NOUN
aiua-10278	11	29	with	with	ADP
aiua-10278	11	30	a	a	DET
aiua-10278	11	31	prior	prior	ADJ
aiua-10278	11	32	negative	negative	ADJ
aiua-10278	11	33	biopsy	biopsy	NOUN
aiua-10278	11	34	(	(	PUNCT
aiua-10278	11	35	12	12	NUM
aiua-10278	11	36	)	)	PUNCT
aiua-10278	11	37	.	.	PUNCT
aiua-10278	12	1	however	however	ADV
aiua-10278	12	2	,	,	PUNCT
aiua-10278	12	3	the	the	DET
aiua-10278	12	4	systematic	systematic	ADJ
aiua-10278	12	5	use	use	NOUN
aiua-10278	12	6	of	of	ADP
aiua-10278	12	7	mpmri	mpmri	PROPN
aiua-10278	12	8	as	as	ADP
aiua-10278	12	9	a	a	DET
aiua-10278	12	10	triage	triage	NOUN
aiua-10278	12	11	test	test	NOUN
aiua-10278	12	12	in	in	ADP
aiua-10278	12	13	patients	patient	NOUN
aiua-10278	12	14	with	with	ADP
aiua-10278	12	15	suspicion	suspicion	NOUN
aiua-10278	12	16	of	of	ADP
aiua-10278	12	17	pca	pca	PROPN
aiua-10278	12	18	is	be	AUX
aiua-10278	12	19	still	still	ADV
aiua-10278	12	20	a	a	DET
aiua-10278	12	21	matter	matter	NOUN
aiua-10278	12	22	of	of	ADP
aiua-10278	12	23	debate	debate	NOUN
aiua-10278	12	24	(	(	PUNCT
aiua-10278	12	25	13	13	NUM
aiua-10278	12	26	,	,	PUNCT
aiua-10278	12	27	14	14	NUM
aiua-10278	12	28	)	)	PUNCT
aiua-10278	12	29	.	.	PUNCT
aiua-10278	13	1	moreover	moreover	ADV
aiua-10278	13	2	,	,	PUNCT
aiua-10278	13	3	mpmri	mpmri	PROPN
aiua-10278	13	4	cost	cost	NOUN
aiua-10278	13	5	is	be	AUX
aiua-10278	13	6	not	not	PART
aiua-10278	13	7	neglectable	neglectable	ADJ
aiua-10278	13	8	(	(	PUNCT
aiua-10278	13	9	8)	8)	NUM
aiua-10278	13	10	and	and	CCONJ
aiua-10278	13	11	may	may	AUX
aiua-10278	13	12	delay	delay	VERB
aiua-10278	13	13	pb	pb	PROPN
aiua-10278	13	14	.	.	PUNCT
aiua-10278	14	1	in	in	ADP
aiua-10278	14	2	order	order	NOUN
aiua-10278	14	3	to	to	PART
aiua-10278	14	4	avoid	avoid	VERB
aiua-10278	14	5	unnecessary	unnecessary	ADJ
aiua-10278	14	6	costs	cost	NOUN
aiua-10278	14	7	and	and	CCONJ
aiua-10278	14	8	minimize	minimize	VERB
aiua-10278	14	9	time	time	NOUN
aiua-10278	14	10	to	to	ADP
aiua-10278	14	11	diagnosis	diagnosis	VERB
aiua-10278	14	12	,	,	PUNCT
aiua-10278	14	13	it	it	PRON
aiua-10278	14	14	is	be	AUX
aiua-10278	14	15	necessary	necessary	ADJ
aiua-10278	14	16	to	to	PART
aiua-10278	14	17	establish	establish	VERB
aiua-10278	14	18	which	which	PRON
aiua-10278	14	19	patients	patient	NOUN
aiua-10278	14	20	benefit	benefit	VERB
aiua-10278	14	21	the	the	DET
aiua-10278	14	22	most	most	ADJ
aiua-10278	14	23	from	from	ADP
aiua-10278	14	24	doing	do	VERB
aiua-10278	14	25	mpmri	mpmri	PROPN
aiua-10278	14	26	prior	prior	ADV
aiua-10278	14	27	to	to	ADP
aiua-10278	14	28	trus	trus	NOUN
aiua-10278	14	29	-	-	PUNCT
aiua-10278	14	30	guided	guide	VERB
aiua-10278	14	31	pb	pb	ADP
aiua-10278	14	32	.	.	PUNCT
aiua-10278	15	1	we	we	PRON
aiua-10278	15	2	hypothesize	hypothesize	VERB
aiua-10278	15	3	that	that	SCONJ
aiua-10278	15	4	mpmri	mpmri	PROPN
aiua-10278	15	5	may	may	AUX
aiua-10278	15	6	not	not	PART
aiua-10278	15	7	add	add	VERB
aiua-10278	15	8	value	value	NOUN
aiua-10278	15	9	to	to	ADP
aiua-10278	15	10	the	the	DET
aiua-10278	15	11	detection	detection	NOUN
aiua-10278	15	12	of	of	ADP
aiua-10278	15	13	pca	pca	PROPN
aiua-10278	15	14	in	in	ADP
aiua-10278	15	15	patients	patient	NOUN
aiua-10278	15	16	with	with	ADP
aiua-10278	15	17	a	a	DET
aiua-10278	15	18	high	high	ADJ
aiua-10278	15	19	clinical	clinical	ADJ
aiua-10278	15	20	suspicion	suspicion	NOUN
aiua-10278	15	21	of	of	ADP
aiua-10278	15	22	cancer	cancer	NOUN
aiua-10278	15	23	and	and	CCONJ
aiua-10278	15	24	mpmri	mpmri	PROPN
aiua-10278	15	25	could	could	AUX
aiua-10278	15	26	be	be	AUX
aiua-10278	15	27	dispensable	dispensable	ADJ
aiua-10278	15	28	in	in	ADP
aiua-10278	15	29	this	this	DET
aiua-10278	15	30	group	group	NOUN
aiua-10278	15	31	of	of	ADP
aiua-10278	15	32	patients	patient	NOUN
aiua-10278	15	33	,	,	PUNCT
aiua-10278	15	34	saving	save	VERB
aiua-10278	15	35	costs	cost	NOUN
aiua-10278	15	36	and	and	CCONJ
aiua-10278	15	37	time	time	NOUN
aiua-10278	15	38	to	to	ADP
aiua-10278	15	39	diagnosis	diagnosis	NOUN
aiua-10278	15	40	.	.	PUNCT
aiua-10278	16	1	the	the	DET
aiua-10278	16	2	aim	aim	NOUN
aiua-10278	16	3	of	of	ADP
aiua-10278	16	4	this	this	DET
aiua-10278	16	5	study	study	NOUN
aiua-10278	16	6	is	be	AUX
aiua-10278	16	7	to	to	PART
aiua-10278	16	8	determine	determine	VERB
aiua-10278	16	9	if	if	SCONJ
aiua-10278	16	10	mpmri	mpmri	PROPN
aiua-10278	16	11	prior	prior	ADV
aiua-10278	16	12	to	to	ADP
aiua-10278	16	13	pb	pb	PROPN
aiua-10278	16	14	is	be	AUX
aiua-10278	16	15	still	still	ADV
aiua-10278	16	16	useful	useful	ADJ
aiua-10278	16	17	in	in	ADP
aiua-10278	16	18	predicting	predict	VERB
aiua-10278	16	19	pca	pca	NOUN
aiua-10278	16	20	and	and	CCONJ
aiua-10278	16	21	cspca	cspca	NOUN
aiua-10278	16	22	in	in	ADP
aiua-10278	16	23	patients	patient	NOUN
aiua-10278	16	24	with	with	ADP
aiua-10278	16	25	high	high	ADJ
aiua-10278	16	26	clinical	clinical	ADJ
aiua-10278	16	27	suspicion	suspicion	NOUN
aiua-10278	16	28	of	of	ADP
aiua-10278	16	29	cancer	cancer	NOUN
aiua-10278	16	30	,	,	PUNCT
aiua-10278	16	31	defined	define	VERB
aiua-10278	16	32	as	as	ADP
aiua-10278	16	33	psa	psa	NOUN
aiua-10278	16	34	>	>	X
aiua-10278	16	35	10	10	NUM
aiua-10278	16	36	ng	ng	PROPN
aiua-10278	16	37	/	/	SYM
aiua-10278	16	38	ml	ml	PROPN
aiua-10278	16	39	,	,	PUNCT
aiua-10278	16	40	psa	psa	NOUN
aiua-10278	16	41	-	-	PUNCT
aiua-10278	16	42	density	density	NOUN
aiua-10278	16	43	(	(	PUNCT
aiua-10278	16	44	psad	psad	PROPN
aiua-10278	16	45	)	)	PUNCT
aiua-10278	16	46	>	>	PUNCT
aiua-10278	16	47	0.15	0.15	NUM
aiua-10278	16	48	ng	ng	PROPN
aiua-10278	16	49	/	/	SYM
aiua-10278	16	50	ml	ml	NOUN
aiua-10278	16	51	/	/	SYM
aiua-10278	16	52	cc	cc	NOUN
aiua-10278	16	53	or	or	CCONJ
aiua-10278	16	54	suspicious	suspicious	ADJ
aiua-10278	16	55	digital	digital	ADJ
aiua-10278	16	56	rectal	rectal	ADJ
aiua-10278	16	57	examination	examination	NOUN
aiua-10278	16	58	(	(	PUNCT
aiua-10278	16	59	dre	dre	PROPN
aiua-10278	16	60	)	)	PUNCT
aiua-10278	16	61	.	.	PUNCT
aiua-10278	17	1	objectives	objective	NOUN
aiua-10278	17	2	:	:	PUNCT
aiua-10278	17	3	multiparametric	multiparametric	ADJ
aiua-10278	17	4	magnetic	magnetic	ADJ
aiua-10278	17	5	resonance	resonance	NOUN
aiua-10278	17	6	imaging	imaging	NOUN
aiua-10278	17	7	(	(	PUNCT
aiua-10278	17	8	mpmri	mpmri	PROPN
aiua-10278	17	9	)	)	PUNCT
aiua-10278	17	10	is	be	AUX
aiua-10278	17	11	a	a	DET
aiua-10278	17	12	useful	useful	ADJ
aiua-10278	17	13	tool	tool	NOUN
aiua-10278	17	14	to	to	PART
aiua-10278	17	15	diagnose	diagnose	VERB
aiua-10278	17	16	prostate	prostate	NOUN
aiua-10278	17	17	cancer	cancer	NOUN
aiua-10278	17	18	(	(	PUNCT
aiua-10278	17	19	pca	pca	PROPN
aiua-10278	17	20	)	)	PUNCT
aiua-10278	17	21	but	but	CCONJ
aiua-10278	17	22	its	its	PRON
aiua-10278	17	23	cost	cost	NOUN
aiua-10278	17	24	is	be	AUX
aiua-10278	17	25	not	not	PART
aiua-10278	17	26	negligible	negligible	ADJ
aiua-10278	17	27	.	.	PUNCT
aiua-10278	18	1	in	in	ADP
aiua-10278	18	2	order	order	NOUN
aiua-10278	18	3	to	to	PART
aiua-10278	18	4	reduce	reduce	VERB
aiua-10278	18	5	costs	cost	NOUN
aiua-10278	18	6	and	and	CCONJ
aiua-10278	18	7	minimize	minimize	VERB
aiua-10278	18	8	time	time	NOUN
aiua-10278	18	9	to	to	ADP
aiua-10278	18	10	diagnosis	diagnosis	VERB
aiua-10278	18	11	,	,	PUNCT
aiua-10278	18	12	it	it	PRON
aiua-10278	18	13	is	be	AUX
aiua-10278	18	14	necessary	necessary	ADJ
aiua-10278	18	15	to	to	PART
aiua-10278	18	16	establish	establish	VERB
aiua-10278	18	17	which	which	PRON
aiua-10278	18	18	patients	patient	NOUN
aiua-10278	18	19	benefit	benefit	VERB
aiua-10278	18	20	the	the	DET
aiua-10278	18	21	most	most	ADJ
aiua-10278	18	22	from	from	ADP
aiua-10278	18	23	doing	do	VERB
aiua-10278	18	24	mpmri	mpmri	PROPN
aiua-10278	18	25	prior	prior	ADV
aiua-10278	18	26	to	to	ADP
aiua-10278	18	27	prostate	prostate	NOUN
aiua-10278	18	28	biopsy	biopsy	NOUN
aiua-10278	18	29	(	(	PUNCT
aiua-10278	18	30	pb	pb	PROPN
aiua-10278	18	31	)	)	PUNCT
aiua-10278	18	32	.	.	PUNCT
aiua-10278	19	1	our	our	PRON
aiua-10278	19	2	aim	aim	NOUN
aiua-10278	19	3	was	be	AUX
aiua-10278	19	4	to	to	PART
aiua-10278	19	5	test	test	VERB
aiua-10278	19	6	if	if	SCONJ
aiua-10278	19	7	mpmri	mpmri	PROPN
aiua-10278	19	8	still	still	ADV
aiua-10278	19	9	predicts	predict	VERB
aiua-10278	19	10	pca	pca	PROPN
aiua-10278	19	11	and	and	CCONJ
aiua-10278	19	12	clinically	clinically	ADV
aiua-10278	19	13	significant	significant	ADJ
aiua-10278	19	14	pca	pca	NOUN
aiua-10278	19	15	(	(	PUNCT
aiua-10278	19	16	cspca	cspca	PROPN
aiua-10278	19	17	)	)	PUNCT
aiua-10278	19	18	in	in	ADP
aiua-10278	19	19	patients	patient	NOUN
aiua-10278	19	20	with	with	ADP
aiua-10278	19	21	high	high	ADJ
aiua-10278	19	22	clinical	clinical	ADJ
aiua-10278	19	23	suspicion	suspicion	NOUN
aiua-10278	19	24	of	of	ADP
aiua-10278	19	25	cancer	cancer	NOUN
aiua-10278	19	26	,	,	PUNCT
aiua-10278	19	27	defined	define	VERB
aiua-10278	19	28	as	as	ADP
aiua-10278	19	29	prostate	prostate	NOUN
aiua-10278	19	30	specific	specific	ADJ
aiua-10278	19	31	antigen	antigen	NOUN
aiua-10278	19	32	(	(	PUNCT
aiua-10278	19	33	psa	psa	NOUN
aiua-10278	19	34	)	)	PUNCT
aiua-10278	19	35	>	>	X
aiua-10278	20	1	10	10	NUM
aiua-10278	20	2	ng	ng	PROPN
aiua-10278	20	3	/	/	SYM
aiua-10278	20	4	ml	ml	PROPN
aiua-10278	20	5	,	,	PUNCT
aiua-10278	20	6	psa	psa	NOUN
aiua-10278	20	7	-	-	PUNCT
aiua-10278	20	8	density	density	NOUN
aiua-10278	20	9	(	(	PUNCT
aiua-10278	20	10	psad	psad	PROPN
aiua-10278	20	11	)	)	PUNCT
aiua-10278	20	12	>	>	PUNCT
aiua-10278	20	13	0.15	0.15	NUM
aiua-10278	20	14	ng	ng	PROPN
aiua-10278	20	15	/	/	SYM
aiua-10278	20	16	ml	ml	NOUN
aiua-10278	20	17	/	/	SYM
aiua-10278	20	18	cc	cc	NOUN
aiua-10278	20	19	or	or	CCONJ
aiua-10278	20	20	suspicious	suspicious	ADJ
aiua-10278	20	21	digital	digital	ADJ
aiua-10278	20	22	rectal	rectal	ADJ
aiua-10278	20	23	examination	examination	NOUN
aiua-10278	20	24	(	(	PUNCT
aiua-10278	20	25	dre	dre	PROPN
aiua-10278	20	26	)	)	PUNCT
aiua-10278	20	27	.	.	PUNCT
aiua-10278	21	1	materials	material	NOUN
aiua-10278	21	2	and	and	CCONJ
aiua-10278	21	3	methods	method	NOUN
aiua-10278	21	4	:	:	PUNCT
aiua-10278	21	5	we	we	PRON
aiua-10278	21	6	retrospectively	retrospectively	ADV
aiua-10278	21	7	collected	collect	VERB
aiua-10278	21	8	data	datum	NOUN
aiua-10278	21	9	on	on	ADP
aiua-10278	21	10	206	206	NUM
aiua-10278	21	11	patients	patient	NOUN
aiua-10278	21	12	who	who	PRON
aiua-10278	21	13	underwent	undergo	VERB
aiua-10278	21	14	mpmri	mpmri	PROPN
aiua-10278	21	15	before	before	ADP
aiua-10278	21	16	pb	pb	X
aiua-10278	21	17	at	at	ADP
aiua-10278	21	18	our	our	PRON
aiua-10278	21	19	department	department	NOUN
aiua-10278	21	20	from	from	ADP
aiua-10278	21	21	january	january	PROPN
aiua-10278	21	22	2017	2017	NUM
aiua-10278	21	23	to	to	ADP
aiua-10278	21	24	july	july	PROPN
aiua-10278	21	25	2018	2018	NUM
aiua-10278	21	26	.	.	PUNCT
aiua-10278	22	1	mpmri	mpmri	PROPN
aiua-10278	22	2	results	result	NOUN
aiua-10278	22	3	were	be	AUX
aiua-10278	22	4	classified	classify	VERB
aiua-10278	22	5	using	use	VERB
aiua-10278	22	6	prostate	prostate	NOUN
aiua-10278	22	7	imaging	imaging	NOUN
aiua-10278	22	8	reporting	reporting	NOUN
aiua-10278	22	9	and	and	CCONJ
aiua-10278	22	10	data	datum	NOUN
aiua-10278	22	11	system	system	NOUN
aiua-10278	22	12	(	(	PUNCT
aiua-10278	22	13	pi	pi	NOUN
aiua-10278	22	14	-	-	PUNCT
aiua-10278	22	15	rads	rad	NOUN
aiua-10278	22	16	)	)	PUNCT
aiua-10278	22	17	version	version	NOUN
aiua-10278	22	18	2	2	NUM
aiua-10278	22	19	.	.	PUNCT
aiua-10278	23	1	in	in	ADP
aiua-10278	23	2	primary	primary	ADJ
aiua-10278	23	3	analysis	analysis	NOUN
aiua-10278	23	4	,	,	PUNCT
aiua-10278	23	5	we	we	PRON
aiua-10278	23	6	evaluated	evaluate	VERB
aiua-10278	23	7	the	the	DET
aiua-10278	23	8	association	association	NOUN
aiua-10278	23	9	of	of	ADP
aiua-10278	23	10	mpmri	mpmri	PROPN
aiua-10278	23	11	with	with	ADP
aiua-10278	23	12	pca	pca	PROPN
aiua-10278	23	13	and	and	CCONJ
aiua-10278	23	14	cspca	cspca	PROPN
aiua-10278	23	15	and	and	CCONJ
aiua-10278	23	16	stratified	stratify	VERB
aiua-10278	23	17	this	this	DET
aiua-10278	23	18	model	model	NOUN
aiua-10278	23	19	for	for	ADP
aiua-10278	23	20	low	low	ADJ
aiua-10278	23	21	and	and	CCONJ
aiua-10278	23	22	high	high	ADJ
aiua-10278	23	23	clinical	clinical	ADJ
aiua-10278	23	24	suspicion	suspicion	NOUN
aiua-10278	23	25	of	of	ADP
aiua-10278	23	26	cancer	cancer	NOUN
aiua-10278	23	27	.	.	PUNCT
aiua-10278	24	1	in	in	ADP
aiua-10278	24	2	secondary	secondary	ADJ
aiua-10278	24	3	analysis	analysis	NOUN
aiua-10278	24	4	,	,	PUNCT
aiua-10278	24	5	we	we	PRON
aiua-10278	24	6	determined	determine	VERB
aiua-10278	24	7	the	the	DET
aiua-10278	24	8	rate	rate	NOUN
aiua-10278	24	9	of	of	ADP
aiua-10278	24	10	negative	negative	ADJ
aiua-10278	24	11	pb	pb	ADP
aiua-10278	24	12	results	result	NOUN
aiua-10278	24	13	in	in	ADP
aiua-10278	24	14	patients	patient	NOUN
aiua-10278	24	15	with	with	ADP
aiua-10278	24	16	high	high	ADJ
aiua-10278	24	17	suspicion	suspicion	NOUN
aiua-10278	24	18	of	of	ADP
aiua-10278	24	19	cancer	cancer	NOUN
aiua-10278	24	20	and	and	CCONJ
aiua-10278	24	21	compared	compare	VERB
aiua-10278	24	22	theses	theses	PROPN
aiua-10278	24	23	rates	rate	NOUN
aiua-10278	24	24	with	with	ADP
aiua-10278	24	25	those	those	PRON
aiua-10278	24	26	obtained	obtain	VERB
aiua-10278	24	27	if	if	SCONJ
aiua-10278	24	28	only	only	ADV
aiua-10278	24	29	those	those	PRON
aiua-10278	24	30	with	with	ADP
aiua-10278	24	31	pi	pi	NOUN
aiua-10278	24	32	-	-	PUNCT
aiua-10278	24	33	rads	rad	NOUN
aiua-10278	24	34	3	3	NUM
aiua-10278	24	35	-	-	SYM
aiua-10278	24	36	5	5	NUM
aiua-10278	24	37	would	would	AUX
aiua-10278	24	38	be	be	AUX
aiua-10278	24	39	biopsied	biopsie	VERB
aiua-10278	24	40	.	.	PUNCT
aiua-10278	25	1	results	result	NOUN
aiua-10278	25	2	:	:	PUNCT
aiua-10278	25	3	in	in	ADP
aiua-10278	25	4	primary	primary	ADJ
aiua-10278	25	5	analysis	analysis	NOUN
aiua-10278	25	6	and	and	CCONJ
aiua-10278	25	7	overall	overall	ADV
aiua-10278	25	8	,	,	PUNCT
aiua-10278	25	9	mpmri	mpmri	PROPN
aiua-10278	25	10	was	be	AUX
aiua-10278	25	11	predictive	predictive	ADJ
aiua-10278	25	12	of	of	ADP
aiua-10278	25	13	pca	pca	NOUN
aiua-10278	25	14	and	and	CCONJ
aiua-10278	25	15	cspca	cspca	NOUN
aiua-10278	25	16	.	.	PUNCT
aiua-10278	26	1	in	in	ADP
aiua-10278	26	2	stratified	stratified	ADJ
aiua-10278	26	3	analysis	analysis	NOUN
aiua-10278	26	4	,	,	PUNCT
aiua-10278	26	5	mpmri	mpmri	PROPN
aiua-10278	26	6	was	be	AUX
aiua-10278	26	7	still	still	ADV
aiua-10278	26	8	significantly	significantly	ADV
aiua-10278	26	9	associated	associate	VERB
aiua-10278	26	10	with	with	ADP
aiua-10278	26	11	cspca	cspca	NOUN
aiua-10278	26	12	in	in	ADP
aiua-10278	26	13	patients	patient	NOUN
aiua-10278	26	14	with	with	ADP
aiua-10278	26	15	psa	psa	PROPN
aiua-10278	26	16	>	>	X
aiua-10278	26	17	10	10	NUM
aiua-10278	26	18	ng	ng	PROPN
aiua-10278	26	19	/	/	SYM
aiua-10278	26	20	ml	ml	PROPN
aiua-10278	26	21	and	and	CCONJ
aiua-10278	26	22	psad	psad	VERB
aiua-10278	26	23	>	>	X
aiua-10278	26	24	0.15	0.15	NUM
aiua-10278	26	25	ng	ng	PROPN
aiua-10278	26	26	/	/	SYM
aiua-10278	26	27	ml	ml	PROPN
aiua-10278	26	28	/	/	SYM
aiua-10278	26	29	cc	cc	NOUN
aiua-10278	26	30	,	,	PUNCT
aiua-10278	26	31	but	but	CCONJ
aiua-10278	26	32	not	not	PART
aiua-10278	26	33	in	in	ADP
aiua-10278	26	34	those	those	PRON
aiua-10278	26	35	with	with	ADP
aiua-10278	26	36	suspicious	suspicious	ADJ
aiua-10278	26	37	dre	dre	NOUN
aiua-10278	26	38	.	.	PUNCT
aiua-10278	27	1	in	in	ADP
aiua-10278	27	2	secondary	secondary	ADJ
aiua-10278	27	3	analysis	analysis	NOUN
aiua-10278	27	4	,	,	PUNCT
aiua-10278	27	5	negative	negative	ADJ
aiua-10278	27	6	result	result	NOUN
aiua-10278	27	7	rates	rate	NOUN
aiua-10278	27	8	were	be	AUX
aiua-10278	27	9	lower	low	ADJ
aiua-10278	27	10	if	if	SCONJ
aiua-10278	27	11	only	only	ADV
aiua-10278	27	12	patients	patient	NOUN
aiua-10278	27	13	with	with	ADP
aiua-10278	27	14	pi	pi	NOUN
aiua-10278	27	15	-	-	PUNCT
aiua-10278	27	16	rads	rad	NOUN
aiua-10278	27	17	3	3	NUM
aiua-10278	27	18	-	-	SYM
aiua-10278	27	19	5	5	NUM
aiua-10278	27	20	were	be	AUX
aiua-10278	27	21	biopsied	biopsie	VERB
aiua-10278	27	22	,	,	PUNCT
aiua-10278	27	23	even	even	ADV
aiua-10278	27	24	in	in	ADP
aiua-10278	27	25	subgroups	subgroup	NOUN
aiua-10278	27	26	with	with	ADP
aiua-10278	27	27	high	high	ADJ
aiua-10278	27	28	suspicion	suspicion	NOUN
aiua-10278	27	29	of	of	ADP
aiua-10278	27	30	cancer	cancer	NOUN
aiua-10278	27	31	based	base	VERB
aiua-10278	27	32	on	on	ADP
aiua-10278	27	33	psa	psa	NOUN
aiua-10278	27	34	and	and	CCONJ
aiua-10278	27	35	psad	psad	VERB
aiua-10278	27	36	.	.	PUNCT
aiua-10278	28	1	in	in	ADP
aiua-10278	28	2	patients	patient	NOUN
aiua-10278	28	3	with	with	ADP
aiua-10278	28	4	suspicious	suspicious	ADJ
aiua-10278	28	5	dre	dre	NOUN
aiua-10278	28	6	,	,	PUNCT
aiua-10278	28	7	however	however	ADV
aiua-10278	28	8	,	,	PUNCT
aiua-10278	28	9	the	the	DET
aiua-10278	28	10	rate	rate	NOUN
aiua-10278	28	11	of	of	ADP
aiua-10278	28	12	negative	negative	ADJ
aiua-10278	28	13	results	result	NOUN
aiua-10278	28	14	did	do	AUX
aiua-10278	28	15	not	not	PART
aiua-10278	28	16	change	change	VERB
aiua-10278	28	17	significantly	significantly	ADV
aiua-10278	28	18	if	if	SCONJ
aiua-10278	28	19	only	only	ADV
aiua-10278	28	20	patients	patient	NOUN
aiua-10278	28	21	with	with	ADP
aiua-10278	28	22	pi	pi	NOUN
aiua-10278	28	23	-	-	PUNCT
aiua-10278	28	24	rads	rad	NOUN
aiua-10278	28	25	3	3	NUM
aiua-10278	28	26	-	-	SYM
aiua-10278	28	27	5	5	NUM
aiua-10278	28	28	were	be	AUX
aiua-10278	28	29	biopsied	biopsie	VERB
aiua-10278	28	30	.	.	PUNCT
aiua-10278	29	1	conclusions	conclusion	NOUN
aiua-10278	29	2	:	:	PUNCT
aiua-10278	30	1	mpmri	mpmri	PROPN
aiua-10278	30	2	is	be	AUX
aiua-10278	30	3	still	still	ADV
aiua-10278	30	4	useful	useful	ADJ
aiua-10278	30	5	in	in	ADP
aiua-10278	30	6	predicting	predict	VERB
aiua-10278	30	7	cspca	cspca	NOUN
aiua-10278	30	8	in	in	ADP
aiua-10278	30	9	patients	patient	NOUN
aiua-10278	30	10	with	with	ADP
aiua-10278	30	11	psa	psa	PROPN
aiua-10278	30	12	>	>	X
aiua-10278	30	13	10	10	NUM
aiua-10278	30	14	ng	ng	PROPN
aiua-10278	30	15	/	/	SYM
aiua-10278	30	16	ml	ml	PROPN
aiua-10278	30	17	and	and	CCONJ
aiua-10278	30	18	psad	psad	VERB
aiua-10278	30	19	>	>	X
aiua-10278	30	20	0.15	0.15	NUM
aiua-10278	30	21	ng	ng	PROPN
aiua-10278	30	22	/	/	SYM
aiua-10278	30	23	ml	ml	PROPN
aiua-10278	30	24	/	/	SYM
aiua-10278	30	25	cc	cc	NOUN
aiua-10278	30	26	.	.	NOUN
aiua-10278	31	1	if	if	SCONJ
aiua-10278	31	2	dre	dre	PROPN
aiua-10278	31	3	is	be	AUX
aiua-10278	31	4	suspicious	suspicious	ADJ
aiua-10278	31	5	,	,	PUNCT
aiua-10278	31	6	though	though	ADV
aiua-10278	31	7	,	,	PUNCT
aiua-10278	31	8	mpmri	mpmri	PROPN
aiua-10278	31	9	might	might	AUX
aiua-10278	31	10	be	be	AUX
aiua-10278	31	11	no	no	ADV
aiua-10278	31	12	longer	long	ADV
aiua-10278	31	13	useful	useful	ADJ
aiua-10278	31	14	in	in	ADP
aiua-10278	31	15	the	the	DET
aiua-10278	31	16	prediction	prediction	NOUN
aiua-10278	31	17	of	of	ADP
aiua-10278	31	18	pca	pca	PROPN
aiua-10278	31	19	.	.	PUNCT
aiua-10278	32	1	key	key	ADJ
aiua-10278	32	2	words	word	NOUN
aiua-10278	32	3	:	:	PUNCT
aiua-10278	32	4	prostate	prostate	NOUN
aiua-10278	32	5	cancer	cancer	NOUN
aiua-10278	32	6	;	;	PUNCT
aiua-10278	32	7	psa	psa	VERB
aiua-10278	32	8	;	;	PUNCT
aiua-10278	32	9	psa	psa	VERB
aiua-10278	32	10	density	density	NOUN
aiua-10278	32	11	;	;	PUNCT
aiua-10278	32	12	digital	digital	ADJ
aiua-10278	32	13	rectal	rectal	ADJ
aiua-10278	32	14	examination	examination	NOUN
aiua-10278	32	15	;	;	PUNCT
aiua-10278	32	16	mpmri	mpmri	PROPN
aiua-10278	32	17	;	;	PUNCT
aiua-10278	32	18	pi	pi	NOUN
aiua-10278	32	19	-	-	PUNCT
aiua-10278	32	20	rads	rad	NOUN
aiua-10278	32	21	.	.	PUNCT
aiua-10278	32	22	submitted	submit	VERB
aiua-10278	32	23	17	17	NUM
aiua-10278	32	24	february	february	NOUN
aiua-10278	32	25	2022	2022	NUM
aiua-10278	32	26	;	;	PUNCT
aiua-10278	32	27	accepted	accept	VERB
aiua-10278	32	28	21	21	NUM
aiua-10278	32	29	february	february	PROPN
aiua-10278	32	30	2022	2022	NUM
aiua-10278	32	31	introduction	introduction	NOUN
aiua-10278	32	32	prostate	prostate	NOUN
aiua-10278	32	33	cancer	cancer	NOUN
aiua-10278	32	34	(	(	PUNCT
aiua-10278	32	35	pca	pca	PROPN
aiua-10278	32	36	)	)	PUNCT
aiua-10278	32	37	is	be	AUX
aiua-10278	32	38	the	the	DET
aiua-10278	32	39	second	second	ADJ
aiua-10278	32	40	most	most	ADV
aiua-10278	32	41	common	common	ADJ
aiua-10278	32	42	cancer	cancer	NOUN
aiua-10278	32	43	among	among	ADP
aiua-10278	32	44	men	man	NOUN
aiua-10278	32	45	worldwide	worldwide	ADV
aiua-10278	32	46	(	(	PUNCT
aiua-10278	32	47	1	1	NUM
aiua-10278	32	48	)	)	PUNCT
aiua-10278	32	49	.	.	PUNCT
aiua-10278	33	1	serum	serum	NOUN
aiua-10278	33	2	prostate	prostate	NOUN
aiua-10278	33	3	specific	specific	ADJ
aiua-10278	33	4	antigen	antigen	NOUN
aiua-10278	33	5	do	do	AUX
aiua-10278	33	6	all	all	DET
aiua-10278	33	7	patients	patient	NOUN
aiua-10278	33	8	with	with	ADP
aiua-10278	33	9	suspicious	suspicious	ADJ
aiua-10278	33	10	prostate	prostate	NOUN
aiua-10278	33	11	cancer	cancer	NOUN
aiua-10278	33	12	need	need	VERB
aiua-10278	33	13	multiparametric	multiparametric	ADJ
aiua-10278	33	14	magnetic	magnetic	ADJ
aiua-10278	33	15	resonance	resonance	NOUN
aiua-10278	33	16	imaging	imaging	NOUN
aiua-10278	33	17	before	before	ADP
aiua-10278	33	18	prostate	prostate	NOUN
aiua-10278	33	19	biopsy	biopsy	NOUN
aiua-10278	33	20	?	?	PUNCT
aiua-10278	34	1	sara	sara	PROPN
aiua-10278	34	2	teixeira	teixeira	PROPN
aiua-10278	34	3	anacleto	anacleto	PROPN
aiua-10278	34	4	1	1	NUM
aiua-10278	34	5	,	,	PUNCT
aiua-10278	34	6	joana	joana	PROPN
aiua-10278	34	7	neves	neves	PROPN
aiua-10278	34	8	alberto	alberto	PROPN
aiua-10278	34	9	2	2	NUM
aiua-10278	34	10	,	,	PUNCT
aiua-10278	34	11	emanuel	emanuel	PROPN
aiua-10278	34	12	carvalho	carvalho	PROPN
aiua-10278	34	13	dias	dias	PROPN
aiua-10278	34	14	1	1	NUM
aiua-10278	34	15	,	,	PUNCT
aiua-10278	34	16	2	2	NUM
aiua-10278	34	17	,	,	PUNCT
aiua-10278	34	18	pedro	pedro	PROPN
aiua-10278	34	19	sousa	sousa	PROPN
aiua-10278	34	20	passos	passos	PROPN
aiua-10278	34	21	3	3	NUM
aiua-10278	34	22	,	,	PUNCT
aiua-10278	34	23	mário	mário	PROPN
aiua-10278	34	24	cerqueira	cerqueira	PROPN
aiua-10278	34	25	alves	alves	PROPN
aiua-10278	34	26	2	2	NUM
aiua-10278	34	27	1	1	NUM
aiua-10278	34	28	department	department	NOUN
aiua-10278	34	29	of	of	ADP
aiua-10278	34	30	urology	urology	NOUN
aiua-10278	34	31	hospital	hospital	NOUN
aiua-10278	34	32	of	of	ADP
aiua-10278	34	33	braga	braga	NOUN
aiua-10278	34	34	,	,	PUNCT
aiua-10278	34	35	braga	braga	NOUN
aiua-10278	34	36	,	,	PUNCT
aiua-10278	34	37	portugal	portugal	PROPN
aiua-10278	34	38	;	;	PUNCT
aiua-10278	34	39	2	2	NUM
aiua-10278	34	40	life	life	NOUN
aiua-10278	34	41	and	and	CCONJ
aiua-10278	34	42	health	health	NOUN
aiua-10278	34	43	sciences	sciences	PROPN
aiua-10278	34	44	research	research	PROPN
aiua-10278	34	45	institute	institute	PROPN
aiua-10278	34	46	(	(	PUNCT
aiua-10278	34	47	icvs	icvs	NOUN
aiua-10278	34	48	)	)	PUNCT
aiua-10278	34	49	,	,	PUNCT
aiua-10278	34	50	school	school	NOUN
aiua-10278	34	51	of	of	ADP
aiua-10278	34	52	medicine	medicine	NOUN
aiua-10278	34	53	,	,	PUNCT
aiua-10278	34	54	university	university	NOUN
aiua-10278	34	55	of	of	ADP
aiua-10278	34	56	minho	minho	PROPN
aiua-10278	34	57	,	,	PUNCT
aiua-10278	34	58	4710	4710	NUM
aiua-10278	34	59	-	-	SYM
aiua-10278	34	60	057	057	NUM
aiua-10278	34	61	,	,	PUNCT
aiua-10278	34	62	braga	braga	NOUN
aiua-10278	34	63	,	,	PUNCT
aiua-10278	34	64	portugal	portugal	PROPN
aiua-10278	34	65	;	;	PUNCT
aiua-10278	34	66	3	3	NUM
aiua-10278	34	67	department	department	NOUN
aiua-10278	34	68	of	of	ADP
aiua-10278	34	69	urology	urology	NOUN
aiua-10278	34	70	hospital	hospital	NOUN
aiua-10278	34	71	da	da	PROPN
aiua-10278	34	72	senhora	senhora	PROPN
aiua-10278	34	73	da	da	PROPN
aiua-10278	34	74	oliveira	oliveira	PROPN
aiua-10278	34	75	,	,	PUNCT
aiua-10278	34	76	guimarães	guimarães	PROPN
aiua-10278	34	77	,	,	PUNCT
aiua-10278	34	78	portugal	portugal	PROPN
aiua-10278	34	79	.	.	PUNCT
aiua-10278	35	1	doi	doi	PROPN
aiua-10278	35	2	:	:	PUNCT
aiua-10278	35	3	10.4081	10.4081	NUM
aiua-10278	35	4	/	/	SYM
aiua-10278	35	5	aiua.2022.1.32	aiua.2022.1.32	NOUN
aiua-10278	35	6	summary	summary	NOUN
aiua-10278	35	7	33archivio	33archivio	NUM
aiua-10278	35	8	italiano	italiano	PROPN
aiua-10278	35	9	di	di	X
aiua-10278	35	10	urologia	urologia	PROPN
aiua-10278	35	11	e	e	PROPN
aiua-10278	35	12	andrologia	andrologia	PROPN
aiua-10278	35	13	2022	2022	NUM
aiua-10278	35	14	;	;	PUNCT
aiua-10278	35	15	94	94	NUM
aiua-10278	35	16	,	,	PUNCT
aiua-10278	35	17	1	1	NUM
aiua-10278	35	18	is	be	AUX
aiua-10278	35	19	magnetic	magnetic	ADJ
aiua-10278	35	20	resonance	resonance	NOUN
aiua-10278	35	21	imaging	imaging	NOUN
aiua-10278	35	22	always	always	ADV
aiua-10278	35	23	needed	need	VERB
aiua-10278	35	24	?	?	PUNCT
aiua-10278	36	1	materials	material	NOUN
aiua-10278	36	2	and	and	CCONJ
aiua-10278	36	3	methods	method	NOUN
aiua-10278	36	4	patients	patient	NOUN
aiua-10278	36	5	demographics	demographic	NOUN
aiua-10278	36	6	and	and	CCONJ
aiua-10278	36	7	variables	variable	NOUN
aiua-10278	36	8	this	this	DET
aiua-10278	36	9	study	study	NOUN
aiua-10278	36	10	was	be	AUX
aiua-10278	36	11	performed	perform	VERB
aiua-10278	36	12	in	in	ADP
aiua-10278	36	13	accordance	accordance	NOUN
aiua-10278	36	14	with	with	ADP
aiua-10278	36	15	the	the	DET
aiua-10278	36	16	declaration	declaration	NOUN
aiua-10278	36	17	of	of	ADP
aiua-10278	36	18	helsinki	helsinki	PROPN
aiua-10278	36	19	and	and	CCONJ
aiua-10278	36	20	was	be	AUX
aiua-10278	36	21	approved	approve	VERB
aiua-10278	36	22	by	by	ADP
aiua-10278	36	23	the	the	DET
aiua-10278	36	24	ethics	ethic	NOUN
aiua-10278	36	25	committee	committee	PROPN
aiua-10278	36	26	of	of	ADP
aiua-10278	36	27	hospital	hospital	PROPN
aiua-10278	36	28	de	de	PROPN
aiua-10278	36	29	braga	braga	NOUN
aiua-10278	36	30	.	.	PUNCT
aiua-10278	37	1	we	we	PRON
aiua-10278	37	2	retrospectively	retrospectively	ADV
aiua-10278	37	3	collected	collect	VERB
aiua-10278	37	4	data	datum	NOUN
aiua-10278	37	5	on	on	ADP
aiua-10278	37	6	594	594	NUM
aiua-10278	37	7	patients	patient	NOUN
aiua-10278	37	8	who	who	PRON
aiua-10278	37	9	underwent	undergo	VERB
aiua-10278	37	10	trus	trus	NOUN
aiua-10278	37	11	-	-	PUNCT
aiua-10278	37	12	guided	guide	VERB
aiua-10278	37	13	pb	pb	ADP
aiua-10278	37	14	at	at	ADP
aiua-10278	37	15	the	the	DET
aiua-10278	37	16	urology	urology	NOUN
aiua-10278	37	17	department	department	PROPN
aiua-10278	37	18	of	of	ADP
aiua-10278	37	19	hospital	hospital	NOUN
aiua-10278	37	20	de	de	PROPN
aiua-10278	37	21	braga	braga	NOUN
aiua-10278	37	22	from	from	ADP
aiua-10278	37	23	january	january	PROPN
aiua-10278	37	24	2017	2017	NUM
aiua-10278	37	25	to	to	ADP
aiua-10278	37	26	july	july	PROPN
aiua-10278	37	27	2018	2018	NUM
aiua-10278	37	28	.	.	PUNCT
aiua-10278	38	1	206	206	NUM
aiua-10278	38	2	patients	patient	NOUN
aiua-10278	38	3	who	who	PRON
aiua-10278	38	4	underwent	undergo	VERB
aiua-10278	38	5	mpmri	mpmri	PROPN
aiua-10278	38	6	before	before	ADP
aiua-10278	38	7	pb	pb	ADP
aiua-10278	38	8	were	be	AUX
aiua-10278	38	9	included	include	VERB
aiua-10278	38	10	in	in	ADP
aiua-10278	38	11	our	our	PRON
aiua-10278	38	12	study	study	NOUN
aiua-10278	38	13	.	.	PUNCT
aiua-10278	39	1	for	for	ADP
aiua-10278	39	2	patients	patient	NOUN
aiua-10278	39	3	who	who	PRON
aiua-10278	39	4	underwent	undergo	VERB
aiua-10278	39	5	repeated	repeat	VERB
aiua-10278	39	6	pb	pb	ADP
aiua-10278	39	7	during	during	ADP
aiua-10278	39	8	this	this	DET
aiua-10278	39	9	period	period	NOUN
aiua-10278	39	10	,	,	PUNCT
aiua-10278	39	11	the	the	DET
aiua-10278	39	12	last	last	ADJ
aiua-10278	39	13	biopsy	biopsy	NOUN
aiua-10278	39	14	was	be	AUX
aiua-10278	39	15	taken	take	VERB
aiua-10278	39	16	as	as	ADP
aiua-10278	39	17	reference	reference	NOUN
aiua-10278	39	18	.	.	PUNCT
aiua-10278	40	1	data	datum	NOUN
aiua-10278	40	2	on	on	ADP
aiua-10278	40	3	age	age	NOUN
aiua-10278	40	4	,	,	PUNCT
aiua-10278	40	5	previous	previous	ADJ
aiua-10278	40	6	biopsies	biopsy	NOUN
aiua-10278	40	7	,	,	PUNCT
aiua-10278	40	8	dre	dre	PROPN
aiua-10278	40	9	,	,	PUNCT
aiua-10278	40	10	psa	psa	NOUN
aiua-10278	40	11	,	,	PUNCT
aiua-10278	40	12	prostate	prostate	NOUN
aiua-10278	40	13	volume	volume	NOUN
aiua-10278	40	14	(	(	PUNCT
aiua-10278	40	15	assessed	assess	VERB
aiua-10278	40	16	by	by	ADP
aiua-10278	40	17	trus	trus	PROPN
aiua-10278	40	18	)	)	PUNCT
aiua-10278	40	19	,	,	PUNCT
aiua-10278	40	20	psad	psad	ADJ
aiua-10278	40	21	,	,	PUNCT
aiua-10278	40	22	pi	pi	NOUN
aiua-10278	40	23	-	-	PUNCT
aiua-10278	40	24	rads	rad	NOUN
aiua-10278	40	25	and	and	CCONJ
aiua-10278	40	26	pb	pb	ADP
aiua-10278	40	27	histological	histological	ADJ
aiua-10278	40	28	results	result	NOUN
aiua-10278	40	29	were	be	AUX
aiua-10278	40	30	recorded	record	VERB
aiua-10278	40	31	.	.	PUNCT
aiua-10278	41	1	psad	psad	PROPN
aiua-10278	41	2	was	be	AUX
aiua-10278	41	3	determined	determine	VERB
aiua-10278	41	4	only	only	ADV
aiua-10278	41	5	in	in	ADP
aiua-10278	41	6	patients	patient	NOUN
aiua-10278	41	7	who	who	PRON
aiua-10278	41	8	underwent	undergo	VERB
aiua-10278	41	9	trus	trus	NOUN
aiua-10278	41	10	before	before	ADP
aiua-10278	41	11	biopsy	biopsy	NOUN
aiua-10278	41	12	(	(	PUNCT
aiua-10278	41	13	psad	psad	ADJ
aiua-10278	41	14	=	=	VERB
aiua-10278	41	15	psa	psa	NOUN
aiua-10278	41	16	/	/	SYM
aiua-10278	41	17	prostate	prostate	NOUN
aiua-10278	41	18	volume	volume	NOUN
aiua-10278	41	19	)	)	PUNCT
aiua-10278	41	20	.	.	PUNCT
aiua-10278	42	1	dre	dre	PROPN
aiua-10278	42	2	was	be	AUX
aiua-10278	42	3	described	describe	VERB
aiua-10278	42	4	as	as	ADP
aiua-10278	42	5	unequivocal	unequivocal	ADJ
aiua-10278	42	6	(	(	PUNCT
aiua-10278	42	7	normal	normal	ADJ
aiua-10278	42	8	and	and	CCONJ
aiua-10278	42	9	abnormal	abnormal	ADJ
aiua-10278	42	10	)	)	PUNCT
aiua-10278	42	11	or	or	CCONJ
aiua-10278	42	12	doubtful	doubtful	ADJ
aiua-10278	42	13	(	(	PUNCT
aiua-10278	42	14	if	if	SCONJ
aiua-10278	42	15	no	no	DET
aiua-10278	42	16	definitive	definitive	ADJ
aiua-10278	42	17	conclusions	conclusion	NOUN
aiua-10278	42	18	could	could	AUX
aiua-10278	42	19	be	be	AUX
aiua-10278	42	20	made	make	VERB
aiua-10278	42	21	)	)	PUNCT
aiua-10278	42	22	.	.	PUNCT
aiua-10278	43	1	mpmri	mpmri	PROPN
aiua-10278	43	2	mpmri	mpmri	PROPN
aiua-10278	43	3	was	be	AUX
aiua-10278	43	4	performed	perform	VERB
aiua-10278	43	5	using	use	VERB
aiua-10278	43	6	a	a	DET
aiua-10278	43	7	1.5	1.5	NUM
aiua-10278	43	8	tesla	tesla	PROPN
aiua-10278	43	9	system	system	NOUN
aiua-10278	43	10	.	.	PUNCT
aiua-10278	44	1	three	three	NUM
aiua-10278	44	2	sequences	sequence	NOUN
aiua-10278	44	3	were	be	AUX
aiua-10278	44	4	used	use	VERB
aiua-10278	44	5	:	:	PUNCT
aiua-10278	44	6	t2	t2	NOUN
aiua-10278	44	7	-	-	PUNCT
aiua-10278	44	8	weighted	weight	VERB
aiua-10278	44	9	,	,	PUNCT
aiua-10278	44	10	dynamic	dynamic	ADJ
aiua-10278	44	11	contrastenhanced	contrastenhance	VERB
aiua-10278	44	12	and	and	CCONJ
aiua-10278	44	13	diffusion	diffusion	NOUN
aiua-10278	44	14	weighed	weigh	VERB
aiua-10278	44	15	images	image	NOUN
aiua-10278	44	16	.	.	PUNCT
aiua-10278	45	1	for	for	ADP
aiua-10278	45	2	diffusion	diffusion	NOUN
aiua-10278	45	3	weighed	weigh	VERB
aiua-10278	45	4	images	image	NOUN
aiua-10278	45	5	,	,	PUNCT
aiua-10278	45	6	b	b	X
aiua-10278	45	7	-	-	PUNCT
aiua-10278	45	8	values	value	NOUN
aiua-10278	45	9	0	0	NUM
aiua-10278	45	10	-	-	SYM
aiua-10278	45	11	1700	1700	NUM
aiua-10278	45	12	were	be	AUX
aiua-10278	45	13	used	use	VERB
aiua-10278	45	14	.	.	PUNCT
aiua-10278	46	1	apparent	apparent	ADJ
aiua-10278	46	2	diffusion	diffusion	NOUN
aiua-10278	46	3	coefficient	coefficient	NOUN
aiua-10278	46	4	-	-	PUNCT
aiua-10278	46	5	maps	map	NOUN
aiua-10278	46	6	were	be	AUX
aiua-10278	46	7	calculated	calculate	VERB
aiua-10278	46	8	using	use	VERB
aiua-10278	46	9	diffusion	diffusion	NOUN
aiua-10278	46	10	weighed	weigh	VERB
aiua-10278	46	11	images	image	NOUN
aiua-10278	46	12	.	.	PUNCT
aiua-10278	47	1	suspicious	suspicious	ADJ
aiua-10278	47	2	lesions	lesion	NOUN
aiua-10278	47	3	were	be	AUX
aiua-10278	47	4	scored	score	VERB
aiua-10278	47	5	according	accord	VERB
aiua-10278	47	6	to	to	ADP
aiua-10278	47	7	the	the	DET
aiua-10278	47	8	validated	validated	ADJ
aiua-10278	47	9	pi	pi	NOUN
aiua-10278	47	10	-	-	PUNCT
aiua-10278	47	11	rads	rad	NOUN
aiua-10278	47	12	version	version	NOUN
aiua-10278	47	13	2	2	NUM
aiua-10278	47	14	.	.	PUNCT
aiua-10278	48	1	in	in	ADP
aiua-10278	48	2	our	our	PRON
aiua-10278	48	3	study	study	NOUN
aiua-10278	48	4	,	,	PUNCT
aiua-10278	48	5	the	the	DET
aiua-10278	48	6	highest	high	ADJ
aiua-10278	48	7	pi	pi	NOUN
aiua-10278	48	8	-	-	PUNCT
aiua-10278	48	9	rads	rad	NOUN
aiua-10278	48	10	score	score	NOUN
aiua-10278	48	11	of	of	ADP
aiua-10278	48	12	each	each	DET
aiua-10278	48	13	mpmri	mpmri	PROPN
aiua-10278	48	14	scan	scan	PROPN
aiua-10278	48	15	was	be	AUX
aiua-10278	48	16	used	use	VERB
aiua-10278	48	17	.	.	PUNCT
aiua-10278	49	1	taking	take	VERB
aiua-10278	49	2	into	into	ADP
aiua-10278	49	3	account	account	NOUN
aiua-10278	49	4	the	the	DET
aiua-10278	49	5	meaning	meaning	NOUN
aiua-10278	49	6	of	of	ADP
aiua-10278	49	7	pi	pi	NOUN
aiua-10278	49	8	-	-	PUNCT
aiua-10278	49	9	rads	rad	NOUN
aiua-10278	49	10	categories	category	NOUN
aiua-10278	49	11	(	(	PUNCT
aiua-10278	49	12	15	15	NUM
aiua-10278	49	13	)	)	PUNCT
aiua-10278	49	14	and	and	CCONJ
aiua-10278	49	15	similarly	similarly	ADV
aiua-10278	49	16	to	to	ADP
aiua-10278	49	17	other	other	ADJ
aiua-10278	49	18	studies	study	NOUN
aiua-10278	49	19	(	(	PUNCT
aiua-10278	49	20	16	16	NUM
aiua-10278	49	21	)	)	PUNCT
aiua-10278	49	22	,	,	PUNCT
aiua-10278	49	23	pi	pi	NOUN
aiua-10278	49	24	-	-	PUNCT
aiua-10278	49	25	rads	rad	NOUN
aiua-10278	49	26	score	score	NOUN
aiua-10278	49	27	was	be	AUX
aiua-10278	49	28	categorized	categorize	VERB
aiua-10278	49	29	in	in	ADP
aiua-10278	49	30	1	1	NUM
aiua-10278	49	31	-	-	SYM
aiua-10278	49	32	2	2	NUM
aiua-10278	49	33	(	(	PUNCT
aiua-10278	49	34	used	use	VERB
aiua-10278	49	35	as	as	ADP
aiua-10278	49	36	reference	reference	NOUN
aiua-10278	49	37	)	)	PUNCT
aiua-10278	49	38	and	and	CCONJ
aiua-10278	49	39	3	3	NUM
aiua-10278	49	40	-	-	SYM
aiua-10278	49	41	5	5	NUM
aiua-10278	49	42	.	.	PUNCT
aiua-10278	49	43	trus	trus	NOUN
aiua-10278	49	44	-	-	PUNCT
aiua-10278	49	45	guided	guide	VERB
aiua-10278	49	46	pb	pb	ADP
aiua-10278	49	47	all	all	DET
aiua-10278	49	48	men	man	NOUN
aiua-10278	49	49	underwent	undergo	VERB
aiua-10278	49	50	randomized	randomize	VERB
aiua-10278	49	51	trus	trus	NOUN
aiua-10278	49	52	guided	guide	VERB
aiua-10278	49	53	-	-	PUNCT
aiua-10278	49	54	pb	pb	PROPN
aiua-10278	49	55	.	.	NOUN
aiua-10278	49	56	twelve	twelve	NUM
aiua-10278	49	57	randomized	randomized	ADJ
aiua-10278	49	58	cores	core	NOUN
aiua-10278	49	59	(	(	PUNCT
aiua-10278	49	60	6	6	NUM
aiua-10278	49	61	from	from	ADP
aiua-10278	49	62	right	right	ADJ
aiua-10278	49	63	lobe	lobe	NOUN
aiua-10278	49	64	and	and	CCONJ
aiua-10278	49	65	6	6	NUM
aiua-10278	49	66	from	from	ADP
aiua-10278	49	67	left	left	ADJ
aiua-10278	49	68	lobe	lobe	NOUN
aiua-10278	49	69	)	)	PUNCT
aiua-10278	49	70	were	be	AUX
aiua-10278	49	71	taken	take	VERB
aiua-10278	49	72	with	with	ADP
aiua-10278	49	73	no	no	DET
aiua-10278	49	74	additional	additional	ADJ
aiua-10278	49	75	cores	core	NOUN
aiua-10278	49	76	to	to	ADP
aiua-10278	49	77	suspicious	suspicious	ADJ
aiua-10278	49	78	lesions	lesion	NOUN
aiua-10278	49	79	.	.	PUNCT
aiua-10278	50	1	histopathological	histopathological	ADJ
aiua-10278	50	2	analysis	analysis	NOUN
aiua-10278	50	3	was	be	AUX
aiua-10278	50	4	performed	perform	VERB
aiua-10278	50	5	at	at	ADP
aiua-10278	50	6	our	our	PRON
aiua-10278	50	7	hospital	hospital	NOUN
aiua-10278	50	8	.	.	PUNCT
aiua-10278	51	1	pca	pca	PROPN
aiua-10278	51	2	was	be	AUX
aiua-10278	51	3	classified	classify	VERB
aiua-10278	51	4	according	accord	VERB
aiua-10278	51	5	to	to	ADP
aiua-10278	51	6	the	the	DET
aiua-10278	51	7	international	international	ADJ
aiua-10278	51	8	society	society	NOUN
aiua-10278	51	9	of	of	ADP
aiua-10278	51	10	urological	urological	ADJ
aiua-10278	51	11	pathology	pathology	NOUN
aiua-10278	51	12	standards	standard	NOUN
aiua-10278	51	13	and	and	CCONJ
aiua-10278	51	14	cspca	cspca	NOUN
aiua-10278	51	15	was	be	AUX
aiua-10278	51	16	defined	define	VERB
aiua-10278	51	17	as	as	ADP
aiua-10278	51	18	gleason	gleason	PROPN
aiua-10278	51	19	score	score	PROPN
aiua-10278	51	20	≥	≥	PROPN
aiua-10278	51	21	7	7	NUM
aiua-10278	51	22	(	(	PUNCT
aiua-10278	51	23	3	3	NUM
aiua-10278	51	24	+	+	NOUN
aiua-10278	51	25	4	4	NUM
aiua-10278	51	26	)	)	PUNCT
aiua-10278	51	27	.	.	PUNCT
aiua-10278	52	1	statistical	statistical	ADJ
aiua-10278	52	2	analysis	analysis	NOUN
aiua-10278	52	3	variables	variable	NOUN
aiua-10278	52	4	analyzed	analyze	VERB
aiua-10278	52	5	were	be	AUX
aiua-10278	52	6	age	age	NOUN
aiua-10278	52	7	,	,	PUNCT
aiua-10278	52	8	previous	previous	ADJ
aiua-10278	52	9	biopsy	biopsy	NOUN
aiua-10278	52	10	(	(	PUNCT
aiua-10278	52	11	yes	yes	INTJ
aiua-10278	52	12	/	/	SYM
aiua-10278	52	13	no	no	NOUN
aiua-10278	52	14	)	)	PUNCT
aiua-10278	52	15	,	,	PUNCT
aiua-10278	52	16	dre	dre	NOUN
aiua-10278	52	17	,	,	PUNCT
aiua-10278	52	18	prostate	prostate	NOUN
aiua-10278	52	19	volume	volume	NOUN
aiua-10278	52	20	,	,	PUNCT
aiua-10278	52	21	psad	psad	ADJ
aiua-10278	52	22	,	,	PUNCT
aiua-10278	52	23	pi	pi	NOUN
aiua-10278	52	24	-	-	PUNCT
aiua-10278	52	25	rads	rad	NOUN
aiua-10278	52	26	,	,	PUNCT
aiua-10278	52	27	pca	pca	NOUN
aiua-10278	52	28	and	and	CCONJ
aiua-10278	52	29	cspca	cspca	NOUN
aiua-10278	52	30	.	.	PUNCT
aiua-10278	53	1	continuous	continuous	ADJ
aiua-10278	53	2	variables	variable	NOUN
aiua-10278	53	3	were	be	AUX
aiua-10278	53	4	expressed	express	VERB
aiua-10278	53	5	as	as	ADP
aiua-10278	53	6	median	median	NOUN
aiua-10278	53	7	and	and	CCONJ
aiua-10278	53	8	interquartile	interquartile	ADJ
aiua-10278	53	9	range	range	NOUN
aiua-10278	53	10	(	(	PUNCT
aiua-10278	53	11	iqr	iqr	NOUN
aiua-10278	53	12	)	)	PUNCT
aiua-10278	53	13	.	.	PUNCT
aiua-10278	54	1	categorical	categorical	ADJ
aiua-10278	54	2	variables	variable	NOUN
aiua-10278	54	3	were	be	AUX
aiua-10278	54	4	expressed	express	VERB
aiua-10278	54	5	as	as	ADP
aiua-10278	54	6	absolute	absolute	ADJ
aiua-10278	54	7	and	and	CCONJ
aiua-10278	54	8	relative	relative	ADJ
aiua-10278	54	9	frequencies	frequency	NOUN
aiua-10278	54	10	.	.	PUNCT
aiua-10278	55	1	for	for	ADP
aiua-10278	55	2	the	the	DET
aiua-10278	55	3	primary	primary	ADJ
aiua-10278	55	4	analysis	analysis	NOUN
aiua-10278	55	5	,	,	PUNCT
aiua-10278	55	6	the	the	DET
aiua-10278	55	7	chi	chi	NOUN
aiua-10278	55	8	-	-	PUNCT
aiua-10278	55	9	squared	square	VERB
aiua-10278	55	10	test	test	NOUN
aiua-10278	55	11	was	be	AUX
aiua-10278	55	12	performed	perform	VERB
aiua-10278	55	13	to	to	PART
aiua-10278	55	14	evaluate	evaluate	VERB
aiua-10278	55	15	the	the	DET
aiua-10278	55	16	association	association	NOUN
aiua-10278	55	17	of	of	ADP
aiua-10278	55	18	mpmri	mpmri	PROPN
aiua-10278	55	19	with	with	ADP
aiua-10278	55	20	pca	pca	PROPN
aiua-10278	55	21	and	and	CCONJ
aiua-10278	55	22	cspca	cspca	NOUN
aiua-10278	55	23	.	.	PUNCT
aiua-10278	56	1	thereafter	thereafter	ADV
aiua-10278	56	2	,	,	PUNCT
aiua-10278	56	3	this	this	DET
aiua-10278	56	4	model	model	NOUN
aiua-10278	56	5	was	be	AUX
aiua-10278	56	6	stratified	stratify	VERB
aiua-10278	56	7	for	for	ADP
aiua-10278	56	8	different	different	ADJ
aiua-10278	56	9	psa	psa	NOUN
aiua-10278	56	10	and	and	CCONJ
aiua-10278	56	11	psad	psad	ADJ
aiua-10278	56	12	cutoffs	cutoff	NOUN
aiua-10278	56	13	as	as	ADV
aiua-10278	56	14	well	well	ADV
aiua-10278	56	15	as	as	ADP
aiua-10278	56	16	dre	dre	PROPN
aiua-10278	56	17	.	.	PUNCT
aiua-10278	57	1	when	when	SCONJ
aiua-10278	57	2	n	n	PRON
aiua-10278	57	3	was	be	AUX
aiua-10278	57	4	low	low	ADJ
aiua-10278	57	5	,	,	PUNCT
aiua-10278	57	6	fisher’s	fisher’s	NOUN
aiua-10278	57	7	-	-	PUNCT
aiua-10278	57	8	exact	exact	ADJ
aiua-10278	57	9	test	test	NOUN
aiua-10278	57	10	was	be	AUX
aiua-10278	57	11	used	use	VERB
aiua-10278	57	12	to	to	PART
aiua-10278	57	13	evaluate	evaluate	VERB
aiua-10278	57	14	this	this	DET
aiua-10278	57	15	association	association	NOUN
aiua-10278	57	16	.	.	PUNCT
aiua-10278	58	1	a	a	DET
aiua-10278	58	2	p	p	X
aiua-10278	58	3	<	<	X
aiua-10278	58	4	0.05	0.05	NUM
aiua-10278	58	5	was	be	AUX
aiua-10278	58	6	considered	consider	VERB
aiua-10278	58	7	to	to	PART
aiua-10278	58	8	indicate	indicate	VERB
aiua-10278	58	9	statistical	statistical	ADJ
aiua-10278	58	10	significance	significance	NOUN
aiua-10278	58	11	.	.	PUNCT
aiua-10278	59	1	for	for	ADP
aiua-10278	59	2	the	the	DET
aiua-10278	59	3	secondary	secondary	ADJ
aiua-10278	59	4	analysis	analysis	NOUN
aiua-10278	59	5	,	,	PUNCT
aiua-10278	59	6	negative	negative	ADJ
aiua-10278	59	7	pb	pb	ADP
aiua-10278	59	8	result	result	NOUN
aiua-10278	59	9	rates	rate	NOUN
aiua-10278	59	10	and	and	CCONJ
aiua-10278	59	11	false	false	ADJ
aiua-10278	59	12	negative	negative	ADJ
aiua-10278	59	13	rates	rate	NOUN
aiua-10278	59	14	of	of	ADP
aiua-10278	59	15	mpmri	mpmri	PROPN
aiua-10278	59	16	were	be	AUX
aiua-10278	59	17	also	also	ADV
aiua-10278	59	18	calculated	calculate	VERB
aiua-10278	59	19	.	.	PUNCT
aiua-10278	60	1	statistical	statistical	ADJ
aiua-10278	60	2	analysis	analysis	NOUN
aiua-10278	60	3	was	be	AUX
aiua-10278	60	4	performed	perform	VERB
aiua-10278	60	5	using	use	VERB
aiua-10278	60	6	stata	stata	NOUN
aiua-10278	60	7	version	version	PROPN
aiua-10278	60	8	15	15	NUM
aiua-10278	60	9	.	.	PUNCT
aiua-10278	61	1	results	result	VERB
aiua-10278	61	2	patients	patient	NOUN
aiua-10278	61	3	’	'	PUNCT
aiua-10278	61	4	demographics	demographic	NOUN
aiua-10278	61	5	206	206	NUM
aiua-10278	61	6	patients	patient	NOUN
aiua-10278	61	7	underwent	undergo	VERB
aiua-10278	61	8	mpmri	mpmri	PROPN
aiua-10278	61	9	and	and	CCONJ
aiua-10278	61	10	were	be	AUX
aiua-10278	61	11	included	include	VERB
aiua-10278	61	12	in	in	ADP
aiua-10278	61	13	our	our	PRON
aiua-10278	61	14	study	study	NOUN
aiua-10278	61	15	.	.	PUNCT
aiua-10278	62	1	patient	patient	PROPN
aiua-10278	62	2	’s	’s	PART
aiua-10278	62	3	characteristics	characteristic	NOUN
aiua-10278	62	4	,	,	PUNCT
aiua-10278	62	5	pi	pi	NOUN
aiua-10278	62	6	-	-	PUNCT
aiua-10278	62	7	rads	rad	NOUN
aiua-10278	62	8	scores	score	NOUN
aiua-10278	62	9	and	and	CCONJ
aiua-10278	62	10	histological	histological	ADJ
aiua-10278	62	11	results	result	NOUN
aiua-10278	62	12	are	be	AUX
aiua-10278	62	13	shown	show	VERB
aiua-10278	62	14	in	in	ADP
aiua-10278	62	15	table	table	NOUN
aiua-10278	62	16	1	1	NUM
aiua-10278	62	17	.	.	PUNCT
aiua-10278	62	18	median	median	PROPN
aiua-10278	62	19	(	(	PUNCT
aiua-10278	62	20	iqr	iqr	NOUN
aiua-10278	62	21	)	)	PUNCT
aiua-10278	62	22	age	age	NOUN
aiua-10278	62	23	was	be	AUX
aiua-10278	62	24	67	67	NUM
aiua-10278	62	25	(	(	PUNCT
aiua-10278	62	26	61	61	NUM
aiua-10278	62	27	-	-	SYM
aiua-10278	62	28	72	72	NUM
aiua-10278	62	29	)	)	PUNCT
aiua-10278	62	30	years	year	NOUN
aiua-10278	62	31	and	and	CCONJ
aiua-10278	62	32	median	median	ADJ
aiua-10278	62	33	prostate	prostate	NOUN
aiua-10278	62	34	volume	volume	NOUN
aiua-10278	62	35	was	be	AUX
aiua-10278	62	36	45.9	45.9	NUM
aiua-10278	62	37	(	(	PUNCT
aiua-10278	62	38	35	35	NUM
aiua-10278	62	39	-	-	SYM
aiua-10278	62	40	66	66	NUM
aiua-10278	62	41	)	)	PUNCT
aiua-10278	62	42	cc	cc	PROPN
aiua-10278	62	43	.	.	PROPN
aiua-10278	62	44	median	median	ADJ
aiua-10278	62	45	psa	psa	PROPN
aiua-10278	62	46	and	and	CCONJ
aiua-10278	62	47	psad	psad	ADJ
aiua-10278	62	48	were	be	AUX
aiua-10278	62	49	8.55	8.55	NUM
aiua-10278	62	50	(	(	PUNCT
aiua-10278	62	51	5.74	5.74	NUM
aiua-10278	62	52	-	-	SYM
aiua-10278	62	53	12.7	12.7	NUM
aiua-10278	62	54	)	)	PUNCT
aiua-10278	62	55	ng	ng	PROPN
aiua-10278	62	56	/	/	SYM
aiua-10278	62	57	ml	ml	PROPN
aiua-10278	62	58	and	and	CCONJ
aiua-10278	62	59	0.17	0.17	NUM
aiua-10278	62	60	(	(	PUNCT
aiua-10278	62	61	0.11	0.11	NUM
aiua-10278	62	62	-	-	NUM
aiua-10278	62	63	0.26	0.26	NUM
aiua-10278	62	64	)	)	PUNCT
aiua-10278	62	65	ng	ng	PROPN
aiua-10278	62	66	/	/	SYM
aiua-10278	62	67	ml	ml	PROPN
aiua-10278	62	68	/	/	SYM
aiua-10278	62	69	cc	cc	NOUN
aiua-10278	62	70	,	,	PUNCT
aiua-10278	62	71	respectively	respectively	ADV
aiua-10278	62	72	.	.	PUNCT
aiua-10278	63	1	dre	dre	PROPN
aiua-10278	63	2	was	be	AUX
aiua-10278	63	3	described	describe	VERB
aiua-10278	63	4	as	as	ADP
aiua-10278	63	5	unequivocal	unequivocal	ADJ
aiua-10278	63	6	for	for	ADP
aiua-10278	63	7	130	130	NUM
aiua-10278	63	8	patients	patient	NOUN
aiua-10278	63	9	,	,	PUNCT
aiua-10278	63	10	with	with	ADP
aiua-10278	63	11	51	51	NUM
aiua-10278	63	12	patients	patient	NOUN
aiua-10278	63	13	(	(	PUNCT
aiua-10278	63	14	24.76	24.76	NUM
aiua-10278	63	15	%	%	NOUN
aiua-10278	63	16	)	)	PUNCT
aiua-10278	63	17	classified	classify	VERB
aiua-10278	63	18	as	as	ADP
aiua-10278	63	19	suspicious	suspicious	ADJ
aiua-10278	63	20	.	.	PUNCT
aiua-10278	64	1	79	79	NUM
aiua-10278	64	2	patients	patient	NOUN
aiua-10278	64	3	(	(	PUNCT
aiua-10278	64	4	38.35	38.35	NUM
aiua-10278	64	5	%	%	NOUN
aiua-10278	64	6	)	)	PUNCT
aiua-10278	64	7	patients	patient	NOUN
aiua-10278	64	8	had	have	AUX
aiua-10278	64	9	previously	previously	ADV
aiua-10278	64	10	undergone	undergo	VERB
aiua-10278	64	11	pb	pb	ADP
aiua-10278	64	12	for	for	ADP
aiua-10278	64	13	suspicious	suspicious	ADJ
aiua-10278	64	14	psa	psa	NOUN
aiua-10278	64	15	or	or	CCONJ
aiua-10278	64	16	dre	dre	PROPN
aiua-10278	64	17	.	.	PUNCT
aiua-10278	65	1	34	34	NUM
aiua-10278	65	2	patients	patient	NOUN
aiua-10278	65	3	(	(	PUNCT
aiua-10278	65	4	16.5	16.5	NUM
aiua-10278	65	5	%	%	NOUN
aiua-10278	65	6	)	)	PUNCT
aiua-10278	65	7	had	have	VERB
aiua-10278	65	8	a	a	DET
aiua-10278	65	9	normal	normal	ADJ
aiua-10278	65	10	mpmri	mpmri	NOUN
aiua-10278	65	11	pi	pi	NOUN
aiua-10278	65	12	-	-	PUNCT
aiua-10278	65	13	rads	rad	NOUN
aiua-10278	65	14	score	score	NOUN
aiua-10278	65	15	(	(	PUNCT
aiua-10278	65	16	pi	pi	NOUN
aiua-10278	65	17	-	-	PUNCT
aiua-10278	65	18	rads	rad	NOUN
aiua-10278	65	19	1	1	NUM
aiua-10278	65	20	-	-	SYM
aiua-10278	65	21	2	2	NUM
aiua-10278	65	22	)	)	PUNCT
aiua-10278	65	23	and	and	CCONJ
aiua-10278	65	24	172	172	NUM
aiua-10278	65	25	patients	patient	NOUN
aiua-10278	65	26	(	(	PUNCT
aiua-10278	65	27	83.5	83.5	NUM
aiua-10278	65	28	%	%	NOUN
aiua-10278	65	29	)	)	PUNCT
aiua-10278	65	30	had	have	VERB
aiua-10278	65	31	a	a	DET
aiua-10278	65	32	suspicious	suspicious	ADJ
aiua-10278	65	33	pi	pi	NOUN
aiua-10278	65	34	-	-	PUNCT
aiua-10278	65	35	rads	rad	NOUN
aiua-10278	65	36	(	(	PUNCT
aiua-10278	65	37	pi	pi	NOUN
aiua-10278	65	38	-	-	PUNCT
aiua-10278	65	39	rads	rad	NOUN
aiua-10278	65	40	3	3	NUM
aiua-10278	65	41	-	-	SYM
aiua-10278	65	42	5	5	NUM
aiua-10278	65	43	)	)	PUNCT
aiua-10278	65	44	.	.	PUNCT
aiua-10278	66	1	pb	pb	ADP
aiua-10278	66	2	result	result	NOUN
aiua-10278	66	3	was	be	AUX
aiua-10278	66	4	normal	normal	ADJ
aiua-10278	66	5	in	in	ADP
aiua-10278	66	6	78	78	NUM
aiua-10278	66	7	(	(	PUNCT
aiua-10278	66	8	37.86	37.86	NUM
aiua-10278	66	9	%	%	NOUN
aiua-10278	66	10	)	)	PUNCT
aiua-10278	66	11	patients	patient	NOUN
aiua-10278	66	12	,	,	PUNCT
aiua-10278	66	13	while	while	SCONJ
aiua-10278	66	14	128	128	NUM
aiua-10278	66	15	(	(	PUNCT
aiua-10278	66	16	62.14	62.14	NUM
aiua-10278	66	17	%	%	NOUN
aiua-10278	66	18	)	)	PUNCT
aiua-10278	66	19	had	have	VERB
aiua-10278	66	20	pca	pca	NOUN
aiua-10278	66	21	and	and	CCONJ
aiua-10278	66	22	100	100	NUM
aiua-10278	66	23	(	(	PUNCT
aiua-10278	66	24	48.54	48.54	NUM
aiua-10278	66	25	%	%	NOUN
aiua-10278	66	26	)	)	PUNCT
aiua-10278	66	27	had	have	VERB
aiua-10278	66	28	cspca	cspca	NOUN
aiua-10278	66	29	.	.	PUNCT
aiua-10278	67	1	prediction	prediction	NOUN
aiua-10278	67	2	of	of	ADP
aiua-10278	67	3	prostate	prostate	NOUN
aiua-10278	67	4	cancer	cancer	NOUN
aiua-10278	67	5	and	and	CCONJ
aiua-10278	67	6	clinically	clinically	ADV
aiua-10278	67	7	significant	significant	ADJ
aiua-10278	67	8	prostate	prostate	NOUN
aiua-10278	67	9	cancer	cancer	NOUN
aiua-10278	67	10	as	as	ADP
aiua-10278	67	11	primary	primary	ADJ
aiua-10278	67	12	analysis	analysis	NOUN
aiua-10278	67	13	,	,	PUNCT
aiua-10278	67	14	chi	chi	ADJ
aiua-10278	67	15	-	-	PUNCT
aiua-10278	67	16	squared	square	VERB
aiua-10278	67	17	test	test	NOUN
aiua-10278	67	18	was	be	AUX
aiua-10278	67	19	used	use	VERB
aiua-10278	67	20	to	to	PART
aiua-10278	67	21	test	test	VERB
aiua-10278	67	22	if	if	SCONJ
aiua-10278	67	23	pi	pi	NOUN
aiua-10278	67	24	-	-	PUNCT
aiua-10278	67	25	rads	rad	NOUN
aiua-10278	67	26	was	be	AUX
aiua-10278	67	27	a	a	DET
aiua-10278	67	28	predictor	predictor	NOUN
aiua-10278	67	29	of	of	ADP
aiua-10278	67	30	pca	pca	PROPN
aiua-10278	67	31	and	and	CCONJ
aiua-10278	67	32	cspca	cspca	NOUN
aiua-10278	67	33	,	,	PUNCT
aiua-10278	67	34	with	with	ADP
aiua-10278	67	35	results	result	NOUN
aiua-10278	67	36	shown	show	VERB
aiua-10278	67	37	in	in	ADP
aiua-10278	67	38	table	table	NOUN
aiua-10278	67	39	2	2	NUM
aiua-10278	67	40	.	.	PUNCT
aiua-10278	68	1	after	after	ADV
aiua-10278	68	2	,	,	PUNCT
aiua-10278	68	3	we	we	PRON
aiua-10278	68	4	stratified	stratify	VERB
aiua-10278	68	5	these	these	DET
aiua-10278	68	6	results	result	NOUN
aiua-10278	68	7	for	for	ADP
aiua-10278	68	8	low	low	ADJ
aiua-10278	68	9	versus	versus	ADP
aiua-10278	68	10	high	high	ADJ
aiua-10278	68	11	clinical	clinical	ADJ
aiua-10278	68	12	suspicion	suspicion	NOUN
aiua-10278	68	13	of	of	ADP
aiua-10278	68	14	pca	pca	PROPN
aiua-10278	68	15	,	,	PUNCT
aiua-10278	68	16	defined	define	VERB
aiua-10278	68	17	as	as	ADP
aiua-10278	68	18	psa	psa	NOUN
aiua-10278	68	19	≤	≤	ADV
aiua-10278	68	20	10	10	NUM
aiua-10278	68	21	versus	versus	ADP
aiua-10278	68	22	psa	psa	VERB
aiua-10278	68	23	>	>	X
aiua-10278	68	24	10	10	NUM
aiua-10278	68	25	ng	ng	PROPN
aiua-10278	68	26	/	/	SYM
aiua-10278	68	27	ml	ml	PROPN
aiua-10278	68	28	,	,	PUNCT
aiua-10278	68	29	psad	psad	ADJ
aiua-10278	68	30	≤	≤	NUM
aiua-10278	68	31	0.15	0.15	NUM
aiua-10278	68	32	versus	versus	ADP
aiua-10278	68	33	psad	psad	PROPN
aiua-10278	68	34	>	>	X
aiua-10278	68	35	0.15	0.15	NUM
aiua-10278	68	36	ng	ng	PROPN
aiua-10278	68	37	/	/	SYM
aiua-10278	68	38	ml	ml	NOUN
aiua-10278	68	39	/	/	SYM
aiua-10278	68	40	cc	cc	NOUN
aiua-10278	68	41	and	and	CCONJ
aiua-10278	68	42	nortable	nortable	ADJ
aiua-10278	68	43	2	2	NUM
aiua-10278	68	44	.	.	PUNCT
aiua-10278	68	45	association	association	NOUN
aiua-10278	68	46	of	of	ADP
aiua-10278	68	47	pi	pi	NOUN
aiua-10278	68	48	-	-	PUNCT
aiua-10278	68	49	rads	rad	NOUN
aiua-10278	68	50	with	with	ADP
aiua-10278	68	51	pca	pca	NOUN
aiua-10278	68	52	and	and	CCONJ
aiua-10278	68	53	cspca	cspca	NOUN
aiua-10278	68	54	.	.	PUNCT
aiua-10278	69	1	prostate	prostate	NOUN
aiua-10278	69	2	cancer	cancer	NOUN
aiua-10278	69	3	significant	significant	ADJ
aiua-10278	69	4	prostate	prostate	NOUN
aiua-10278	69	5	cancer	cancer	NOUN
aiua-10278	69	6	n	n	CCONJ
aiua-10278	69	7	no	no	DET
aiua-10278	69	8	cancer	cancer	NOUN
aiua-10278	69	9	pca	pca	NOUN
aiua-10278	69	10	p	p	NOUN
aiua-10278	69	11	no	no	DET
aiua-10278	69	12	cancer	cancer	NOUN
aiua-10278	69	13	cspca	cspca	NOUN
aiua-10278	69	14	p	p	PROPN
aiua-10278	69	15	206	206	NUM
aiua-10278	69	16	pi	pi	NOUN
aiua-10278	69	17	-	-	PUNCT
aiua-10278	69	18	rads	rad	NOUN
aiua-10278	69	19	1	1	NUM
aiua-10278	69	20	-	-	SYM
aiua-10278	69	21	2	2	NUM
aiua-10278	69	22	22	22	NUM
aiua-10278	69	23	(	(	PUNCT
aiua-10278	69	24	64.71	64.71	NUM
aiua-10278	69	25	%	%	NOUN
aiua-10278	69	26	)	)	PUNCT
aiua-10278	69	27	12	12	NUM
aiua-10278	69	28	(	(	PUNCT
aiua-10278	69	29	35.29	35.29	NUM
aiua-10278	69	30	%	%	NOUN
aiua-10278	69	31	)	)	PUNCT
aiua-10278	69	32	<	<	X
aiua-10278	69	33	0.001	0.001	NUM
aiua-10278	69	34	*	*	SYM
aiua-10278	69	35	29	29	NUM
aiua-10278	69	36	(	(	PUNCT
aiua-10278	69	37	85.29	85.29	NUM
aiua-10278	69	38	%	%	NOUN
aiua-10278	69	39	)	)	PUNCT
aiua-10278	69	40	5	5	NUM
aiua-10278	69	41	(	(	PUNCT
aiua-10278	69	42	14.71	14.71	NUM
aiua-10278	69	43	%	%	NOUN
aiua-10278	69	44	)	)	PUNCT
aiua-10278	69	45	<	<	X
aiua-10278	69	46	0.001	0.001	NUM
aiua-10278	69	47	*	*	NOUN
aiua-10278	69	48	pi	pi	NOUN
aiua-10278	69	49	-	-	PUNCT
aiua-10278	69	50	rads	rad	NOUN
aiua-10278	69	51	3	3	NUM
aiua-10278	69	52	-	-	SYM
aiua-10278	69	53	5	5	NUM
aiua-10278	69	54	56	56	NUM
aiua-10278	69	55	(	(	PUNCT
aiua-10278	69	56	32.56	32.56	NUM
aiua-10278	69	57	%	%	NOUN
aiua-10278	69	58	)	)	PUNCT
aiua-10278	69	59	116	116	NUM
aiua-10278	69	60	(	(	PUNCT
aiua-10278	69	61	67.44	67.44	NUM
aiua-10278	69	62	%	%	NOUN
aiua-10278	69	63	)	)	PUNCT
aiua-10278	69	64	76	76	NUM
aiua-10278	69	65	(	(	PUNCT
aiua-10278	69	66	44.19	44.19	NUM
aiua-10278	69	67	%	%	NOUN
aiua-10278	69	68	)	)	PUNCT
aiua-10278	69	69	96	96	NUM
aiua-10278	69	70	(	(	PUNCT
aiua-10278	69	71	55.81	55.81	NUM
aiua-10278	69	72	%	%	NOUN
aiua-10278	69	73	)	)	PUNCT
aiua-10278	70	1	p	p	X
aiua-10278	70	2	:	:	PUNCT
aiua-10278	70	3	p	p	ADJ
aiua-10278	70	4	-	-	PUNCT
aiua-10278	70	5	value	value	NOUN
aiua-10278	70	6	;	;	PUNCT
aiua-10278	70	7	*	*	PUNCT
aiua-10278	70	8	chi	chi	ADJ
aiua-10278	70	9	-	-	PUNCT
aiua-10278	70	10	squared	square	VERB
aiua-10278	70	11	test	test	NOUN
aiua-10278	70	12	.	.	PUNCT
aiua-10278	71	1	table	table	NOUN
aiua-10278	71	2	1	1	NUM
aiua-10278	71	3	.	.	PUNCT
aiua-10278	72	1	patients	patient	NOUN
aiua-10278	72	2	’	'	PUNCT
aiua-10278	72	3	characteristics	characteristic	NOUN
aiua-10278	72	4	.	.	PUNCT
aiua-10278	73	1	variable	variable	ADJ
aiua-10278	73	2	n	n	CCONJ
aiua-10278	73	3	value	value	NOUN
aiua-10278	73	4	age	age	NOUN
aiua-10278	73	5	(	(	PUNCT
aiua-10278	73	6	years	year	NOUN
aiua-10278	73	7	)	)	PUNCT
aiua-10278	73	8	median	median	NOUN
aiua-10278	73	9	(	(	PUNCT
aiua-10278	73	10	iqr	iqr	NOUN
aiua-10278	73	11	)	)	PUNCT
aiua-10278	73	12	206	206	NUM
aiua-10278	73	13	67	67	NUM
aiua-10278	73	14	(	(	PUNCT
aiua-10278	73	15	61	61	NUM
aiua-10278	73	16	-	-	SYM
aiua-10278	73	17	72	72	NUM
aiua-10278	73	18	)	)	PUNCT
aiua-10278	73	19	previous	previous	ADJ
aiua-10278	73	20	biopsy	biopsy	NOUN
aiua-10278	73	21	206	206	NUM
aiua-10278	74	1	no	no	DET
aiua-10278	74	2	n	n	NOUN
aiua-10278	74	3	(	(	PUNCT
aiua-10278	74	4	%	%	INTJ
aiua-10278	74	5	)	)	PUNCT
aiua-10278	74	6	127	127	NUM
aiua-10278	74	7	(	(	PUNCT
aiua-10278	74	8	61.65	61.65	NUM
aiua-10278	74	9	%	%	NOUN
aiua-10278	74	10	)	)	PUNCT
aiua-10278	75	1	yes	yes	INTJ
aiua-10278	75	2	n	n	CCONJ
aiua-10278	75	3	(	(	PUNCT
aiua-10278	75	4	%	%	INTJ
aiua-10278	75	5	)	)	PUNCT
aiua-10278	75	6	79	79	NUM
aiua-10278	75	7	(	(	PUNCT
aiua-10278	75	8	38.35	38.35	NUM
aiua-10278	75	9	%	%	NOUN
aiua-10278	75	10	)	)	PUNCT
aiua-10278	75	11	dre	dre	PROPN
aiua-10278	75	12	206	206	NUM
aiua-10278	76	1	doubtful	doubtful	ADJ
aiua-10278	76	2	76	76	NUM
aiua-10278	76	3	(	(	PUNCT
aiua-10278	76	4	36.89	36.89	NUM
aiua-10278	76	5	%	%	NOUN
aiua-10278	76	6	)	)	PUNCT
aiua-10278	76	7	unequivocal	unequivocal	ADJ
aiua-10278	76	8	normal	normal	ADJ
aiua-10278	76	9	79	79	NUM
aiua-10278	76	10	(	(	PUNCT
aiua-10278	76	11	38.35	38.35	NUM
aiua-10278	76	12	%	%	NOUN
aiua-10278	76	13	)	)	PUNCT
aiua-10278	76	14	suspicious	suspicious	ADJ
aiua-10278	76	15	51	51	NUM
aiua-10278	76	16	(	(	PUNCT
aiua-10278	76	17	24.76	24.76	NUM
aiua-10278	76	18	%	%	NOUN
aiua-10278	76	19	)	)	PUNCT
aiua-10278	76	20	prostate	prostate	NOUN
aiua-10278	76	21	volume	volume	NOUN
aiua-10278	76	22	(	(	PUNCT
aiua-10278	76	23	cc	cc	NOUN
aiua-10278	76	24	)	)	PUNCT
aiua-10278	76	25	median	median	NOUN
aiua-10278	76	26	(	(	PUNCT
aiua-10278	76	27	iqr	iqr	PROPN
aiua-10278	76	28	)	)	PUNCT
aiua-10278	76	29	138	138	NUM
aiua-10278	76	30	45.9	45.9	NUM
aiua-10278	76	31	(	(	PUNCT
aiua-10278	76	32	35	35	NUM
aiua-10278	76	33	-	-	SYM
aiua-10278	76	34	66	66	NUM
aiua-10278	76	35	)	)	PUNCT
aiua-10278	76	36	psa	psa	NOUN
aiua-10278	76	37	(	(	PUNCT
aiua-10278	76	38	ng	ng	PROPN
aiua-10278	76	39	/	/	SYM
aiua-10278	76	40	ml	ml	NOUN
aiua-10278	76	41	)	)	PUNCT
aiua-10278	76	42	median	median	NOUN
aiua-10278	76	43	(	(	PUNCT
aiua-10278	76	44	iqr	iqr	NOUN
aiua-10278	76	45	)	)	PUNCT
aiua-10278	76	46	206	206	NUM
aiua-10278	76	47	8.55	8.55	NUM
aiua-10278	76	48	(	(	PUNCT
aiua-10278	76	49	5.74	5.74	NUM
aiua-10278	76	50	-	-	SYM
aiua-10278	76	51	12.7	12.7	NUM
aiua-10278	76	52	)	)	PUNCT
aiua-10278	76	53	psa	psa	VERB
aiua-10278	76	54	density	density	NOUN
aiua-10278	76	55	(	(	PUNCT
aiua-10278	76	56	ng	ng	PROPN
aiua-10278	76	57	/	/	SYM
aiua-10278	76	58	ml	ml	PROPN
aiua-10278	76	59	/	/	SYM
aiua-10278	76	60	cc	cc	NOUN
aiua-10278	76	61	)	)	PUNCT
aiua-10278	76	62	median	median	NOUN
aiua-10278	76	63	(	(	PUNCT
aiua-10278	76	64	iqr	iqr	PROPN
aiua-10278	76	65	)	)	PUNCT
aiua-10278	76	66	138	138	NUM
aiua-10278	76	67	0.17	0.17	NUM
aiua-10278	76	68	(	(	PUNCT
aiua-10278	76	69	0.11	0.11	NUM
aiua-10278	76	70	-	-	NUM
aiua-10278	76	71	0.26	0.26	NUM
aiua-10278	76	72	)	)	PUNCT
aiua-10278	76	73	pi	pi	NOUN
aiua-10278	76	74	-	-	PUNCT
aiua-10278	76	75	rads	rad	VERB
aiua-10278	76	76	206	206	NUM
aiua-10278	76	77	1	1	NUM
aiua-10278	76	78	18	18	NUM
aiua-10278	76	79	(	(	PUNCT
aiua-10278	76	80	8.74	8.74	NUM
aiua-10278	76	81	%	%	NOUN
aiua-10278	76	82	)	)	PUNCT
aiua-10278	76	83	2	2	NUM
aiua-10278	76	84	16	16	NUM
aiua-10278	76	85	(	(	PUNCT
aiua-10278	76	86	7.77	7.77	NUM
aiua-10278	76	87	%	%	NOUN
aiua-10278	76	88	)	)	PUNCT
aiua-10278	76	89	3	3	NUM
aiua-10278	76	90	38	38	NUM
aiua-10278	76	91	(	(	PUNCT
aiua-10278	76	92	18.45	18.45	NUM
aiua-10278	76	93	%	%	NOUN
aiua-10278	76	94	)	)	PUNCT
aiua-10278	76	95	4	4	NUM
aiua-10278	76	96	66	66	NUM
aiua-10278	76	97	(	(	PUNCT
aiua-10278	76	98	32.04	32.04	NUM
aiua-10278	76	99	%	%	NOUN
aiua-10278	76	100	)	)	PUNCT
aiua-10278	76	101	5	5	NUM
aiua-10278	76	102	68	68	NUM
aiua-10278	76	103	(	(	PUNCT
aiua-10278	76	104	33.01	33.01	NUM
aiua-10278	76	105	%	%	NOUN
aiua-10278	76	106	)	)	PUNCT
aiua-10278	76	107	prostate	prostate	NOUN
aiua-10278	76	108	cancer	cancer	NOUN
aiua-10278	76	109	206	206	NUM
aiua-10278	76	110	no	no	PRON
aiua-10278	76	111	%	%	NOUN
aiua-10278	76	112	(	(	PUNCT
aiua-10278	76	113	n	n	CCONJ
aiua-10278	76	114	)	)	PUNCT
aiua-10278	76	115	78	78	NUM
aiua-10278	76	116	(	(	PUNCT
aiua-10278	76	117	37.86	37.86	NUM
aiua-10278	76	118	%	%	NOUN
aiua-10278	76	119	)	)	PUNCT
aiua-10278	77	1	yes	yes	INTJ
aiua-10278	77	2	%	%	INTJ
aiua-10278	77	3	(	(	PUNCT
aiua-10278	77	4	n	n	CCONJ
aiua-10278	77	5	)	)	PUNCT
aiua-10278	77	6	128	128	NUM
aiua-10278	77	7	(	(	PUNCT
aiua-10278	77	8	62.14	62.14	NUM
aiua-10278	77	9	%	%	NOUN
aiua-10278	77	10	)	)	PUNCT
aiua-10278	77	11	clinically	clinically	ADV
aiua-10278	77	12	significant	significant	ADJ
aiua-10278	77	13	prostate	prostate	NOUN
aiua-10278	77	14	cancer	cancer	NOUN
aiua-10278	77	15	206	206	NUM
aiua-10278	78	1	no	no	DET
aiua-10278	78	2	%	%	NOUN
aiua-10278	78	3	(	(	PUNCT
aiua-10278	78	4	n	n	CCONJ
aiua-10278	78	5	)	)	PUNCT
aiua-10278	78	6	106	106	NUM
aiua-10278	78	7	(	(	PUNCT
aiua-10278	78	8	51.46	51.46	NUM
aiua-10278	78	9	%	%	NOUN
aiua-10278	78	10	)	)	PUNCT
aiua-10278	79	1	yes	yes	INTJ
aiua-10278	79	2	%	%	INTJ
aiua-10278	79	3	(	(	PUNCT
aiua-10278	79	4	n	n	CCONJ
aiua-10278	79	5	)	)	PUNCT
aiua-10278	79	6	100	100	NUM
aiua-10278	79	7	(	(	PUNCT
aiua-10278	79	8	48.54	48.54	NUM
aiua-10278	79	9	%	%	NOUN
aiua-10278	79	10	)	)	PUNCT
aiua-10278	79	11	archivio	archivio	NOUN
aiua-10278	79	12	italiano	italiano	X
aiua-10278	79	13	di	di	X
aiua-10278	79	14	urologia	urologia	PROPN
aiua-10278	79	15	e	e	PROPN
aiua-10278	79	16	andrologia	andrologia	PROPN
aiua-10278	79	17	2022	2022	NUM
aiua-10278	79	18	;	;	PUNCT
aiua-10278	79	19	94	94	NUM
aiua-10278	79	20	,	,	PUNCT
aiua-10278	79	21	1	1	NUM
aiua-10278	79	22	s.	s.	PROPN
aiua-10278	79	23	teixeira	teixeira	PROPN
aiua-10278	79	24	anacleto	anacleto	PROPN
aiua-10278	79	25	,	,	PUNCT
aiua-10278	80	1	j.	j.	PROPN
aiua-10278	80	2	neves	neves	PROPN
aiua-10278	80	3	alberto	alberto	PROPN
aiua-10278	80	4	,	,	PUNCT
aiua-10278	80	5	e.	e.	PROPN
aiua-10278	80	6	carvalho	carvalho	PROPN
aiua-10278	80	7	dias	dias	PROPN
aiua-10278	80	8	,	,	PUNCT
aiua-10278	80	9	p.	p.	PROPN
aiua-10278	80	10	sousa	sousa	PROPN
aiua-10278	80	11	passos	passos	PROPN
aiua-10278	80	12	,	,	PUNCT
aiua-10278	80	13	m.	m.	PROPN
aiua-10278	80	14	cerqueira	cerqueira	PROPN
aiua-10278	80	15	alves	alves	PROPN
aiua-10278	80	16	34	34	NUM
aiua-10278	80	17	mal	mal	PROPN
aiua-10278	80	18	dre	dre	PROPN
aiua-10278	80	19	versus	versus	ADP
aiua-10278	80	20	suspicious	suspicious	PROPN
aiua-10278	80	21	dre	dre	PROPN
aiua-10278	80	22	,	,	PUNCT
aiua-10278	80	23	respectively	respectively	ADV
aiua-10278	80	24	(	(	PUNCT
aiua-10278	80	25	tables	table	NOUN
aiua-10278	80	26	3	3	NUM
aiua-10278	80	27	,	,	PUNCT
aiua-10278	80	28	4	4	NUM
aiua-10278	80	29	)	)	PUNCT
aiua-10278	80	30	.	.	PUNCT
aiua-10278	81	1	in	in	ADP
aiua-10278	81	2	our	our	PRON
aiua-10278	81	3	primary	primary	ADJ
aiua-10278	81	4	analysis	analysis	NOUN
aiua-10278	81	5	,	,	PUNCT
aiua-10278	81	6	we	we	PRON
aiua-10278	81	7	found	find	VERB
aiua-10278	81	8	that	that	SCONJ
aiua-10278	81	9	pi	pi	NOUN
aiua-10278	81	10	-	-	PUNCT
aiua-10278	81	11	rads	rad	NOUN
aiua-10278	81	12	3	3	NUM
aiua-10278	81	13	-	-	SYM
aiua-10278	81	14	5	5	NUM
aiua-10278	81	15	was	be	AUX
aiua-10278	81	16	a	a	DET
aiua-10278	81	17	significant	significant	ADJ
aiua-10278	81	18	predictor	predictor	NOUN
aiua-10278	81	19	of	of	ADP
aiua-10278	81	20	both	both	DET
aiua-10278	81	21	pca	pca	PROPN
aiua-10278	81	22	and	and	CCONJ
aiua-10278	81	23	cspca	cspca	PROPN
aiua-10278	81	24	(	(	PUNCT
aiua-10278	81	25	p	p	X
aiua-10278	81	26	<	<	X
aiua-10278	81	27	0.001	0.001	NUM
aiua-10278	81	28	)	)	PUNCT
aiua-10278	81	29	.	.	PUNCT
aiua-10278	82	1	low	low	ADJ
aiua-10278	82	2	vs.	vs.	ADP
aiua-10278	82	3	high	high	ADJ
aiua-10278	82	4	risk	risk	NOUN
aiua-10278	82	5	based	base	VERB
aiua-10278	82	6	on	on	ADP
aiua-10278	82	7	psa	psa	NOUN
aiua-10278	82	8	after	after	ADP
aiua-10278	82	9	stratification	stratification	NOUN
aiua-10278	82	10	in	in	ADP
aiua-10278	82	11	low	low	ADJ
aiua-10278	82	12	vs.	vs.	X
aiua-10278	82	13	high	high	ADJ
aiua-10278	82	14	risk	risk	NOUN
aiua-10278	82	15	based	base	VERB
aiua-10278	82	16	on	on	ADP
aiua-10278	82	17	psa	psa	NOUN
aiua-10278	82	18	,	,	PUNCT
aiua-10278	82	19	we	we	PRON
aiua-10278	82	20	found	find	VERB
aiua-10278	82	21	that	that	SCONJ
aiua-10278	82	22	in	in	ADP
aiua-10278	82	23	patients	patient	NOUN
aiua-10278	82	24	with	with	ADP
aiua-10278	82	25	low	low	ADJ
aiua-10278	82	26	clinical	clinical	ADJ
aiua-10278	82	27	suspicion	suspicion	NOUN
aiua-10278	82	28	of	of	ADP
aiua-10278	82	29	pca	pca	PROPN
aiua-10278	82	30	(	(	PUNCT
aiua-10278	82	31	psa	psa	VERB
aiua-10278	82	32	≤	≤	NUM
aiua-10278	82	33	10	10	NUM
aiua-10278	82	34	ng	ng	PROPN
aiua-10278	82	35	/	/	SYM
aiua-10278	82	36	ml	ml	PROPN
aiua-10278	82	37	)	)	PUNCT
aiua-10278	82	38	,	,	PUNCT
aiua-10278	82	39	pi	pi	NOUN
aiua-10278	82	40	-	-	PUNCT
aiua-10278	82	41	rads	rad	NOUN
aiua-10278	82	42	3	3	NUM
aiua-10278	82	43	-	-	SYM
aiua-10278	82	44	5	5	NUM
aiua-10278	82	45	was	be	AUX
aiua-10278	82	46	a	a	DET
aiua-10278	82	47	significant	significant	ADJ
aiua-10278	82	48	predictor	predictor	NOUN
aiua-10278	82	49	of	of	ADP
aiua-10278	82	50	pca	pca	PROPN
aiua-10278	82	51	and	and	CCONJ
aiua-10278	82	52	cspca	cspca	PROPN
aiua-10278	82	53	(	(	PUNCT
aiua-10278	82	54	p	p	NOUN
aiua-10278	82	55	=	=	NOUN
aiua-10278	82	56	0.004	0.004	NUM
aiua-10278	82	57	and	and	CCONJ
aiua-10278	82	58	p	p	NOUN
aiua-10278	82	59	=	=	PROPN
aiua-10278	82	60	0.018	0.018	NUM
aiua-10278	82	61	,	,	PUNCT
aiua-10278	82	62	respectively	respectively	ADV
aiua-10278	82	63	)	)	PUNCT
aiua-10278	82	64	and	and	CCONJ
aiua-10278	82	65	that	that	SCONJ
aiua-10278	82	66	in	in	ADP
aiua-10278	82	67	patients	patient	NOUN
aiua-10278	82	68	with	with	ADP
aiua-10278	82	69	high	high	ADJ
aiua-10278	82	70	psa	psa	NOUN
aiua-10278	82	71	levels	level	NOUN
aiua-10278	82	72	(	(	PUNCT
aiua-10278	82	73	psa	psa	VERB
aiua-10278	82	74	>	>	X
aiua-10278	82	75	10	10	NUM
aiua-10278	82	76	ng	ng	PROPN
aiua-10278	82	77	/	/	SYM
aiua-10278	82	78	ml	ml	PROPN
aiua-10278	82	79	)	)	PUNCT
aiua-10278	82	80	,	,	PUNCT
aiua-10278	82	81	pi	pi	NOUN
aiua-10278	82	82	-	-	PUNCT
aiua-10278	82	83	rads	rad	NOUN
aiua-10278	82	84	3	3	NUM
aiua-10278	82	85	-	-	SYM
aiua-10278	82	86	5	5	NUM
aiua-10278	82	87	was	be	AUX
aiua-10278	82	88	also	also	ADV
aiua-10278	82	89	significantly	significantly	ADV
aiua-10278	82	90	associated	associate	VERB
aiua-10278	82	91	with	with	ADP
aiua-10278	82	92	pca	pca	PROPN
aiua-10278	82	93	and	and	CCONJ
aiua-10278	82	94	cspca	cspca	NOUN
aiua-10278	82	95	(	(	PUNCT
aiua-10278	82	96	p	p	NOUN
aiua-10278	82	97	=	=	NOUN
aiua-10278	82	98	0.004	0.004	NUM
aiua-10278	82	99	and	and	CCONJ
aiua-10278	82	100	p	p	X
aiua-10278	82	101	<	<	X
aiua-10278	82	102	0.001	0.001	NUM
aiua-10278	82	103	,	,	PUNCT
aiua-10278	82	104	respectively	respectively	ADV
aiua-10278	82	105	)	)	PUNCT
aiua-10278	82	106	.	.	PUNCT
aiua-10278	83	1	low	low	ADJ
aiua-10278	83	2	vs.	vs.	ADP
aiua-10278	83	3	high	high	ADJ
aiua-10278	83	4	risk	risk	NOUN
aiua-10278	83	5	based	base	VERB
aiua-10278	83	6	on	on	ADP
aiua-10278	83	7	psad	psad	ADJ
aiua-10278	83	8	in	in	ADP
aiua-10278	83	9	stratified	stratified	ADJ
aiua-10278	83	10	analysis	analysis	NOUN
aiua-10278	83	11	by	by	ADP
aiua-10278	83	12	clinical	clinical	ADJ
aiua-10278	83	13	suspicion	suspicion	NOUN
aiua-10278	83	14	based	base	VERB
aiua-10278	83	15	on	on	ADP
aiua-10278	83	16	psad	psad	PROPN
aiua-10278	83	17	,	,	PUNCT
aiua-10278	83	18	we	we	PRON
aiua-10278	83	19	found	find	VERB
aiua-10278	83	20	that	that	SCONJ
aiua-10278	83	21	in	in	ADP
aiua-10278	83	22	patients	patient	NOUN
aiua-10278	83	23	with	with	ADP
aiua-10278	83	24	low	low	ADJ
aiua-10278	83	25	clinical	clinical	ADJ
aiua-10278	83	26	suspicion	suspicion	NOUN
aiua-10278	83	27	of	of	ADP
aiua-10278	83	28	cancer	cancer	NOUN
aiua-10278	83	29	(	(	PUNCT
aiua-10278	83	30	psad	psad	ADJ
aiua-10278	83	31	≤	≤	NUM
aiua-10278	83	32	0.15	0.15	NUM
aiua-10278	83	33	ng	ng	NOUN
aiua-10278	83	34	/	/	SYM
aiua-10278	83	35	ml	ml	PROPN
aiua-10278	83	36	/	/	SYM
aiua-10278	83	37	cc	cc	NOUN
aiua-10278	83	38	)	)	PUNCT
aiua-10278	83	39	,	,	PUNCT
aiua-10278	83	40	pi	pi	NOUN
aiua-10278	83	41	-	-	PUNCT
aiua-10278	83	42	rads	rad	NOUN
aiua-10278	83	43	3	3	NUM
aiua-10278	83	44	-	-	SYM
aiua-10278	83	45	5	5	NUM
aiua-10278	83	46	was	be	AUX
aiua-10278	83	47	a	a	DET
aiua-10278	83	48	predictor	predictor	NOUN
aiua-10278	83	49	of	of	ADP
aiua-10278	83	50	cspca	cspca	NOUN
aiua-10278	83	51	(	(	PUNCT
aiua-10278	83	52	p	p	X
aiua-10278	83	53	=	=	NOUN
aiua-10278	83	54	0.044	0.044	NUM
aiua-10278	83	55	)	)	PUNCT
aiua-10278	83	56	.	.	PUNCT
aiua-10278	84	1	however	however	ADV
aiua-10278	84	2	,	,	PUNCT
aiua-10278	84	3	in	in	ADP
aiua-10278	84	4	this	this	DET
aiua-10278	84	5	group	group	NOUN
aiua-10278	84	6	,	,	PUNCT
aiua-10278	84	7	pirads	pirad	VERB
aiua-10278	84	8	3	3	NUM
aiua-10278	84	9	-	-	SYM
aiua-10278	84	10	5	5	NUM
aiua-10278	84	11	was	be	AUX
aiua-10278	84	12	not	not	PART
aiua-10278	84	13	significantly	significantly	ADV
aiua-10278	84	14	associated	associate	VERB
aiua-10278	84	15	with	with	ADP
aiua-10278	84	16	pca	pca	PROPN
aiua-10278	84	17	(	(	PUNCT
aiua-10278	84	18	p	p	X
aiua-10278	84	19	=	=	NOUN
aiua-10278	84	20	0.139	0.139	NUM
aiua-10278	84	21	)	)	PUNCT
aiua-10278	84	22	.	.	PUNCT
aiua-10278	85	1	in	in	ADP
aiua-10278	85	2	patients	patient	NOUN
aiua-10278	85	3	with	with	ADP
aiua-10278	85	4	high	high	ADJ
aiua-10278	85	5	clinical	clinical	ADJ
aiua-10278	85	6	suspicion	suspicion	NOUN
aiua-10278	85	7	of	of	ADP
aiua-10278	85	8	pca	pca	PROPN
aiua-10278	85	9	(	(	PUNCT
aiua-10278	85	10	psad	psad	VERB
aiua-10278	85	11	>	>	X
aiua-10278	85	12	0.15	0.15	NUM
aiua-10278	85	13	ng	ng	PROPN
aiua-10278	85	14	/	/	SYM
aiua-10278	85	15	ml	ml	PROPN
aiua-10278	85	16	/	/	SYM
aiua-10278	85	17	cc	cc	NOUN
aiua-10278	85	18	)	)	PUNCT
aiua-10278	85	19	,	,	PUNCT
aiua-10278	85	20	pi	pi	NOUN
aiua-10278	85	21	-	-	PUNCT
aiua-10278	85	22	rads	rad	NOUN
aiua-10278	85	23	3	3	NUM
aiua-10278	85	24	-	-	SYM
aiua-10278	85	25	5	5	NUM
aiua-10278	85	26	was	be	AUX
aiua-10278	85	27	significantly	significantly	ADV
aiua-10278	85	28	associated	associate	VERB
aiua-10278	85	29	with	with	ADP
aiua-10278	85	30	both	both	PRON
aiua-10278	85	31	pca	pca	NOUN
aiua-10278	85	32	and	and	CCONJ
aiua-10278	85	33	cspca	cspca	PROPN
aiua-10278	85	34	(	(	PUNCT
aiua-10278	85	35	p	p	X
aiua-10278	85	36	<	<	X
aiua-10278	85	37	0.001	0.001	NUM
aiua-10278	85	38	)	)	PUNCT
aiua-10278	85	39	.	.	PUNCT
aiua-10278	86	1	low	low	ADJ
aiua-10278	86	2	vs.	vs.	ADP
aiua-10278	86	3	high	high	ADJ
aiua-10278	86	4	risk	risk	NOUN
aiua-10278	86	5	based	base	VERB
aiua-10278	86	6	on	on	ADP
aiua-10278	86	7	dre	dre	PROPN
aiua-10278	86	8	in	in	ADP
aiua-10278	86	9	stratified	stratified	ADJ
aiua-10278	86	10	analysis	analysis	NOUN
aiua-10278	86	11	by	by	ADP
aiua-10278	86	12	clinical	clinical	ADJ
aiua-10278	86	13	suspicion	suspicion	NOUN
aiua-10278	86	14	based	base	VERB
aiua-10278	86	15	on	on	ADP
aiua-10278	86	16	dre	dre	PROPN
aiua-10278	86	17	,	,	PUNCT
aiua-10278	86	18	we	we	PRON
aiua-10278	86	19	found	find	VERB
aiua-10278	86	20	that	that	SCONJ
aiua-10278	86	21	in	in	ADP
aiua-10278	86	22	patients	patient	NOUN
aiua-10278	86	23	with	with	ADP
aiua-10278	86	24	low	low	ADJ
aiua-10278	86	25	clinical	clinical	ADJ
aiua-10278	86	26	suspicion	suspicion	NOUN
aiua-10278	86	27	of	of	ADP
aiua-10278	86	28	cancer	cancer	NOUN
aiua-10278	86	29	(	(	PUNCT
aiua-10278	86	30	normal	normal	ADJ
aiua-10278	86	31	dre	dre	NOUN
aiua-10278	86	32	)	)	PUNCT
aiua-10278	86	33	,	,	PUNCT
aiua-10278	86	34	pi	pi	NOUN
aiua-10278	86	35	-	-	PUNCT
aiua-10278	86	36	rads	rad	NOUN
aiua-10278	86	37	3	3	NUM
aiua-10278	86	38	-	-	SYM
aiua-10278	86	39	5	5	NUM
aiua-10278	86	40	was	be	AUX
aiua-10278	86	41	a	a	DET
aiua-10278	86	42	predictor	predictor	NOUN
aiua-10278	86	43	of	of	ADP
aiua-10278	86	44	both	both	DET
aiua-10278	86	45	pca	pca	PROPN
aiua-10278	86	46	and	and	CCONJ
aiua-10278	86	47	cspca	cspca	PROPN
aiua-10278	86	48	(	(	PUNCT
aiua-10278	86	49	p	p	X
aiua-10278	86	50	=	=	PROPN
aiua-10278	86	51	0.007	0.007	NUM
aiua-10278	86	52	and	and	CCONJ
aiua-10278	86	53	p	p	NOUN
aiua-10278	86	54	=	=	NOUN
aiua-10278	86	55	0.004	0.004	NUM
aiua-10278	86	56	,	,	PUNCT
aiua-10278	86	57	respectively	respectively	ADV
aiua-10278	86	58	)	)	PUNCT
aiua-10278	86	59	.	.	PUNCT
aiua-10278	87	1	conversely	conversely	ADV
aiua-10278	87	2	,	,	PUNCT
aiua-10278	87	3	in	in	ADP
aiua-10278	87	4	patients	patient	NOUN
aiua-10278	87	5	with	with	ADP
aiua-10278	87	6	suspicious	suspicious	ADJ
aiua-10278	87	7	dre	dre	NOUN
aiua-10278	87	8	,	,	PUNCT
aiua-10278	87	9	pirads	pirad	NOUN
aiua-10278	87	10	3	3	NUM
aiua-10278	87	11	-	-	SYM
aiua-10278	87	12	5	5	NUM
aiua-10278	87	13	was	be	AUX
aiua-10278	87	14	neither	neither	CCONJ
aiua-10278	87	15	associated	associate	VERB
aiua-10278	87	16	with	with	ADP
aiua-10278	87	17	pca	pca	NOUN
aiua-10278	87	18	nor	nor	CCONJ
aiua-10278	87	19	with	with	ADP
aiua-10278	87	20	cspca	cspca	NOUN
aiua-10278	87	21	(	(	PUNCT
aiua-10278	87	22	p	p	NOUN
aiua-10278	87	23	=	=	NOUN
aiua-10278	87	24	0.168	0.168	NUM
aiua-10278	87	25	and	and	CCONJ
aiua-10278	87	26	p	p	X
aiua-10278	87	27	=	=	PROPN
aiua-10278	87	28	0.571	0.571	NUM
aiua-10278	87	29	,	,	PUNCT
aiua-10278	87	30	respectively	respectively	ADV
aiua-10278	87	31	)	)	PUNCT
aiua-10278	87	32	.	.	PUNCT
aiua-10278	88	1	noticeably	noticeably	ADV
aiua-10278	88	2	,	,	PUNCT
aiua-10278	88	3	in	in	ADP
aiua-10278	88	4	this	this	DET
aiua-10278	88	5	group	group	NOUN
aiua-10278	88	6	of	of	ADP
aiua-10278	88	7	patients	patient	NOUN
aiua-10278	88	8	,	,	PUNCT
aiua-10278	88	9	only	only	ADV
aiua-10278	88	10	4	4	NUM
aiua-10278	88	11	patients	patient	NOUN
aiua-10278	88	12	(	(	PUNCT
aiua-10278	88	13	7.84	7.84	NUM
aiua-10278	88	14	%	%	NOUN
aiua-10278	88	15	)	)	PUNCT
aiua-10278	88	16	with	with	ADP
aiua-10278	88	17	suspicious	suspicious	ADJ
aiua-10278	88	18	dre	dre	NOUN
aiua-10278	88	19	had	have	VERB
aiua-10278	88	20	normal	normal	ADJ
aiua-10278	88	21	mpmri	mpmri	PROPN
aiua-10278	88	22	findings	finding	NOUN
aiua-10278	88	23	(	(	PUNCT
aiua-10278	88	24	pi	pi	NOUN
aiua-10278	88	25	-	-	PUNCT
aiua-10278	88	26	rads	rad	NOUN
aiua-10278	88	27	1	1	NUM
aiua-10278	88	28	-	-	SYM
aiua-10278	88	29	2	2	NUM
aiua-10278	88	30	)	)	PUNCT
aiua-10278	88	31	and	and	CCONJ
aiua-10278	88	32	out	out	ADP
aiua-10278	88	33	of	of	ADP
aiua-10278	88	34	them	they	PRON
aiua-10278	88	35	2	2	NUM
aiua-10278	88	36	(	(	PUNCT
aiua-10278	88	37	50	50	NUM
aiua-10278	88	38	%	%	NOUN
aiua-10278	88	39	)	)	PUNCT
aiua-10278	88	40	had	have	VERB
aiua-10278	88	41	cspca	cspca	NOUN
aiua-10278	88	42	.	.	PUNCT
aiua-10278	89	1	negative	negative	ADJ
aiua-10278	89	2	prostate	prostate	NOUN
aiua-10278	89	3	biopsy	biopsy	NOUN
aiua-10278	89	4	(	(	PUNCT
aiua-10278	89	5	pb	pb	NOUN
aiua-10278	89	6	)	)	PUNCT
aiua-10278	89	7	result	result	NOUN
aiua-10278	89	8	rates	rate	NOUN
aiua-10278	89	9	of	of	ADP
aiua-10278	89	10	prostate	prostate	NOUN
aiua-10278	89	11	cancer	cancer	NOUN
aiua-10278	89	12	and	and	CCONJ
aiua-10278	89	13	clinically	clinically	ADV
aiua-10278	89	14	significant	significant	ADJ
aiua-10278	89	15	prostate	prostate	NOUN
aiua-10278	89	16	cancer	cancer	NOUN
aiua-10278	89	17	as	as	ADP
aiua-10278	89	18	secondary	secondary	ADJ
aiua-10278	89	19	analysis	analysis	NOUN
aiua-10278	89	20	,	,	PUNCT
aiua-10278	89	21	we	we	PRON
aiua-10278	89	22	evaluated	evaluate	VERB
aiua-10278	89	23	the	the	DET
aiua-10278	89	24	rate	rate	NOUN
aiua-10278	89	25	of	of	ADP
aiua-10278	89	26	negative	negative	ADJ
aiua-10278	89	27	pb	pb	ADV
aiua-10278	89	28	in	in	ADP
aiua-10278	89	29	the	the	DET
aiua-10278	89	30	subgroup	subgroup	NOUN
aiua-10278	89	31	of	of	ADP
aiua-10278	89	32	patients	patient	NOUN
aiua-10278	89	33	with	with	ADP
aiua-10278	89	34	pi	pi	NOUN
aiua-10278	89	35	-	-	PUNCT
aiua-10278	89	36	rads	rad	NOUN
aiua-10278	89	37	3	3	NUM
aiua-10278	89	38	-	-	SYM
aiua-10278	89	39	5	5	NUM
aiua-10278	89	40	.	.	PUNCT
aiua-10278	90	1	these	these	DET
aiua-10278	90	2	results	result	NOUN
aiua-10278	90	3	are	be	AUX
aiua-10278	90	4	shown	show	VERB
aiua-10278	90	5	in	in	ADP
aiua-10278	90	6	table	table	NOUN
aiua-10278	90	7	5	5	NUM
aiua-10278	90	8	.	.	PUNCT
aiua-10278	91	1	in	in	ADP
aiua-10278	91	2	total	total	NOUN
aiua-10278	91	3	,	,	PUNCT
aiua-10278	91	4	37.9	37.9	NUM
aiua-10278	91	5	%	%	NOUN
aiua-10278	91	6	of	of	ADP
aiua-10278	91	7	patients	patient	NOUN
aiua-10278	91	8	biopsied	biopsie	VERB
aiua-10278	91	9	had	have	VERB
aiua-10278	91	10	no	no	DET
aiua-10278	91	11	pca	pca	NOUN
aiua-10278	91	12	and	and	CCONJ
aiua-10278	91	13	51	51	NUM
aiua-10278	91	14	%	%	NOUN
aiua-10278	91	15	no	no	DET
aiua-10278	91	16	cspca	cspca	NOUN
aiua-10278	91	17	.	.	PUNCT
aiua-10278	92	1	if	if	SCONJ
aiua-10278	92	2	only	only	ADV
aiua-10278	92	3	patients	patient	NOUN
aiua-10278	92	4	with	with	ADP
aiua-10278	92	5	pi	pi	NOUN
aiua-10278	92	6	-	-	PUNCT
aiua-10278	92	7	rads	rad	NOUN
aiua-10278	92	8	3	3	NUM
aiua-10278	92	9	-	-	SYM
aiua-10278	92	10	5	5	NUM
aiua-10278	92	11	were	be	AUX
aiua-10278	92	12	considered	consider	VERB
aiua-10278	92	13	,	,	PUNCT
aiua-10278	92	14	negative	negative	ADJ
aiua-10278	92	15	pb	pb	ADP
aiua-10278	92	16	rate	rate	NOUN
aiua-10278	92	17	dropped	drop	VERB
aiua-10278	92	18	to	to	ADP
aiua-10278	92	19	27.2	27.2	NUM
aiua-10278	92	20	%	%	NOUN
aiua-10278	92	21	and	and	CCONJ
aiua-10278	92	22	36.9	36.9	NUM
aiua-10278	92	23	%	%	NOUN
aiua-10278	92	24	for	for	ADP
aiua-10278	92	25	pca	pca	NOUN
aiua-10278	92	26	and	and	CCONJ
aiua-10278	92	27	cspca	cspca	NOUN
aiua-10278	92	28	respectively	respectively	ADV
aiua-10278	92	29	.	.	PUNCT
aiua-10278	93	1	the	the	DET
aiua-10278	93	2	rate	rate	NOUN
aiua-10278	93	3	of	of	ADP
aiua-10278	93	4	patients	patient	NOUN
aiua-10278	93	5	with	with	ADP
aiua-10278	93	6	pca	pca	NOUN
aiua-10278	93	7	and	and	CCONJ
aiua-10278	93	8	cspca	cspca	NOUN
aiua-10278	93	9	and	and	CCONJ
aiua-10278	93	10	pirads	pirad	NOUN
aiua-10278	93	11	1	1	NUM
aiua-10278	93	12	-	-	SYM
aiua-10278	93	13	2	2	NUM
aiua-10278	93	14	who	who	PRON
aiua-10278	93	15	would	would	AUX
aiua-10278	93	16	not	not	PART
aiua-10278	93	17	be	be	AUX
aiua-10278	93	18	biopsied	biopsie	VERB
aiua-10278	93	19	or	or	CCONJ
aiua-10278	93	20	diagnosed	diagnose	VERB
aiua-10278	93	21	with	with	ADP
aiua-10278	93	22	this	this	DET
aiua-10278	93	23	approach	approach	NOUN
aiua-10278	93	24	(	(	PUNCT
aiua-10278	93	25	false	false	ADJ
aiua-10278	93	26	negative	negative	ADJ
aiua-10278	93	27	rate	rate	NOUN
aiua-10278	93	28	)	)	PUNCT
aiua-10278	93	29	would	would	AUX
aiua-10278	93	30	be	be	AUX
aiua-10278	93	31	5.8	5.8	NUM
aiua-10278	93	32	%	%	NOUN
aiua-10278	93	33	and	and	CCONJ
aiua-10278	93	34	2.4	2.4	NUM
aiua-10278	93	35	%	%	NOUN
aiua-10278	93	36	,	,	PUNCT
aiua-10278	93	37	respectively	respectively	ADV
aiua-10278	93	38	.	.	PUNCT
aiua-10278	94	1	patients	patient	NOUN
aiua-10278	94	2	with	with	ADP
aiua-10278	94	3	high	high	ADJ
aiua-10278	94	4	risk	risk	NOUN
aiua-10278	94	5	based	base	VERB
aiua-10278	94	6	on	on	ADP
aiua-10278	94	7	psa	psa	NOUN
aiua-10278	94	8	among	among	ADP
aiua-10278	94	9	patients	patient	NOUN
aiua-10278	94	10	with	with	ADP
aiua-10278	94	11	psa	psa	PROPN
aiua-10278	94	12	>	>	X
aiua-10278	94	13	10	10	NUM
aiua-10278	94	14	ng	ng	PROPN
aiua-10278	94	15	/	/	SYM
aiua-10278	94	16	ml	ml	PROPN
aiua-10278	94	17	,	,	PUNCT
aiua-10278	94	18	the	the	DET
aiua-10278	94	19	rate	rate	NOUN
aiua-10278	94	20	of	of	ADP
aiua-10278	94	21	negative	negative	ADJ
aiua-10278	94	22	pb	pb	ADP
aiua-10278	94	23	was	be	AUX
aiua-10278	94	24	35.4	35.4	NUM
aiua-10278	94	25	%	%	NOUN
aiua-10278	94	26	for	for	ADP
aiua-10278	94	27	pca	pca	PROPN
aiua-10278	94	28	and	and	CCONJ
aiua-10278	94	29	43	43	NUM
aiua-10278	94	30	%	%	NOUN
aiua-10278	94	31	for	for	ADP
aiua-10278	94	32	cspca	cspca	NOUN
aiua-10278	94	33	.	.	PUNCT
aiua-10278	95	1	patients	patient	NOUN
aiua-10278	95	2	with	with	ADP
aiua-10278	95	3	psa	psa	PROPN
aiua-10278	95	4	>	>	X
aiua-10278	95	5	10	10	NUM
aiua-10278	95	6	ng	ng	PROPN
aiua-10278	95	7	/	/	SYM
aiua-10278	95	8	ml	ml	NOUN
aiua-10278	95	9	and	and	CCONJ
aiua-10278	95	10	pirads	pirad	NOUN
aiua-10278	95	11	3	3	NUM
aiua-10278	95	12	-	-	SYM
aiua-10278	95	13	5	5	NUM
aiua-10278	95	14	did	do	AUX
aiua-10278	95	15	not	not	PART
aiua-10278	95	16	have	have	VERB
aiua-10278	95	17	pca	pca	NOUN
aiua-10278	95	18	and	and	CCONJ
aiua-10278	95	19	cspca	cspca	NOUN
aiua-10278	95	20	in	in	ADP
aiua-10278	95	21	22.8	22.8	NUM
aiua-10278	95	22	%	%	NOUN
aiua-10278	95	23	and	and	CCONJ
aiua-10278	95	24	26.6	26.6	NUM
aiua-10278	95	25	%	%	NOUN
aiua-10278	95	26	respectively	respectively	ADV
aiua-10278	95	27	.	.	PUNCT
aiua-10278	96	1	if	if	SCONJ
aiua-10278	96	2	among	among	ADP
aiua-10278	96	3	patients	patient	NOUN
aiua-10278	96	4	with	with	ADP
aiua-10278	96	5	psa	psa	PROPN
aiua-10278	96	6	>	>	X
aiua-10278	96	7	10	10	NUM
aiua-10278	96	8	ng	ng	PROPN
aiua-10278	96	9	/	/	SYM
aiua-10278	96	10	m	m	PROPN
aiua-10278	96	11	,	,	PUNCT
aiua-10278	96	12	only	only	ADV
aiua-10278	96	13	those	those	PRON
aiua-10278	96	14	with	with	ADP
aiua-10278	96	15	pi	pi	NOUN
aiua-10278	96	16	-	-	PUNCT
aiua-10278	96	17	rads	rad	NOUN
aiua-10278	96	18	3	3	NUM
aiua-10278	96	19	-	-	SYM
aiua-10278	96	20	5	5	NUM
aiua-10278	96	21	were	be	AUX
aiua-10278	96	22	biopsied	biopsie	VERB
aiua-10278	96	23	,	,	PUNCT
aiua-10278	96	24	the	the	DET
aiua-10278	96	25	false	false	ADJ
aiua-10278	96	26	negative	negative	ADJ
aiua-10278	96	27	rates	rate	NOUN
aiua-10278	96	28	would	would	AUX
aiua-10278	96	29	be	be	AUX
aiua-10278	96	30	5.1	5.1	NUM
aiua-10278	96	31	%	%	NOUN
aiua-10278	96	32	for	for	ADP
aiua-10278	96	33	pca	pca	NOUN
aiua-10278	96	34	and	and	CCONJ
aiua-10278	96	35	1.3	1.3	NUM
aiua-10278	96	36	%	%	NOUN
aiua-10278	96	37	for	for	ADP
aiua-10278	96	38	cspca	cspca	NOUN
aiua-10278	96	39	.	.	PUNCT
aiua-10278	97	1	patients	patient	NOUN
aiua-10278	97	2	with	with	ADP
aiua-10278	97	3	high	high	ADJ
aiua-10278	97	4	risk	risk	NOUN
aiua-10278	97	5	based	base	VERB
aiua-10278	97	6	on	on	ADP
aiua-10278	97	7	psad	psad	ADJ
aiua-10278	97	8	patients	patient	NOUN
aiua-10278	97	9	with	with	ADP
aiua-10278	97	10	psad	psad	PROPN
aiua-10278	97	11	>	>	X
aiua-10278	97	12	0.15	0.15	NUM
aiua-10278	97	13	ng	ng	PROPN
aiua-10278	97	14	/	/	SYM
aiua-10278	97	15	ml	ml	PROPN
aiua-10278	97	16	/	/	SYM
aiua-10278	97	17	cc	cc	NOUN
aiua-10278	97	18	had	have	VERB
aiua-10278	97	19	a	a	DET
aiua-10278	97	20	negative	negative	ADJ
aiua-10278	97	21	pb	pb	ADP
aiua-10278	97	22	result	result	NOUN
aiua-10278	97	23	rate	rate	NOUN
aiua-10278	97	24	of	of	ADP
aiua-10278	97	25	22.5	22.5	NUM
aiua-10278	97	26	%	%	NOUN
aiua-10278	97	27	for	for	ADP
aiua-10278	97	28	pca	pca	PROPN
aiua-10278	97	29	and	and	CCONJ
aiua-10278	97	30	of	of	ADP
aiua-10278	97	31	33.8	33.8	NUM
aiua-10278	97	32	%	%	NOUN
aiua-10278	97	33	for	for	ADP
aiua-10278	97	34	cspca	cspca	NOUN
aiua-10278	97	35	,	,	PUNCT
aiua-10278	97	36	respectively	respectively	ADV
aiua-10278	97	37	.	.	PUNCT
aiua-10278	98	1	patients	patient	NOUN
aiua-10278	98	2	with	with	ADP
aiua-10278	98	3	psad	psad	ADJ
aiua-10278	98	4	>	>	PUNCT
aiua-10278	98	5	0.15	0.15	NUM
aiua-10278	98	6	and	and	CCONJ
aiua-10278	98	7	pi	pi	NOUN
aiua-10278	98	8	-	-	PUNCT
aiua-10278	98	9	rads	rad	NOUN
aiua-10278	98	10	3	3	NUM
aiua-10278	98	11	-	-	SYM
aiua-10278	98	12	5	5	NUM
aiua-10278	98	13	had	have	VERB
aiua-10278	98	14	no	no	DET
aiua-10278	98	15	pca	pca	NOUN
aiua-10278	98	16	in	in	ADP
aiua-10278	98	17	12.5	12.5	NUM
aiua-10278	98	18	%	%	NOUN
aiua-10278	98	19	and	and	CCONJ
aiua-10278	98	20	no	no	DET
aiua-10278	98	21	cspca	cspca	NOUN
aiua-10278	98	22	in	in	ADP
aiua-10278	98	23	21.3	21.3	NUM
aiua-10278	98	24	%	%	NOUN
aiua-10278	98	25	.	.	PUNCT
aiua-10278	99	1	if	if	SCONJ
aiua-10278	99	2	only	only	ADV
aiua-10278	99	3	patients	patient	NOUN
aiua-10278	99	4	with	with	ADP
aiua-10278	99	5	pirads	pirad	NOUN
aiua-10278	99	6	3	3	NUM
aiua-10278	99	7	-	-	SYM
aiua-10278	99	8	5	5	NUM
aiua-10278	99	9	were	be	AUX
aiua-10278	99	10	biopsied	biopsie	VERB
aiua-10278	99	11	,	,	PUNCT
aiua-10278	99	12	5.0	5.0	NUM
aiua-10278	99	13	%	%	NOUN
aiua-10278	99	14	of	of	ADP
aiua-10278	99	15	patients	patient	NOUN
aiua-10278	99	16	with	with	ADP
aiua-10278	99	17	pca	pca	PROPN
aiua-10278	99	18	and	and	CCONJ
aiua-10278	99	19	2.5	2.5	NUM
aiua-10278	99	20	%	%	NOUN
aiua-10278	99	21	of	of	ADP
aiua-10278	99	22	patients	patient	NOUN
aiua-10278	99	23	with	with	ADP
aiua-10278	99	24	cspca	cspca	NOUN
aiua-10278	99	25	would	would	AUX
aiua-10278	99	26	be	be	AUX
aiua-10278	99	27	missed	miss	VERB
aiua-10278	99	28	.	.	PUNCT
aiua-10278	100	1	patients	patient	NOUN
aiua-10278	100	2	with	with	ADP
aiua-10278	100	3	high	high	ADJ
aiua-10278	100	4	risk	risk	NOUN
aiua-10278	100	5	based	base	VERB
aiua-10278	100	6	on	on	ADP
aiua-10278	100	7	dre	dre	PROPN
aiua-10278	100	8	patients	patient	NOUN
aiua-10278	100	9	with	with	ADP
aiua-10278	100	10	suspicious	suspicious	ADJ
aiua-10278	100	11	dre	dre	NOUN
aiua-10278	100	12	had	have	VERB
aiua-10278	100	13	no	no	DET
aiua-10278	100	14	pca	pca	NOUN
aiua-10278	100	15	in	in	ADP
aiua-10278	100	16	19.6	19.6	NUM
aiua-10278	100	17	%	%	NOUN
aiua-10278	100	18	and	and	CCONJ
aiua-10278	100	19	no	no	DET
aiua-10278	100	20	cspca	cspca	NOUN
aiua-10278	100	21	in	in	ADP
aiua-10278	100	22	29.4	29.4	NUM
aiua-10278	100	23	%	%	NOUN
aiua-10278	100	24	.	.	PUNCT
aiua-10278	101	1	if	if	SCONJ
aiua-10278	101	2	only	only	ADV
aiua-10278	101	3	patients	patient	NOUN
aiua-10278	101	4	with	with	ADP
aiua-10278	101	5	suspicious	suspicious	ADJ
aiua-10278	101	6	dre	dre	NOUN
aiua-10278	101	7	and	and	CCONJ
aiua-10278	101	8	pi	pi	NOUN
aiua-10278	101	9	-	-	PUNCT
aiua-10278	101	10	rads	rad	NOUN
aiua-10278	101	11	3	3	NUM
aiua-10278	101	12	-	-	SYM
aiua-10278	101	13	5	5	NUM
aiua-10278	101	14	had	have	VERB
aiua-10278	101	15	undergone	undergo	VERB
aiua-10278	101	16	biopsy	biopsy	NOUN
aiua-10278	101	17	,	,	PUNCT
aiua-10278	101	18	15.7	15.7	NUM
aiua-10278	101	19	%	%	NOUN
aiua-10278	101	20	would	would	AUX
aiua-10278	101	21	have	have	VERB
aiua-10278	101	22	no	no	DET
aiua-10278	101	23	pca	pca	NOUN
aiua-10278	101	24	and	and	CCONJ
aiua-10278	101	25	25.5	25.5	NUM
aiua-10278	101	26	%	%	NOUN
aiua-10278	101	27	would	would	AUX
aiua-10278	101	28	have	have	VERB
aiua-10278	101	29	no	no	DET
aiua-10278	101	30	cspca	cspca	NOUN
aiua-10278	101	31	.	.	PUNCT
aiua-10278	102	1	according	accord	VERB
aiua-10278	102	2	to	to	ADP
aiua-10278	102	3	this	this	DET
aiua-10278	102	4	approach	approach	NOUN
aiua-10278	102	5	,	,	PUNCT
aiua-10278	102	6	3.9	3.9	NUM
aiua-10278	102	7	%	%	NOUN
aiua-10278	102	8	of	of	ADP
aiua-10278	102	9	patients	patient	NOUN
aiua-10278	102	10	with	with	ADP
aiua-10278	102	11	suspicious	suspicious	ADJ
aiua-10278	102	12	dre	dre	NOUN
aiua-10278	102	13	and	and	CCONJ
aiua-10278	102	14	pi	pi	NOUN
aiua-10278	102	15	-	-	PUNCT
aiua-10278	102	16	rads	rad	NOUN
aiua-10278	102	17	1	1	NUM
aiua-10278	102	18	-	-	SYM
aiua-10278	102	19	2	2	NUM
aiua-10278	102	20	bearing	bear	VERB
aiua-10278	102	21	pca	pca	NOUN
aiua-10278	102	22	or	or	CCONJ
aiua-10278	102	23	cspca	cspca	NOUN
aiua-10278	102	24	would	would	AUX
aiua-10278	102	25	be	be	AUX
aiua-10278	102	26	missed	miss	VERB
aiua-10278	102	27	.	.	PUNCT
aiua-10278	103	1	table	table	NOUN
aiua-10278	103	2	3	3	NUM
aiua-10278	103	3	.	.	PUNCT
aiua-10278	103	4	association	association	NOUN
aiua-10278	103	5	of	of	ADP
aiua-10278	103	6	pi	pi	NOUN
aiua-10278	103	7	-	-	PUNCT
aiua-10278	103	8	rads	rad	NOUN
aiua-10278	103	9	with	with	ADP
aiua-10278	103	10	pca	pca	NOUN
aiua-10278	103	11	and	and	CCONJ
aiua-10278	103	12	cspca	cspca	NOUN
aiua-10278	103	13	stratified	stratify	VERB
aiua-10278	103	14	for	for	ADP
aiua-10278	103	15	psa	psa	VERB
aiua-10278	103	16	≤	≤	PROPN
aiua-10278	103	17	10	10	NUM
aiua-10278	103	18	ng	ng	PROPN
aiua-10278	103	19	/	/	SYM
aiua-10278	103	20	ml	ml	PROPN
aiua-10278	103	21	and	and	CCONJ
aiua-10278	103	22	>	>	X
aiua-10278	103	23	10	10	NUM
aiua-10278	103	24	ng	ng	PROPN
aiua-10278	103	25	/	/	SYM
aiua-10278	103	26	ml	ml	PROPN
aiua-10278	103	27	and	and	CCONJ
aiua-10278	103	28	psad	psad	VERB
aiua-10278	103	29	≤	≤	NUM
aiua-10278	103	30	0.15	0.15	NUM
aiua-10278	103	31	ng	ng	NOUN
aiua-10278	103	32	/	/	SYM
aiua-10278	103	33	ml	ml	NOUN
aiua-10278	103	34	/	/	SYM
aiua-10278	103	35	cc	cc	NOUN
aiua-10278	103	36	and	and	CCONJ
aiua-10278	103	37	>	>	X
aiua-10278	103	38	0.15	0.15	NUM
aiua-10278	103	39	ng	ng	PROPN
aiua-10278	103	40	/	/	SYM
aiua-10278	103	41	ml	ml	PROPN
aiua-10278	103	42	/	/	SYM
aiua-10278	103	43	cc	cc	NOUN
aiua-10278	103	44	.	.	NOUN
aiua-10278	103	45	prostate	prostate	NOUN
aiua-10278	103	46	cancer	cancer	NOUN
aiua-10278	103	47	significant	significant	ADJ
aiua-10278	103	48	prostate	prostate	NOUN
aiua-10278	103	49	cancer	cancer	NOUN
aiua-10278	103	50	n	n	CCONJ
aiua-10278	103	51	no	no	DET
aiua-10278	103	52	cancer	cancer	NOUN
aiua-10278	103	53	pca	pca	NOUN
aiua-10278	103	54	p	p	NOUN
aiua-10278	103	55	no	no	DET
aiua-10278	103	56	cancer	cancer	NOUN
aiua-10278	103	57	cspca	cspca	NOUN
aiua-10278	103	58	p	p	NOUN
aiua-10278	103	59	psa	psa	VERB
aiua-10278	103	60	≤	≤	NUM
aiua-10278	103	61	10	10	NUM
aiua-10278	103	62	ng	ng	PROPN
aiua-10278	103	63	/	/	SYM
aiua-10278	103	64	ml	ml	PROPN
aiua-10278	103	65	127	127	NUM
aiua-10278	103	66	pi	pi	NOUN
aiua-10278	103	67	-	-	PUNCT
aiua-10278	103	68	rads	rad	NOUN
aiua-10278	103	69	1	1	NUM
aiua-10278	103	70	-	-	SYM
aiua-10278	103	71	2	2	NUM
aiua-10278	103	72	12	12	NUM
aiua-10278	103	73	(	(	PUNCT
aiua-10278	103	74	60.0	60.0	NUM
aiua-10278	103	75	%	%	NOUN
aiua-10278	103	76	)	)	PUNCT
aiua-10278	103	77	8	8	NUM
aiua-10278	103	78	(	(	PUNCT
aiua-10278	103	79	40.0	40.0	NUM
aiua-10278	103	80	%	%	NOUN
aiua-10278	103	81	)	)	PUNCT
aiua-10278	103	82	0.004	0.004	NUM
aiua-10278	104	1	*	*	SYM
aiua-10278	104	2	16	16	NUM
aiua-10278	104	3	(	(	PUNCT
aiua-10278	104	4	80.0	80.0	NUM
aiua-10278	104	5	%	%	NOUN
aiua-10278	104	6	)	)	PUNCT
aiua-10278	104	7	4	4	NUM
aiua-10278	104	8	(	(	PUNCT
aiua-10278	104	9	20.0	20.0	NUM
aiua-10278	104	10	%	%	NOUN
aiua-10278	104	11	)	)	PUNCT
aiua-10278	104	12	0.018	0.018	NUM
aiua-10278	104	13	*	*	NOUN
aiua-10278	104	14	pi	pi	NOUN
aiua-10278	104	15	-	-	PUNCT
aiua-10278	104	16	rads	rad	NOUN
aiua-10278	104	17	3	3	NUM
aiua-10278	104	18	-	-	SYM
aiua-10278	104	19	5	5	NUM
aiua-10278	104	20	38	38	NUM
aiua-10278	104	21	(	(	PUNCT
aiua-10278	104	22	35.51	35.51	NUM
aiua-10278	104	23	%	%	NOUN
aiua-10278	104	24	)	)	PUNCT
aiua-10278	104	25	69	69	NUM
aiua-10278	104	26	(	(	PUNCT
aiua-10278	104	27	64.49	64.49	NUM
aiua-10278	104	28	%	%	NOUN
aiua-10278	104	29	)	)	PUNCT
aiua-10278	104	30	55	55	NUM
aiua-10278	104	31	(	(	PUNCT
aiua-10278	104	32	51.40	51.40	NUM
aiua-10278	104	33	%	%	NOUN
aiua-10278	104	34	)	)	PUNCT
aiua-10278	104	35	52	52	NUM
aiua-10278	104	36	(	(	PUNCT
aiua-10278	104	37	48.60	48.60	NUM
aiua-10278	104	38	%	%	NOUN
aiua-10278	104	39	)	)	PUNCT
aiua-10278	104	40	psa	psa	VERB
aiua-10278	104	41	>	>	X
aiua-10278	104	42	10	10	NUM
aiua-10278	104	43	ng	ng	PROPN
aiua-10278	104	44	/	/	SYM
aiua-10278	104	45	ml	ml	PROPN
aiua-10278	104	46	79	79	NUM
aiua-10278	104	47	pi	pi	NOUN
aiua-10278	104	48	-	-	PUNCT
aiua-10278	104	49	rads	rad	NOUN
aiua-10278	104	50	1	1	NUM
aiua-10278	104	51	-	-	SYM
aiua-10278	104	52	2	2	NUM
aiua-10278	104	53	10	10	NUM
aiua-10278	104	54	(	(	PUNCT
aiua-10278	104	55	71.43%9	71.43%9	NUM
aiua-10278	104	56	4	4	NUM
aiua-10278	104	57	(	(	PUNCT
aiua-10278	104	58	28.57	28.57	NUM
aiua-10278	104	59	%	%	NOUN
aiua-10278	104	60	)	)	PUNCT
aiua-10278	104	61	0.004	0.004	NUM
aiua-10278	105	1	*	*	PUNCT
aiua-10278	105	2	*	*	SYM
aiua-10278	105	3	13	13	NUM
aiua-10278	105	4	(	(	PUNCT
aiua-10278	105	5	92.86	92.86	NUM
aiua-10278	105	6	%	%	NOUN
aiua-10278	105	7	)	)	PUNCT
aiua-10278	105	8	1	1	NUM
aiua-10278	105	9	(	(	PUNCT
aiua-10278	105	10	7.14	7.14	NUM
aiua-10278	105	11	%	%	NOUN
aiua-10278	105	12	)	)	PUNCT
aiua-10278	105	13	<	<	X
aiua-10278	106	1	0.001	0.001	NUM
aiua-10278	106	2	*	*	NOUN
aiua-10278	106	3	*	*	NOUN
aiua-10278	106	4	pi	pi	NOUN
aiua-10278	106	5	-	-	PUNCT
aiua-10278	106	6	rads	rad	NOUN
aiua-10278	106	7	3	3	NUM
aiua-10278	106	8	-	-	SYM
aiua-10278	106	9	5	5	NUM
aiua-10278	106	10	18	18	NUM
aiua-10278	106	11	(	(	PUNCT
aiua-10278	106	12	27.69	27.69	NUM
aiua-10278	106	13	%	%	NOUN
aiua-10278	106	14	)	)	PUNCT
aiua-10278	106	15	47	47	NUM
aiua-10278	106	16	(	(	PUNCT
aiua-10278	106	17	72.31	72.31	NUM
aiua-10278	106	18	%	%	NOUN
aiua-10278	106	19	)	)	PUNCT
aiua-10278	106	20	21	21	NUM
aiua-10278	106	21	(	(	PUNCT
aiua-10278	106	22	32.31	32.31	NUM
aiua-10278	106	23	%	%	NOUN
aiua-10278	106	24	)	)	PUNCT
aiua-10278	106	25	44	44	NUM
aiua-10278	106	26	(	(	PUNCT
aiua-10278	106	27	67.69	67.69	NUM
aiua-10278	106	28	%	%	NOUN
aiua-10278	106	29	)	)	PUNCT
aiua-10278	106	30	psad	psad	ADJ
aiua-10278	106	31	≤	≤	NUM
aiua-10278	106	32	0.15	0.15	NUM
aiua-10278	106	33	ng	ng	NOUN
aiua-10278	106	34	/	/	SYM
aiua-10278	106	35	ml	ml	PROPN
aiua-10278	106	36	/	/	SYM
aiua-10278	106	37	cc	cc	PROPN
aiua-10278	106	38	58	58	NUM
aiua-10278	106	39	pi	pi	NOUN
aiua-10278	106	40	-	-	PUNCT
aiua-10278	106	41	rads	rad	NOUN
aiua-10278	106	42	1	1	NUM
aiua-10278	106	43	-	-	SYM
aiua-10278	106	44	2	2	NUM
aiua-10278	106	45	10	10	NUM
aiua-10278	106	46	(	(	PUNCT
aiua-10278	106	47	71.43	71.43	NUM
aiua-10278	106	48	%	%	NOUN
aiua-10278	106	49	)	)	PUNCT
aiua-10278	106	50	4	4	NUM
aiua-10278	106	51	(	(	PUNCT
aiua-10278	106	52	28.57	28.57	NUM
aiua-10278	106	53	%	%	NOUN
aiua-10278	106	54	)	)	PUNCT
aiua-10278	106	55	0.139	0.139	NUM
aiua-10278	107	1	*	*	PUNCT
aiua-10278	107	2	*	*	X
aiua-10278	107	3	13	13	NUM
aiua-10278	107	4	(	(	PUNCT
aiua-10278	107	5	92.86	92.86	NUM
aiua-10278	107	6	%	%	NOUN
aiua-10278	107	7	)	)	PUNCT
aiua-10278	107	8	1	1	NUM
aiua-10278	107	9	(	(	PUNCT
aiua-10278	107	10	7.14	7.14	NUM
aiua-10278	107	11	%	%	NOUN
aiua-10278	107	12	)	)	PUNCT
aiua-10278	107	13	0.044	0.044	NUM
aiua-10278	107	14	*	*	PUNCT
aiua-10278	107	15	*	*	ADJ
aiua-10278	107	16	pi	pi	NOUN
aiua-10278	107	17	-	-	PUNCT
aiua-10278	107	18	rads	rad	NOUN
aiua-10278	107	19	3	3	NUM
aiua-10278	107	20	-	-	SYM
aiua-10278	107	21	5	5	NUM
aiua-10278	107	22	21	21	NUM
aiua-10278	107	23	(	(	PUNCT
aiua-10278	107	24	47.73	47.73	NUM
aiua-10278	107	25	%	%	NOUN
aiua-10278	107	26	)	)	PUNCT
aiua-10278	107	27	23	23	NUM
aiua-10278	107	28	(	(	PUNCT
aiua-10278	107	29	52.27	52.27	NUM
aiua-10278	107	30	%	%	NOUN
aiua-10278	107	31	)	)	PUNCT
aiua-10278	107	32	27	27	NUM
aiua-10278	107	33	(	(	PUNCT
aiua-10278	107	34	61.36	61.36	NUM
aiua-10278	107	35	%	%	NOUN
aiua-10278	107	36	)	)	PUNCT
aiua-10278	107	37	17	17	NUM
aiua-10278	107	38	(	(	PUNCT
aiua-10278	107	39	38.64	38.64	NUM
aiua-10278	107	40	%	%	NOUN
aiua-10278	107	41	)	)	PUNCT
aiua-10278	107	42	psad	psad	ADJ
aiua-10278	107	43	>	>	X
aiua-10278	107	44	0.15	0.15	NUM
aiua-10278	107	45	ng	ng	PROPN
aiua-10278	107	46	/	/	SYM
aiua-10278	107	47	ml	ml	PROPN
aiua-10278	107	48	/	/	SYM
aiua-10278	107	49	cc	cc	PROPN
aiua-10278	107	50	80	80	NUM
aiua-10278	107	51	pi	pi	NOUN
aiua-10278	107	52	-	-	PUNCT
aiua-10278	107	53	rads	rad	NOUN
aiua-10278	107	54	1	1	NUM
aiua-10278	107	55	-	-	SYM
aiua-10278	107	56	2	2	NUM
aiua-10278	107	57	8	8	NUM
aiua-10278	107	58	(	(	PUNCT
aiua-10278	107	59	66.67	66.67	NUM
aiua-10278	107	60	%	%	NOUN
aiua-10278	107	61	)	)	PUNCT
aiua-10278	107	62	4	4	NUM
aiua-10278	107	63	(	(	PUNCT
aiua-10278	107	64	33.33	33.33	NUM
aiua-10278	107	65	%	%	NOUN
aiua-10278	107	66	)	)	PUNCT
aiua-10278	107	67	<	<	X
aiua-10278	107	68	0.001	0.001	NUM
aiua-10278	107	69	*	*	SYM
aiua-10278	107	70	*	*	NOUN
aiua-10278	107	71	10	10	NUM
aiua-10278	107	72	(	(	PUNCT
aiua-10278	107	73	83.33	83.33	NUM
aiua-10278	107	74	%	%	NOUN
aiua-10278	107	75	)	)	PUNCT
aiua-10278	107	76	2	2	NUM
aiua-10278	107	77	(	(	PUNCT
aiua-10278	107	78	16.67	16.67	NUM
aiua-10278	107	79	%	%	NOUN
aiua-10278	107	80	)	)	PUNCT
aiua-10278	107	81	<	<	X
aiua-10278	108	1	0.001	0.001	NUM
aiua-10278	108	2	*	*	NOUN
aiua-10278	108	3	*	*	NOUN
aiua-10278	108	4	pi	pi	NOUN
aiua-10278	108	5	-	-	PUNCT
aiua-10278	108	6	rads	rad	NOUN
aiua-10278	108	7	3	3	NUM
aiua-10278	108	8	-	-	SYM
aiua-10278	108	9	5	5	NUM
aiua-10278	108	10	10	10	NUM
aiua-10278	108	11	(	(	PUNCT
aiua-10278	108	12	14.71	14.71	NUM
aiua-10278	108	13	%	%	NOUN
aiua-10278	108	14	)	)	PUNCT
aiua-10278	108	15	58	58	NUM
aiua-10278	108	16	(	(	PUNCT
aiua-10278	108	17	85.29	85.29	NUM
aiua-10278	108	18	%	%	NOUN
aiua-10278	108	19	)	)	PUNCT
aiua-10278	108	20	17	17	NUM
aiua-10278	108	21	(	(	PUNCT
aiua-10278	108	22	25.0	25.0	NUM
aiua-10278	108	23	%	%	NOUN
aiua-10278	108	24	)	)	PUNCT
aiua-10278	108	25	51	51	NUM
aiua-10278	108	26	(	(	PUNCT
aiua-10278	108	27	75.0	75.0	NUM
aiua-10278	108	28	%	%	NOUN
aiua-10278	108	29	)	)	PUNCT
aiua-10278	109	1	p	p	X
aiua-10278	109	2	:	:	PUNCT
aiua-10278	109	3	p	p	ADJ
aiua-10278	109	4	-	-	PUNCT
aiua-10278	109	5	value	value	NOUN
aiua-10278	109	6	;	;	PUNCT
aiua-10278	109	7	*	*	PUNCT
aiua-10278	109	8	chi	chi	ADJ
aiua-10278	109	9	-	-	PUNCT
aiua-10278	109	10	squared	square	VERB
aiua-10278	109	11	test	test	NOUN
aiua-10278	109	12	;	;	PUNCT
aiua-10278	109	13	*	*	PUNCT
aiua-10278	109	14	*	*	PUNCT
aiua-10278	109	15	fisher	fisher	PROPN
aiua-10278	109	16	’s	’s	PART
aiua-10278	109	17	exact	exact	ADJ
aiua-10278	109	18	test	test	NOUN
aiua-10278	109	19	.	.	PUNCT
aiua-10278	110	1	table	table	NOUN
aiua-10278	110	2	4	4	NUM
aiua-10278	110	3	.	.	PUNCT
aiua-10278	110	4	association	association	NOUN
aiua-10278	110	5	of	of	ADP
aiua-10278	110	6	pi	pi	NOUN
aiua-10278	110	7	-	-	PUNCT
aiua-10278	110	8	rads	rad	NOUN
aiua-10278	110	9	with	with	ADP
aiua-10278	110	10	pca	pca	NOUN
aiua-10278	110	11	and	and	CCONJ
aiua-10278	110	12	cspca	cspca	NOUN
aiua-10278	110	13	stratified	stratify	VERB
aiua-10278	110	14	for	for	ADP
aiua-10278	110	15	normal	normal	ADJ
aiua-10278	110	16	and	and	CCONJ
aiua-10278	110	17	suspicious	suspicious	ADJ
aiua-10278	110	18	dre	dre	PROPN
aiua-10278	110	19	.	.	PUNCT
aiua-10278	111	1	prostate	prostate	NOUN
aiua-10278	111	2	cancer	cancer	NOUN
aiua-10278	111	3	significant	significant	ADJ
aiua-10278	111	4	prostate	prostate	NOUN
aiua-10278	111	5	cancer	cancer	NOUN
aiua-10278	111	6	n	n	CCONJ
aiua-10278	111	7	no	no	DET
aiua-10278	111	8	cancer	cancer	NOUN
aiua-10278	111	9	pca	pca	NOUN
aiua-10278	111	10	p	p	NOUN
aiua-10278	111	11	no	no	DET
aiua-10278	111	12	cancer	cancer	NOUN
aiua-10278	111	13	cspca	cspca	NOUN
aiua-10278	111	14	p	p	PROPN
aiua-10278	111	15	normal	normal	ADJ
aiua-10278	111	16	dre	dre	NOUN
aiua-10278	111	17	79	79	NUM
aiua-10278	111	18	pi	pi	NOUN
aiua-10278	111	19	-	-	PUNCT
aiua-10278	111	20	rads	rad	NOUN
aiua-10278	111	21	1	1	NUM
aiua-10278	111	22	-	-	SYM
aiua-10278	111	23	2	2	NUM
aiua-10278	111	24	14	14	NUM
aiua-10278	111	25	(	(	PUNCT
aiua-10278	111	26	70.0	70.0	NUM
aiua-10278	111	27	%	%	NOUN
aiua-10278	111	28	)	)	PUNCT
aiua-10278	111	29	6	6	NUM
aiua-10278	111	30	(	(	PUNCT
aiua-10278	111	31	30.0	30.0	NUM
aiua-10278	111	32	%	%	NOUN
aiua-10278	111	33	)	)	PUNCT
aiua-10278	111	34	0.007	0.007	NUM
aiua-10278	111	35	*	*	SYM
aiua-10278	111	36	18	18	NUM
aiua-10278	111	37	(	(	PUNCT
aiua-10278	111	38	90.0	90.0	NUM
aiua-10278	111	39	%	%	NOUN
aiua-10278	111	40	)	)	PUNCT
aiua-10278	111	41	2	2	NUM
aiua-10278	111	42	(	(	PUNCT
aiua-10278	111	43	10.0	10.0	NUM
aiua-10278	111	44	%	%	NOUN
aiua-10278	111	45	)	)	PUNCT
aiua-10278	111	46	0.004	0.004	NUM
aiua-10278	111	47	*	*	PUNCT
aiua-10278	111	48	pi	pi	NOUN
aiua-10278	111	49	-	-	PUNCT
aiua-10278	111	50	rads	rad	NOUN
aiua-10278	111	51	3	3	NUM
aiua-10278	111	52	-	-	SYM
aiua-10278	111	53	5	5	NUM
aiua-10278	111	54	21	21	NUM
aiua-10278	111	55	(	(	PUNCT
aiua-10278	111	56	35.59	35.59	NUM
aiua-10278	111	57	%	%	NOUN
aiua-10278	111	58	)	)	PUNCT
aiua-10278	111	59	38	38	NUM
aiua-10278	111	60	(	(	PUNCT
aiua-10278	111	61	64.41	64.41	NUM
aiua-10278	111	62	%	%	NOUN
aiua-10278	111	63	)	)	PUNCT
aiua-10278	111	64	32	32	NUM
aiua-10278	111	65	(	(	PUNCT
aiua-10278	111	66	54.24	54.24	NUM
aiua-10278	111	67	%	%	NOUN
aiua-10278	111	68	)	)	PUNCT
aiua-10278	111	69	27	27	NUM
aiua-10278	111	70	(	(	PUNCT
aiua-10278	111	71	45.76	45.76	NUM
aiua-10278	111	72	%	%	NOUN
aiua-10278	111	73	)	)	PUNCT
aiua-10278	111	74	suspicious	suspicious	ADJ
aiua-10278	111	75	dre	dre	NOUN
aiua-10278	111	76	51	51	NUM
aiua-10278	111	77	pi	pi	NOUN
aiua-10278	111	78	-	-	PUNCT
aiua-10278	111	79	rads	rad	NOUN
aiua-10278	111	80	1	1	NUM
aiua-10278	111	81	-	-	SYM
aiua-10278	111	82	2	2	NUM
aiua-10278	111	83	2	2	NUM
aiua-10278	111	84	(	(	PUNCT
aiua-10278	111	85	50.0	50.0	NUM
aiua-10278	111	86	%	%	NOUN
aiua-10278	111	87	)	)	PUNCT
aiua-10278	111	88	2	2	NUM
aiua-10278	111	89	(	(	PUNCT
aiua-10278	111	90	50.0	50.0	NUM
aiua-10278	111	91	%	%	NOUN
aiua-10278	111	92	)	)	PUNCT
aiua-10278	112	1	0.168	0.168	NUM
aiua-10278	112	2	*	*	SYM
aiua-10278	112	3	*	*	SYM
aiua-10278	112	4	2	2	NUM
aiua-10278	112	5	(	(	PUNCT
aiua-10278	112	6	50.0	50.0	NUM
aiua-10278	112	7	%	%	NOUN
aiua-10278	112	8	)	)	PUNCT
aiua-10278	112	9	2	2	NUM
aiua-10278	112	10	(	(	PUNCT
aiua-10278	112	11	50.0	50.0	NUM
aiua-10278	112	12	%	%	NOUN
aiua-10278	112	13	)	)	PUNCT
aiua-10278	112	14	0.571	0.571	NUM
aiua-10278	113	1	*	*	PUNCT
aiua-10278	113	2	*	*	PUNCT
aiua-10278	113	3	pi	pi	NOUN
aiua-10278	113	4	-	-	PUNCT
aiua-10278	113	5	rads	rad	NOUN
aiua-10278	113	6	3	3	NUM
aiua-10278	113	7	-	-	SYM
aiua-10278	113	8	5	5	NUM
aiua-10278	113	9	8	8	NUM
aiua-10278	113	10	(	(	PUNCT
aiua-10278	113	11	17.02	17.02	NUM
aiua-10278	113	12	%	%	NOUN
aiua-10278	113	13	)	)	PUNCT
aiua-10278	113	14	39	39	NUM
aiua-10278	113	15	(	(	PUNCT
aiua-10278	113	16	82.98	82.98	NUM
aiua-10278	113	17	%	%	NOUN
aiua-10278	113	18	)	)	PUNCT
aiua-10278	113	19	13	13	NUM
aiua-10278	113	20	(	(	PUNCT
aiua-10278	113	21	27.66	27.66	NUM
aiua-10278	113	22	%	%	NOUN
aiua-10278	113	23	)	)	PUNCT
aiua-10278	113	24	34	34	NUM
aiua-10278	113	25	(	(	PUNCT
aiua-10278	113	26	72.34	72.34	NUM
aiua-10278	113	27	%	%	NOUN
aiua-10278	113	28	)	)	PUNCT
aiua-10278	114	1	p	p	X
aiua-10278	114	2	:	:	PUNCT
aiua-10278	114	3	p	p	ADJ
aiua-10278	114	4	-	-	PUNCT
aiua-10278	114	5	value	value	NOUN
aiua-10278	114	6	;	;	PUNCT
aiua-10278	114	7	*	*	PUNCT
aiua-10278	114	8	chi	chi	ADJ
aiua-10278	114	9	-	-	PUNCT
aiua-10278	114	10	squared	square	VERB
aiua-10278	114	11	test	test	NOUN
aiua-10278	114	12	;	;	PUNCT
aiua-10278	114	13	*	*	PUNCT
aiua-10278	114	14	*	*	PUNCT
aiua-10278	114	15	fisher	fisher	PROPN
aiua-10278	114	16	’s	’s	PART
aiua-10278	114	17	exact	exact	ADJ
aiua-10278	114	18	test	test	NOUN
aiua-10278	114	19	.	.	PUNCT
aiua-10278	115	1	table	table	NOUN
aiua-10278	115	2	5	5	NUM
aiua-10278	115	3	.	.	PUNCT
aiua-10278	115	4	negative	negative	ADJ
aiua-10278	115	5	pb	pb	ADP
aiua-10278	115	6	result	result	NOUN
aiua-10278	115	7	rates	rate	NOUN
aiua-10278	115	8	and	and	CCONJ
aiua-10278	115	9	false	false	ADJ
aiua-10278	115	10	negative	negative	ADJ
aiua-10278	115	11	rates	rate	NOUN
aiua-10278	115	12	for	for	ADP
aiua-10278	115	13	pca	pca	NOUN
aiua-10278	115	14	and	and	CCONJ
aiua-10278	115	15	cspca	cspca	NOUN
aiua-10278	115	16	globally	globally	ADV
aiua-10278	115	17	and	and	CCONJ
aiua-10278	115	18	in	in	ADP
aiua-10278	115	19	patients	patient	NOUN
aiua-10278	115	20	with	with	ADP
aiua-10278	115	21	pi	pi	NOUN
aiua-10278	115	22	-	-	PUNCT
aiua-10278	115	23	rads	rad	NOUN
aiua-10278	115	24	3	3	NUM
aiua-10278	115	25	-	-	SYM
aiua-10278	115	26	5	5	NUM
aiua-10278	115	27	in	in	ADP
aiua-10278	115	28	different	different	ADJ
aiua-10278	115	29	subgroups	subgroup	NOUN
aiua-10278	115	30	.	.	PUNCT
aiua-10278	116	1	pca	pca	PROPN
aiua-10278	116	2	cspca	cspca	PROPN
aiua-10278	116	3	total	total	ADJ
aiua-10278	116	4	pi	pi	NOUN
aiua-10278	116	5	-	-	PUNCT
aiua-10278	116	6	rads	rad	NOUN
aiua-10278	116	7	3	3	NUM
aiua-10278	116	8	-	-	SYM
aiua-10278	116	9	5	5	NUM
aiua-10278	116	10	total	total	ADJ
aiua-10278	116	11	pi	pi	NOUN
aiua-10278	116	12	-	-	PUNCT
aiua-10278	116	13	rads	rad	NOUN
aiua-10278	116	14	3	3	NUM
aiua-10278	116	15	-	-	SYM
aiua-10278	116	16	5	5	NUM
aiua-10278	116	17	npbr	npbr	NOUN
aiua-10278	116	18	npbr	npbr	PROPN
aiua-10278	116	19	fnr	fnr	PROPN
aiua-10278	116	20	npbr	npbr	PROPN
aiua-10278	116	21	npbr	npbr	PROPN
aiua-10278	116	22	fnr	fnr	PROPN
aiua-10278	116	23	total	total	NOUN
aiua-10278	116	24	37.9	37.9	NUM
aiua-10278	116	25	%	%	NOUN
aiua-10278	116	26	27.2	27.2	NUM
aiua-10278	116	27	%	%	NOUN
aiua-10278	116	28	5.8	5.8	NUM
aiua-10278	116	29	%	%	NOUN
aiua-10278	116	30	51	51	NUM
aiua-10278	116	31	%	%	NOUN
aiua-10278	116	32	36.9	36.9	NUM
aiua-10278	116	33	%	%	NOUN
aiua-10278	116	34	2.4	2.4	NUM
aiua-10278	116	35	%	%	NOUN
aiua-10278	116	36	psa	psa	NOUN
aiua-10278	116	37	>	>	X
aiua-10278	116	38	10	10	NUM
aiua-10278	116	39	ng	ng	PROPN
aiua-10278	116	40	/	/	SYM
aiua-10278	116	41	ml	ml	PROPN
aiua-10278	116	42	35.4	35.4	NUM
aiua-10278	116	43	%	%	NOUN
aiua-10278	116	44	22.8	22.8	NUM
aiua-10278	116	45	%	%	NOUN
aiua-10278	116	46	5.1	5.1	NUM
aiua-10278	116	47	%	%	NOUN
aiua-10278	116	48	43	43	NUM
aiua-10278	116	49	%	%	NOUN
aiua-10278	116	50	26.6	26.6	NUM
aiua-10278	116	51	%	%	NOUN
aiua-10278	116	52	1.3	1.3	NUM
aiua-10278	116	53	%	%	NOUN
aiua-10278	116	54	psad	psad	NOUN
aiua-10278	116	55	>	>	X
aiua-10278	116	56	0.15	0.15	NUM
aiua-10278	116	57	ng	ng	PROPN
aiua-10278	116	58	/	/	SYM
aiua-10278	116	59	ml	ml	PROPN
aiua-10278	116	60	/	/	SYM
aiua-10278	116	61	cc	cc	NOUN
aiua-10278	116	62	22.5	22.5	NUM
aiua-10278	116	63	%	%	NOUN
aiua-10278	116	64	12.5	12.5	NUM
aiua-10278	116	65	%	%	NOUN
aiua-10278	116	66	5.0	5.0	NUM
aiua-10278	116	67	%	%	NOUN
aiua-10278	116	68	33.8	33.8	NUM
aiua-10278	116	69	%	%	NOUN
aiua-10278	116	70	21.3	21.3	NUM
aiua-10278	116	71	%	%	NOUN
aiua-10278	116	72	2.5	2.5	NUM
aiua-10278	116	73	%	%	NOUN
aiua-10278	116	74	suspicious	suspicious	ADJ
aiua-10278	116	75	dre	dre	NOUN
aiua-10278	116	76	19.6	19.6	NUM
aiua-10278	116	77	%	%	NOUN
aiua-10278	116	78	15.7	15.7	NUM
aiua-10278	116	79	%	%	NOUN
aiua-10278	116	80	3.9	3.9	NUM
aiua-10278	116	81	%	%	NOUN
aiua-10278	116	82	29.4	29.4	NUM
aiua-10278	116	83	%	%	NOUN
aiua-10278	116	84	25.5	25.5	NUM
aiua-10278	116	85	%	%	NOUN
aiua-10278	116	86	3.9	3.9	NUM
aiua-10278	116	87	%	%	NOUN
aiua-10278	116	88	npbr	npbr	NOUN
aiua-10278	116	89	:	:	PUNCT
aiua-10278	116	90	negative	negative	ADJ
aiua-10278	116	91	pb	pb	ADP
aiua-10278	116	92	result	result	NOUN
aiua-10278	116	93	rates	rate	NOUN
aiua-10278	116	94	;	;	PUNCT
aiua-10278	116	95	fnr	fnr	NOUN
aiua-10278	116	96	:	:	PUNCT
aiua-10278	116	97	false	false	ADJ
aiua-10278	116	98	negative	negative	ADJ
aiua-10278	116	99	rates	rate	NOUN
aiua-10278	116	100	.	.	PUNCT
aiua-10278	117	1	35archivio	35archivio	NUM
aiua-10278	117	2	italiano	italiano	PROPN
aiua-10278	117	3	di	di	X
aiua-10278	117	4	urologia	urologia	PROPN
aiua-10278	117	5	e	e	PROPN
aiua-10278	117	6	andrologia	andrologia	PROPN
aiua-10278	117	7	2022	2022	NUM
aiua-10278	117	8	;	;	PUNCT
aiua-10278	117	9	94	94	NUM
aiua-10278	117	10	,	,	PUNCT
aiua-10278	117	11	1	1	NUM
aiua-10278	117	12	is	be	AUX
aiua-10278	117	13	magnetic	magnetic	ADJ
aiua-10278	117	14	resonance	resonance	NOUN
aiua-10278	117	15	imaging	imaging	NOUN
aiua-10278	117	16	always	always	ADV
aiua-10278	117	17	needed	need	VERB
aiua-10278	117	18	?	?	PUNCT
aiua-10278	118	1	discussion	discussion	NOUN
aiua-10278	118	2	to	to	ADP
aiua-10278	118	3	our	our	PRON
aiua-10278	118	4	knowledge	knowledge	NOUN
aiua-10278	118	5	,	,	PUNCT
aiua-10278	118	6	this	this	PRON
aiua-10278	118	7	is	be	AUX
aiua-10278	118	8	the	the	DET
aiua-10278	118	9	first	first	ADJ
aiua-10278	118	10	study	study	NOUN
aiua-10278	118	11	to	to	PART
aiua-10278	118	12	test	test	VERB
aiua-10278	118	13	mpmri	mpmri	PROPN
aiua-10278	118	14	accuracy	accuracy	NOUN
aiua-10278	118	15	in	in	ADP
aiua-10278	118	16	detection	detection	NOUN
aiua-10278	118	17	of	of	ADP
aiua-10278	118	18	pca	pca	NOUN
aiua-10278	118	19	stratified	stratify	VERB
aiua-10278	118	20	by	by	ADP
aiua-10278	118	21	clinical	clinical	ADJ
aiua-10278	118	22	suspicion	suspicion	NOUN
aiua-10278	118	23	of	of	ADP
aiua-10278	118	24	cancer	cancer	NOUN
aiua-10278	118	25	based	base	VERB
aiua-10278	118	26	on	on	ADP
aiua-10278	118	27	various	various	ADJ
aiua-10278	118	28	clinical	clinical	ADJ
aiua-10278	118	29	markers	marker	NOUN
aiua-10278	118	30	,	,	PUNCT
aiua-10278	118	31	including	include	VERB
aiua-10278	118	32	psa	psa	NOUN
aiua-10278	118	33	,	,	PUNCT
aiua-10278	118	34	psad	psad	ADJ
aiua-10278	118	35	,	,	PUNCT
aiua-10278	118	36	and	and	CCONJ
aiua-10278	118	37	dre	dre	PROPN
aiua-10278	118	38	.	.	PUNCT
aiua-10278	119	1	according	accord	VERB
aiua-10278	119	2	to	to	ADP
aiua-10278	119	3	the	the	DET
aiua-10278	119	4	european	european	PROPN
aiua-10278	119	5	association	association	PROPN
aiua-10278	119	6	of	of	ADP
aiua-10278	119	7	urology	urology	NOUN
aiua-10278	119	8	guidelines	guideline	NOUN
aiua-10278	119	9	,	,	PUNCT
aiua-10278	119	10	mpmri	mpmri	PROPN
aiua-10278	119	11	before	before	ADP
aiua-10278	119	12	biopsy	biopsy	NOUN
aiua-10278	119	13	could	could	AUX
aiua-10278	119	14	improve	improve	VERB
aiua-10278	119	15	the	the	DET
aiua-10278	119	16	detection	detection	NOUN
aiua-10278	119	17	cspca	cspca	NOUN
aiua-10278	119	18	in	in	ADP
aiua-10278	119	19	two	two	NUM
aiua-10278	119	20	different	different	ADJ
aiua-10278	119	21	ways	way	NOUN
aiua-10278	119	22	.	.	PUNCT
aiua-10278	120	1	first	first	ADV
aiua-10278	120	2	it	it	PRON
aiua-10278	120	3	allows	allow	VERB
aiua-10278	120	4	to	to	PART
aiua-10278	120	5	target	target	VERB
aiua-10278	120	6	specific	specific	ADJ
aiua-10278	120	7	lesions	lesion	NOUN
aiua-10278	120	8	visible	visible	ADJ
aiua-10278	120	9	on	on	ADP
aiua-10278	120	10	mpmri	mpmri	PROPN
aiua-10278	120	11	.	.	PUNCT
aiua-10278	121	1	secondly	secondly	ADV
aiua-10278	121	2	,	,	PUNCT
aiua-10278	121	3	mpmri	mpmri	PROPN
aiua-10278	121	4	could	could	AUX
aiua-10278	121	5	be	be	AUX
aiua-10278	121	6	used	use	VERB
aiua-10278	121	7	as	as	ADP
aiua-10278	121	8	a	a	DET
aiua-10278	121	9	triage	triage	NOUN
aiua-10278	121	10	test	test	NOUN
aiua-10278	121	11	before	before	ADP
aiua-10278	121	12	biopsy	biopsy	NOUN
aiua-10278	121	13	,	,	PUNCT
aiua-10278	121	14	so	so	SCONJ
aiua-10278	121	15	that	that	SCONJ
aiua-10278	121	16	mpmri	mpmri	PROPN
aiua-10278	121	17	-	-	PUNCT
aiua-10278	121	18	pb	pb	PROPN
aiua-10278	121	19	would	would	AUX
aiua-10278	121	20	be	be	AUX
aiua-10278	121	21	performed	perform	VERB
aiua-10278	121	22	only	only	ADV
aiua-10278	121	23	in	in	ADP
aiua-10278	121	24	case	case	NOUN
aiua-10278	121	25	of	of	ADP
aiua-10278	121	26	a	a	DET
aiua-10278	121	27	positive	positive	ADJ
aiua-10278	121	28	mpmri	mpmri	NOUN
aiua-10278	121	29	whereas	whereas	SCONJ
aiua-10278	121	30	patients	patient	NOUN
aiua-10278	121	31	with	with	ADP
aiua-10278	121	32	negative	negative	ADJ
aiua-10278	121	33	mpmri	mpmri	PROPN
aiua-10278	121	34	findings	finding	NOUN
aiua-10278	121	35	would	would	AUX
aiua-10278	121	36	not	not	PART
aiua-10278	121	37	undergo	undergo	VERB
aiua-10278	121	38	prostate	prostate	NOUN
aiua-10278	121	39	biopsy	biopsy	NOUN
aiua-10278	121	40	at	at	ADV
aiua-10278	121	41	all	all	ADV
aiua-10278	121	42	.	.	PUNCT
aiua-10278	122	1	based	base	VERB
aiua-10278	122	2	on	on	ADP
aiua-10278	122	3	this	this	DET
aiua-10278	122	4	assumption	assumption	NOUN
aiua-10278	122	5	most	most	ADJ
aiua-10278	122	6	studies	study	NOUN
aiua-10278	122	7	focused	focus	VERB
aiua-10278	122	8	on	on	ADP
aiua-10278	122	9	using	use	VERB
aiua-10278	122	10	mpmri	mpmri	PROPN
aiua-10278	122	11	to	to	PART
aiua-10278	122	12	avoid	avoid	VERB
aiua-10278	122	13	pb	pb	ADP
aiua-10278	122	14	and	and	CCONJ
aiua-10278	122	15	diagnosis	diagnosis	NOUN
aiua-10278	122	16	of	of	ADP
aiua-10278	122	17	clinical	clinical	ADJ
aiua-10278	122	18	insignificant	insignificant	ADJ
aiua-10278	122	19	pca	pca	NOUN
aiua-10278	122	20	(	(	PUNCT
aiua-10278	122	21	17	17	NUM
aiua-10278	122	22	)	)	PUNCT
aiua-10278	122	23	,	,	PUNCT
aiua-10278	122	24	rather	rather	ADV
aiua-10278	122	25	than	than	ADP
aiua-10278	122	26	evaluating	evaluate	VERB
aiua-10278	122	27	where	where	SCONJ
aiua-10278	122	28	mpmri	mpmri	PROPN
aiua-10278	122	29	can	can	AUX
aiua-10278	122	30	add	add	VERB
aiua-10278	122	31	value	value	NOUN
aiua-10278	122	32	compared	compare	VERB
aiua-10278	122	33	to	to	ADP
aiua-10278	122	34	standard	standard	ADJ
aiua-10278	122	35	clinical	clinical	ADJ
aiua-10278	122	36	tools	tool	NOUN
aiua-10278	122	37	alone	alone	ADV
aiua-10278	122	38	.	.	PUNCT
aiua-10278	123	1	the	the	DET
aiua-10278	123	2	promis	promis	PROPN
aiua-10278	123	3	trial	trial	NOUN
aiua-10278	123	4	showed	show	VERB
aiua-10278	123	5	high	high	ADJ
aiua-10278	123	6	sensitivity	sensitivity	NOUN
aiua-10278	123	7	and	and	CCONJ
aiua-10278	123	8	high	high	ADJ
aiua-10278	123	9	negative	negative	ADJ
aiua-10278	123	10	predictive	predictive	ADJ
aiua-10278	123	11	value	value	NOUN
aiua-10278	123	12	of	of	ADP
aiua-10278	123	13	mpmri	mpmri	PROPN
aiua-10278	123	14	for	for	ADP
aiua-10278	123	15	the	the	DET
aiua-10278	123	16	detection	detection	NOUN
aiua-10278	123	17	of	of	ADP
aiua-10278	123	18	cspca	cspca	NOUN
aiua-10278	123	19	,	,	PUNCT
aiua-10278	123	20	defined	define	VERB
aiua-10278	123	21	as	as	ADP
aiua-10278	123	22	gleason	gleason	PROPN
aiua-10278	123	23	score	score	PROPN
aiua-10278	123	24	≥	≥	PROPN
aiua-10278	123	25	7	7	NUM
aiua-10278	123	26	(	(	PUNCT
aiua-10278	123	27	4	4	NUM
aiua-10278	123	28	+	+	NOUN
aiua-10278	123	29	3	3	NUM
aiua-10278	123	30	)	)	PUNCT
aiua-10278	123	31	or	or	CCONJ
aiua-10278	123	32	cancer	cancer	NOUN
aiua-10278	123	33	core	core	NOUN
aiua-10278	123	34	length	length	NOUN
aiua-10278	123	35	≥	≥	PROPN
aiua-10278	123	36	6	6	NUM
aiua-10278	123	37	mm	mm	NOUN
aiua-10278	123	38	.	.	PUNCT
aiua-10278	124	1	however	however	ADV
aiua-10278	124	2	,	,	PUNCT
aiua-10278	124	3	the	the	DET
aiua-10278	124	4	false	false	ADJ
aiua-10278	124	5	-	-	PUNCT
aiua-10278	124	6	positive	positive	ADJ
aiua-10278	124	7	rate	rate	NOUN
aiua-10278	124	8	for	for	ADP
aiua-10278	124	9	mpmri	mpmri	PROPN
aiua-10278	124	10	was	be	AUX
aiua-10278	124	11	49	49	NUM
aiua-10278	124	12	%	%	NOUN
aiua-10278	124	13	,	,	PUNCT
aiua-10278	124	14	needing	need	VERB
aiua-10278	124	15	follow	follow	VERB
aiua-10278	124	16	-	-	PUNCT
aiua-10278	124	17	up	up	ADP
aiua-10278	124	18	biopsy	biopsy	NOUN
aiua-10278	124	19	sampling	sample	VERB
aiua-10278	124	20	to	to	PART
aiua-10278	124	21	confirm	confirm	VERB
aiua-10278	124	22	suspicious	suspicious	ADJ
aiua-10278	124	23	findings	finding	NOUN
aiua-10278	124	24	.	.	PUNCT
aiua-10278	125	1	moreover	moreover	ADV
aiua-10278	125	2	,	,	PUNCT
aiua-10278	125	3	as	as	ADP
aiua-10278	125	4	negative	negative	ADJ
aiua-10278	125	5	and	and	CCONJ
aiua-10278	125	6	positive	positive	ADJ
aiua-10278	125	7	predictive	predictive	ADJ
aiua-10278	125	8	values	value	NOUN
aiua-10278	125	9	depend	depend	VERB
aiua-10278	125	10	on	on	ADP
aiua-10278	125	11	prevalence	prevalence	NOUN
aiua-10278	125	12	,	,	PUNCT
aiua-10278	125	13	it	it	PRON
aiua-10278	125	14	becomes	become	VERB
aiua-10278	125	15	mandatory	mandatory	ADJ
aiua-10278	125	16	to	to	AUX
aiua-10278	125	17	pre	pre	VERB
aiua-10278	125	18	-	-	VERB
aiua-10278	125	19	evaluate	evaluate	VERB
aiua-10278	125	20	the	the	DET
aiua-10278	125	21	risk	risk	NOUN
aiua-10278	125	22	of	of	ADP
aiua-10278	125	23	cspca	cspca	NOUN
aiua-10278	125	24	in	in	ADP
aiua-10278	125	25	patients	patient	NOUN
aiua-10278	125	26	with	with	ADP
aiua-10278	125	27	a	a	DET
aiua-10278	125	28	suspicion	suspicion	NOUN
aiua-10278	125	29	of	of	ADP
aiua-10278	125	30	pca	pca	PROPN
aiua-10278	125	31	(	(	PUNCT
aiua-10278	125	32	16	16	NUM
aiua-10278	125	33	)	)	PUNCT
aiua-10278	125	34	.	.	PUNCT
aiua-10278	126	1	biomarkers	biomarker	NOUN
aiua-10278	126	2	and	and	CCONJ
aiua-10278	126	3	nomograms	nomogram	NOUN
aiua-10278	126	4	are	be	AUX
aiua-10278	126	5	very	very	ADV
aiua-10278	126	6	helpful	helpful	ADJ
aiua-10278	126	7	in	in	ADP
aiua-10278	126	8	this	this	DET
aiua-10278	126	9	setting	setting	NOUN
aiua-10278	126	10	,	,	PUNCT
aiua-10278	126	11	but	but	CCONJ
aiua-10278	126	12	standard	standard	ADJ
aiua-10278	126	13	clinical	clinical	ADJ
aiua-10278	126	14	examination	examination	NOUN
aiua-10278	126	15	should	should	AUX
aiua-10278	126	16	remain	remain	VERB
aiua-10278	126	17	of	of	ADP
aiua-10278	126	18	pivotal	pivotal	ADJ
aiua-10278	126	19	importance	importance	NOUN
aiua-10278	126	20	(	(	PUNCT
aiua-10278	126	21	18	18	NUM
aiua-10278	126	22	)	)	PUNCT
aiua-10278	126	23	.	.	PUNCT
aiua-10278	127	1	our	our	PRON
aiua-10278	127	2	primary	primary	ADJ
aiua-10278	127	3	analysis	analysis	NOUN
aiua-10278	127	4	among	among	ADP
aiua-10278	127	5	all	all	DET
aiua-10278	127	6	included	include	VERB
aiua-10278	127	7	patients	patient	NOUN
aiua-10278	127	8	unsurprisingly	unsurprisingly	ADV
aiua-10278	127	9	demonstrated	demonstrate	VERB
aiua-10278	127	10	that	that	SCONJ
aiua-10278	127	11	mpmri	mpmri	PROPN
aiua-10278	127	12	pi	pi	NOUN
aiua-10278	127	13	-	-	PUNCT
aiua-10278	127	14	rads	rad	NOUN
aiua-10278	127	15	3	3	NUM
aiua-10278	127	16	-	-	SYM
aiua-10278	127	17	5	5	NUM
aiua-10278	127	18	was	be	AUX
aiua-10278	127	19	associated	associate	VERB
aiua-10278	127	20	both	both	CCONJ
aiua-10278	127	21	with	with	ADP
aiua-10278	127	22	pca	pca	NOUN
aiua-10278	127	23	and	and	CCONJ
aiua-10278	127	24	cspca	cspca	NOUN
aiua-10278	127	25	,	,	PUNCT
aiua-10278	127	26	as	as	SCONJ
aiua-10278	127	27	previously	previously	ADV
aiua-10278	127	28	described	describe	VERB
aiua-10278	127	29	(	(	PUNCT
aiua-10278	127	30	7	7	NUM
aiua-10278	127	31	-	-	SYM
aiua-10278	127	32	10	10	NUM
aiua-10278	127	33	)	)	PUNCT
aiua-10278	127	34	.	.	PUNCT
aiua-10278	128	1	after	after	ADP
aiua-10278	128	2	stratification	stratification	NOUN
aiua-10278	128	3	by	by	ADP
aiua-10278	128	4	clinical	clinical	ADJ
aiua-10278	128	5	suspicion	suspicion	NOUN
aiua-10278	128	6	of	of	ADP
aiua-10278	128	7	pca	pca	PROPN
aiua-10278	128	8	,	,	PUNCT
aiua-10278	128	9	also	also	ADV
aiua-10278	128	10	as	as	SCONJ
aiua-10278	128	11	expected	expect	VERB
aiua-10278	128	12	,	,	PUNCT
aiua-10278	128	13	in	in	ADP
aiua-10278	128	14	patients	patient	NOUN
aiua-10278	128	15	with	with	ADP
aiua-10278	128	16	low	low	ADJ
aiua-10278	128	17	clinical	clinical	ADJ
aiua-10278	128	18	suspicion	suspicion	NOUN
aiua-10278	128	19	of	of	ADP
aiua-10278	128	20	pca	pca	PROPN
aiua-10278	128	21	,	,	PUNCT
aiua-10278	128	22	defined	define	VERB
aiua-10278	128	23	as	as	ADP
aiua-10278	128	24	psa	psa	NOUN
aiua-10278	128	25	≤	≤	NUM
aiua-10278	128	26	10	10	NUM
aiua-10278	128	27	ng	ng	PROPN
aiua-10278	128	28	/	/	SYM
aiua-10278	128	29	ml	ml	PROPN
aiua-10278	128	30	,	,	PUNCT
aiua-10278	128	31	psad	psad	ADJ
aiua-10278	128	32	≤	≤	NUM
aiua-10278	128	33	0.15	0.15	NUM
aiua-10278	128	34	ng	ng	NOUN
aiua-10278	128	35	/	/	SYM
aiua-10278	128	36	ml	ml	NOUN
aiua-10278	128	37	/	/	SYM
aiua-10278	128	38	cc	cc	NOUN
aiua-10278	128	39	and	and	CCONJ
aiua-10278	128	40	normal	normal	ADJ
aiua-10278	128	41	dre	dre	PROPN
aiua-10278	128	42	,	,	PUNCT
aiua-10278	128	43	mpmri	mpmri	PROPN
aiua-10278	128	44	pi	pi	NOUN
aiua-10278	128	45	-	-	PUNCT
aiua-10278	128	46	rads	rad	NOUN
aiua-10278	128	47	3	3	NUM
aiua-10278	128	48	-	-	SYM
aiua-10278	128	49	5	5	NUM
aiua-10278	128	50	was	be	AUX
aiua-10278	128	51	significantly	significantly	ADV
aiua-10278	128	52	associated	associate	VERB
aiua-10278	128	53	with	with	ADP
aiua-10278	128	54	pca	pca	PROPN
aiua-10278	128	55	in	in	ADP
aiua-10278	128	56	most	most	ADJ
aiua-10278	128	57	evaluations	evaluation	NOUN
aiua-10278	128	58	(	(	PUNCT
aiua-10278	128	59	except	except	SCONJ
aiua-10278	128	60	for	for	ADP
aiua-10278	128	61	lowest	low	ADJ
aiua-10278	128	62	psad	psad	ADJ
aiua-10278	128	63	values	value	NOUN
aiua-10278	128	64	≤	≤	NUM
aiua-10278	128	65	0.15	0.15	NUM
aiua-10278	128	66	ng	ng	PROPN
aiua-10278	128	67	/	/	SYM
aiua-10278	128	68	ml	ml	PROPN
aiua-10278	128	69	/	/	SYM
aiua-10278	128	70	cc	cc	NOUN
aiua-10278	128	71	)	)	PUNCT
aiua-10278	128	72	and	and	CCONJ
aiua-10278	128	73	with	with	ADP
aiua-10278	128	74	diagnosis	diagnosis	NOUN
aiua-10278	128	75	of	of	ADP
aiua-10278	128	76	cspca	cspca	NOUN
aiua-10278	128	77	in	in	ADP
aiua-10278	128	78	all	all	DET
aiua-10278	128	79	evaluations	evaluation	NOUN
aiua-10278	128	80	.	.	PUNCT
aiua-10278	129	1	however	however	ADV
aiua-10278	129	2	,	,	PUNCT
aiua-10278	129	3	importantly	importantly	ADV
aiua-10278	129	4	we	we	PRON
aiua-10278	129	5	observed	observe	VERB
aiua-10278	129	6	that	that	SCONJ
aiua-10278	129	7	among	among	ADP
aiua-10278	129	8	patients	patient	NOUN
aiua-10278	129	9	with	with	ADP
aiua-10278	129	10	high	high	ADJ
aiua-10278	129	11	clinical	clinical	ADJ
aiua-10278	129	12	suspicion	suspicion	NOUN
aiua-10278	129	13	of	of	ADP
aiua-10278	129	14	pca	pca	PROPN
aiua-10278	129	15	,	,	PUNCT
aiua-10278	129	16	defined	define	VERB
aiua-10278	129	17	as	as	ADP
aiua-10278	129	18	psa	psa	NOUN
aiua-10278	129	19	>	>	X
aiua-10278	129	20	10	10	NUM
aiua-10278	129	21	ng	ng	PROPN
aiua-10278	129	22	/	/	SYM
aiua-10278	129	23	ml	ml	PROPN
aiua-10278	129	24	and	and	CCONJ
aiua-10278	129	25	psad	psad	VERB
aiua-10278	129	26	>	>	X
aiua-10278	129	27	0.15	0.15	NUM
aiua-10278	129	28	ng	ng	PROPN
aiua-10278	129	29	/	/	SYM
aiua-10278	129	30	ml	ml	PROPN
aiua-10278	129	31	/	/	SYM
aiua-10278	129	32	cc	cc	PROPN
aiua-10278	129	33	,	,	PUNCT
aiua-10278	129	34	mpmri	mpmri	PROPN
aiua-10278	129	35	pi	pi	NOUN
aiua-10278	129	36	-	-	PUNCT
aiua-10278	129	37	rads	rad	NOUN
aiua-10278	129	38	3	3	NUM
aiua-10278	129	39	-	-	SYM
aiua-10278	129	40	5	5	NUM
aiua-10278	129	41	remained	remain	VERB
aiua-10278	129	42	significantly	significantly	ADV
aiua-10278	129	43	associated	associate	VERB
aiua-10278	129	44	with	with	ADP
aiua-10278	129	45	cspca	cspca	NOUN
aiua-10278	129	46	and	and	CCONJ
aiua-10278	129	47	pca	pca	PROPN
aiua-10278	129	48	.	.	PUNCT
aiua-10278	130	1	however	however	ADV
aiua-10278	130	2	,	,	PUNCT
aiua-10278	130	3	in	in	ADP
aiua-10278	130	4	patients	patient	NOUN
aiua-10278	130	5	with	with	ADP
aiua-10278	130	6	high	high	ADJ
aiua-10278	130	7	clinical	clinical	ADJ
aiua-10278	130	8	suspicion	suspicion	NOUN
aiua-10278	130	9	of	of	ADP
aiua-10278	130	10	pca	pca	PROPN
aiua-10278	130	11	based	base	VERB
aiua-10278	130	12	on	on	ADP
aiua-10278	130	13	dre	dre	PROPN
aiua-10278	130	14	,	,	PUNCT
aiua-10278	130	15	mpmri	mpmri	PROPN
aiua-10278	130	16	pi	pi	NOUN
aiua-10278	130	17	-	-	PUNCT
aiua-10278	130	18	rads	rad	NOUN
aiua-10278	130	19	3	3	NUM
aiua-10278	130	20	-	-	SYM
aiua-10278	130	21	5	5	NUM
aiua-10278	130	22	was	be	AUX
aiua-10278	130	23	not	not	PART
aiua-10278	130	24	significantly	significantly	ADV
aiua-10278	130	25	associated	associate	VERB
aiua-10278	130	26	with	with	ADP
aiua-10278	130	27	pca	pca	NOUN
aiua-10278	130	28	or	or	CCONJ
aiua-10278	130	29	cspca	cspca	NOUN
aiua-10278	130	30	.	.	PUNCT
aiua-10278	131	1	the	the	DET
aiua-10278	131	2	main	main	ADJ
aiua-10278	131	3	explanation	explanation	NOUN
aiua-10278	131	4	of	of	ADP
aiua-10278	131	5	this	this	DET
aiua-10278	131	6	finding	finding	NOUN
aiua-10278	131	7	is	be	AUX
aiua-10278	131	8	that	that	SCONJ
aiua-10278	131	9	almost	almost	ADV
aiua-10278	131	10	all	all	DET
aiua-10278	131	11	patients	patient	NOUN
aiua-10278	131	12	with	with	ADP
aiua-10278	131	13	an	an	DET
aiua-10278	131	14	unequivocal	unequivocal	ADJ
aiua-10278	131	15	abnormal	abnormal	ADJ
aiua-10278	131	16	dre	dre	NOUN
aiua-10278	131	17	have	have	VERB
aiua-10278	131	18	a	a	DET
aiua-10278	131	19	mpmri	mpmri	PROPN
aiua-10278	131	20	pi	pi	NOUN
aiua-10278	131	21	-	-	PUNCT
aiua-10278	131	22	rads	rad	NOUN
aiua-10278	131	23	of	of	ADP
aiua-10278	131	24	3	3	NUM
aiua-10278	131	25	-	-	SYM
aiua-10278	131	26	5	5	NUM
aiua-10278	131	27	.	.	PUNCT
aiua-10278	131	28	altogether	altogether	ADV
aiua-10278	131	29	,	,	PUNCT
aiua-10278	131	30	these	these	DET
aiua-10278	131	31	findings	finding	NOUN
aiua-10278	131	32	demonstrate	demonstrate	VERB
aiua-10278	131	33	an	an	DET
aiua-10278	131	34	added	add	VERB
aiua-10278	131	35	value	value	NOUN
aiua-10278	131	36	of	of	ADP
aiua-10278	131	37	mpmri	mpmri	PROPN
aiua-10278	131	38	even	even	ADV
aiua-10278	131	39	among	among	ADP
aiua-10278	131	40	patients	patient	NOUN
aiua-10278	131	41	with	with	ADP
aiua-10278	131	42	psa	psa	PROPN
aiua-10278	131	43	>	>	X
aiua-10278	131	44	10	10	NUM
aiua-10278	131	45	ng	ng	PROPN
aiua-10278	131	46	/	/	SYM
aiua-10278	131	47	ml	ml	PROPN
aiua-10278	131	48	and	and	CCONJ
aiua-10278	131	49	psad	psad	VERB
aiua-10278	131	50	>	>	X
aiua-10278	131	51	0.15	0.15	NUM
aiua-10278	131	52	ng	ng	PROPN
aiua-10278	131	53	/	/	SYM
aiua-10278	131	54	ml	ml	PROPN
aiua-10278	131	55	/	/	SYM
aiua-10278	131	56	cc	cc	NOUN
aiua-10278	131	57	.	.	NOUN
aiua-10278	132	1	patients	patient	NOUN
aiua-10278	132	2	with	with	ADP
aiua-10278	132	3	suspicious	suspicious	ADJ
aiua-10278	132	4	dre	dre	NOUN
aiua-10278	132	5	,	,	PUNCT
aiua-10278	132	6	however	however	ADV
aiua-10278	132	7	,	,	PUNCT
aiua-10278	132	8	might	might	AUX
aiua-10278	132	9	not	not	PART
aiua-10278	132	10	benefit	benefit	VERB
aiua-10278	132	11	from	from	ADP
aiua-10278	132	12	mpmri	mpmri	PROPN
aiua-10278	132	13	for	for	ADP
aiua-10278	132	14	the	the	PRON
aiua-10278	132	15	pb	pb	ADP
aiua-10278	132	16	diagnosis	diagnosis	NOUN
aiua-10278	132	17	of	of	ADP
aiua-10278	132	18	cancer	cancer	NOUN
aiua-10278	132	19	.	.	PUNCT
aiua-10278	133	1	our	our	PRON
aiua-10278	133	2	secondary	secondary	ADJ
aiua-10278	133	3	analysis	analysis	NOUN
aiua-10278	133	4	showed	show	VERB
aiua-10278	133	5	that	that	SCONJ
aiua-10278	133	6	the	the	DET
aiua-10278	133	7	rate	rate	NOUN
aiua-10278	133	8	of	of	ADP
aiua-10278	133	9	negative	negative	ADJ
aiua-10278	133	10	pb	pb	ADP
aiua-10278	133	11	results	result	NOUN
aiua-10278	133	12	would	would	AUX
aiua-10278	133	13	drop	drop	VERB
aiua-10278	133	14	significantly	significantly	ADV
aiua-10278	133	15	if	if	SCONJ
aiua-10278	133	16	pb	pb	PRON
aiua-10278	133	17	was	be	AUX
aiua-10278	133	18	only	only	ADV
aiua-10278	133	19	performed	perform	VERB
aiua-10278	133	20	in	in	ADP
aiua-10278	133	21	patients	patient	NOUN
aiua-10278	133	22	with	with	ADP
aiua-10278	133	23	pi	pi	NOUN
aiua-10278	133	24	-	-	PUNCT
aiua-10278	133	25	rads	rad	NOUN
aiua-10278	133	26	3	3	NUM
aiua-10278	133	27	-	-	SYM
aiua-10278	133	28	5	5	NUM
aiua-10278	133	29	.	.	PUNCT
aiua-10278	134	1	the	the	DET
aiua-10278	134	2	rate	rate	NOUN
aiua-10278	134	3	of	of	ADP
aiua-10278	134	4	negative	negative	ADJ
aiua-10278	134	5	pb	pb	ADP
aiua-10278	134	6	results	result	NOUN
aiua-10278	134	7	was	be	AUX
aiua-10278	134	8	37.9	37.9	NUM
aiua-10278	134	9	%	%	NOUN
aiua-10278	134	10	vs	vs	ADP
aiua-10278	134	11	27.2	27.2	NUM
aiua-10278	134	12	%	%	NOUN
aiua-10278	134	13	for	for	ADP
aiua-10278	134	14	pca	pca	NOUN
aiua-10278	134	15	and	and	CCONJ
aiua-10278	134	16	51	51	NUM
aiua-10278	134	17	%	%	NOUN
aiua-10278	134	18	vs	vs	ADP
aiua-10278	134	19	36.9	36.9	NUM
aiua-10278	134	20	%	%	NOUN
aiua-10278	134	21	for	for	ADP
aiua-10278	134	22	cspca	cspca	NOUN
aiua-10278	134	23	when	when	SCONJ
aiua-10278	134	24	the	the	DET
aiua-10278	134	25	total	total	ADJ
aiua-10278	134	26	rate	rate	NOUN
aiua-10278	134	27	was	be	AUX
aiua-10278	134	28	compared	compare	VERB
aiua-10278	134	29	with	with	ADP
aiua-10278	134	30	the	the	DET
aiua-10278	134	31	rate	rate	NOUN
aiua-10278	134	32	in	in	ADP
aiua-10278	134	33	patients	patient	NOUN
aiua-10278	134	34	with	with	ADP
aiua-10278	134	35	pi	pi	NOUN
aiua-10278	134	36	-	-	PUNCT
aiua-10278	134	37	rads	rad	NOUN
aiua-10278	134	38	3	3	NUM
aiua-10278	134	39	-	-	SYM
aiua-10278	134	40	5	5	NUM
aiua-10278	134	41	.	.	PUNCT
aiua-10278	134	42	even	even	ADV
aiua-10278	134	43	in	in	ADP
aiua-10278	134	44	subgroups	subgroup	NOUN
aiua-10278	134	45	with	with	ADP
aiua-10278	134	46	high	high	ADJ
aiua-10278	134	47	clinical	clinical	ADJ
aiua-10278	134	48	suspicion	suspicion	NOUN
aiua-10278	134	49	of	of	ADP
aiua-10278	134	50	cancer	cancer	NOUN
aiua-10278	134	51	,	,	PUNCT
aiua-10278	134	52	defined	define	VERB
aiua-10278	134	53	as	as	ADP
aiua-10278	134	54	psa	psa	NOUN
aiua-10278	134	55	>	>	X
aiua-10278	134	56	10ng	10ng	ADJ
aiua-10278	134	57	/	/	SYM
aiua-10278	134	58	ml	ml	ADV
aiua-10278	134	59	and	and	CCONJ
aiua-10278	134	60	psad	psad	VERB
aiua-10278	134	61	>	>	X
aiua-10278	134	62	0.15	0.15	NUM
aiua-10278	134	63	ng	ng	PROPN
aiua-10278	134	64	/	/	SYM
aiua-10278	134	65	ml	ml	PROPN
aiua-10278	134	66	/	/	SYM
aiua-10278	134	67	cc	cc	PROPN
aiua-10278	134	68	,	,	PUNCT
aiua-10278	134	69	mpmri	mpmri	PROPN
aiua-10278	134	70	would	would	AUX
aiua-10278	134	71	be	be	AUX
aiua-10278	134	72	useful	useful	ADJ
aiua-10278	134	73	to	to	PART
aiua-10278	134	74	avoid	avoid	VERB
aiua-10278	134	75	unnecessary	unnecessary	ADJ
aiua-10278	134	76	pb	pb	ADP
aiua-10278	134	77	.	.	PUNCT
aiua-10278	135	1	the	the	DET
aiua-10278	135	2	rate	rate	NOUN
aiua-10278	135	3	of	of	ADP
aiua-10278	135	4	negative	negative	ADJ
aiua-10278	135	5	pb	pb	ADP
aiua-10278	135	6	results	result	NOUN
aiua-10278	135	7	was	be	AUX
aiua-10278	135	8	35.4	35.4	NUM
aiua-10278	135	9	%	%	NOUN
aiua-10278	135	10	vs	vs	ADP
aiua-10278	135	11	22.8	22.8	NUM
aiua-10278	135	12	%	%	NOUN
aiua-10278	135	13	for	for	ADP
aiua-10278	135	14	pca	pca	PROPN
aiua-10278	135	15	and	and	CCONJ
aiua-10278	135	16	43	43	NUM
aiua-10278	135	17	%	%	NOUN
aiua-10278	135	18	vs	vs	ADP
aiua-10278	135	19	26.6	26.6	NUM
aiua-10278	135	20	%	%	NOUN
aiua-10278	135	21	for	for	ADP
aiua-10278	135	22	cspca	cspca	NOUN
aiua-10278	135	23	when	when	SCONJ
aiua-10278	135	24	total	total	ADJ
aiua-10278	135	25	rate	rate	NOUN
aiua-10278	135	26	was	be	AUX
aiua-10278	135	27	compared	compare	VERB
aiua-10278	135	28	with	with	ADP
aiua-10278	135	29	the	the	DET
aiua-10278	135	30	rate	rate	NOUN
aiua-10278	135	31	in	in	ADP
aiua-10278	135	32	patients	patient	NOUN
aiua-10278	135	33	with	with	ADP
aiua-10278	135	34	pi	pi	NOUN
aiua-10278	135	35	-	-	PUNCT
aiua-10278	135	36	rads	rad	NOUN
aiua-10278	135	37	3	3	NUM
aiua-10278	135	38	-	-	SYM
aiua-10278	135	39	5	5	NUM
aiua-10278	135	40	and	and	CCONJ
aiua-10278	135	41	psa	psa	VERB
aiua-10278	135	42	>	>	PROPN
aiua-10278	135	43	10	10	NUM
aiua-10278	135	44	ng	ng	PROPN
aiua-10278	135	45	/	/	SYM
aiua-10278	135	46	ml	ml	NOUN
aiua-10278	135	47	and	and	CCONJ
aiua-10278	135	48	22.5	22.5	NUM
aiua-10278	135	49	%	%	NOUN
aiua-10278	135	50	vs	vs	ADP
aiua-10278	135	51	12.5	12.5	NUM
aiua-10278	135	52	%	%	NOUN
aiua-10278	135	53	for	for	ADP
aiua-10278	135	54	pca	pca	NOUN
aiua-10278	135	55	and	and	CCONJ
aiua-10278	135	56	33.8	33.8	NUM
aiua-10278	135	57	%	%	NOUN
aiua-10278	135	58	vs	vs	ADP
aiua-10278	135	59	21.3	21.3	NUM
aiua-10278	135	60	%	%	NOUN
aiua-10278	135	61	for	for	ADP
aiua-10278	135	62	cspca	cspca	NOUN
aiua-10278	135	63	when	when	SCONJ
aiua-10278	135	64	total	total	ADJ
aiua-10278	135	65	rate	rate	NOUN
aiua-10278	135	66	was	be	AUX
aiua-10278	135	67	compared	compare	VERB
aiua-10278	135	68	with	with	ADP
aiua-10278	135	69	the	the	DET
aiua-10278	135	70	rate	rate	NOUN
aiua-10278	135	71	in	in	ADP
aiua-10278	135	72	patients	patient	NOUN
aiua-10278	135	73	with	with	ADP
aiua-10278	135	74	pi	pi	NOUN
aiua-10278	135	75	-	-	PUNCT
aiua-10278	135	76	rads	rad	NOUN
aiua-10278	135	77	3	3	NUM
aiua-10278	135	78	-	-	SYM
aiua-10278	135	79	5	5	NUM
aiua-10278	135	80	and	and	CCONJ
aiua-10278	135	81	psad	psad	VERB
aiua-10278	135	82	>	>	X
aiua-10278	135	83	0.15	0.15	NUM
aiua-10278	135	84	ng	ng	PROPN
aiua-10278	135	85	/	/	SYM
aiua-10278	135	86	ml	ml	PROPN
aiua-10278	135	87	/	/	SYM
aiua-10278	135	88	cc	cc	PROPN
aiua-10278	135	89	.	.	PROPN
aiua-10278	135	90	mpmri	mpmri	PROPN
aiua-10278	135	91	was	be	AUX
aiua-10278	135	92	thus	thus	ADV
aiua-10278	135	93	helpful	helpful	ADJ
aiua-10278	135	94	in	in	ADP
aiua-10278	135	95	selecting	select	VERB
aiua-10278	135	96	patients	patient	NOUN
aiua-10278	135	97	with	with	ADP
aiua-10278	135	98	pca	pca	NOUN
aiua-10278	135	99	and	and	CCONJ
aiua-10278	135	100	cspca	cspca	PROPN
aiua-10278	135	101	who	who	PRON
aiua-10278	135	102	needed	need	VERB
aiua-10278	135	103	to	to	PART
aiua-10278	135	104	undergo	undergo	VERB
aiua-10278	135	105	pb	pb	ADP
aiua-10278	135	106	even	even	ADV
aiua-10278	135	107	in	in	ADP
aiua-10278	135	108	the	the	DET
aiua-10278	135	109	subgroup	subgroup	NOUN
aiua-10278	135	110	with	with	ADP
aiua-10278	135	111	high	high	ADJ
aiua-10278	135	112	clinical	clinical	ADJ
aiua-10278	135	113	suspicion	suspicion	NOUN
aiua-10278	135	114	of	of	ADP
aiua-10278	135	115	cancer	cancer	NOUN
aiua-10278	135	116	,	,	PUNCT
aiua-10278	135	117	defined	define	VERB
aiua-10278	135	118	as	as	ADP
aiua-10278	135	119	psa	psa	NOUN
aiua-10278	135	120	>	>	X
aiua-10278	135	121	10	10	NUM
aiua-10278	135	122	ng	ng	PROPN
aiua-10278	135	123	/	/	SYM
aiua-10278	135	124	ml	ml	PROPN
aiua-10278	135	125	and	and	CCONJ
aiua-10278	135	126	psad	psad	VERB
aiua-10278	135	127	>	>	X
aiua-10278	135	128	0.15	0.15	NUM
aiua-10278	135	129	ng	ng	PROPN
aiua-10278	135	130	/	/	SYM
aiua-10278	135	131	ml	ml	PROPN
aiua-10278	135	132	/	/	SYM
aiua-10278	135	133	cc	cc	NOUN
aiua-10278	135	134	.	.	PROPN
aiua-10278	135	135	however	however	ADV
aiua-10278	135	136	,	,	PUNCT
aiua-10278	135	137	in	in	ADP
aiua-10278	135	138	patients	patient	NOUN
aiua-10278	135	139	with	with	ADP
aiua-10278	135	140	suspicious	suspicious	ADJ
aiua-10278	135	141	dre	dre	NOUN
aiua-10278	135	142	performing	perform	VERB
aiua-10278	135	143	pb	pb	ADP
aiua-10278	135	144	only	only	ADV
aiua-10278	135	145	in	in	ADP
aiua-10278	135	146	those	those	PRON
aiua-10278	135	147	with	with	ADP
aiua-10278	135	148	pi	pi	NOUN
aiua-10278	135	149	-	-	PUNCT
aiua-10278	135	150	rads	rad	NOUN
aiua-10278	135	151	3	3	NUM
aiua-10278	135	152	-	-	SYM
aiua-10278	135	153	5	5	NUM
aiua-10278	135	154	would	would	AUX
aiua-10278	135	155	not	not	PART
aiua-10278	135	156	change	change	VERB
aiua-10278	135	157	significantly	significantly	ADV
aiua-10278	135	158	the	the	DET
aiua-10278	135	159	rate	rate	NOUN
aiua-10278	135	160	of	of	ADP
aiua-10278	135	161	negative	negative	ADJ
aiua-10278	135	162	pb	pb	ADP
aiua-10278	135	163	results	result	NOUN
aiua-10278	135	164	.	.	PUNCT
aiua-10278	136	1	the	the	DET
aiua-10278	136	2	negative	negative	ADJ
aiua-10278	136	3	pb	pb	ADP
aiua-10278	136	4	result	result	NOUN
aiua-10278	136	5	rate	rate	NOUN
aiua-10278	136	6	was	be	AUX
aiua-10278	136	7	19.6	19.6	NUM
aiua-10278	136	8	%	%	NOUN
aiua-10278	136	9	vs	vs	ADP
aiua-10278	136	10	15.7	15.7	NUM
aiua-10278	136	11	%	%	NOUN
aiua-10278	136	12	for	for	ADP
aiua-10278	136	13	pca	pca	NOUN
aiua-10278	136	14	and	and	CCONJ
aiua-10278	136	15	29.4	29.4	NUM
aiua-10278	136	16	%	%	NOUN
aiua-10278	136	17	vs	vs	ADP
aiua-10278	136	18	25.5	25.5	NUM
aiua-10278	136	19	%	%	NOUN
aiua-10278	136	20	for	for	ADP
aiua-10278	136	21	cspca	cspca	NOUN
aiua-10278	136	22	when	when	SCONJ
aiua-10278	136	23	total	total	ADJ
aiua-10278	136	24	rate	rate	NOUN
aiua-10278	136	25	was	be	AUX
aiua-10278	136	26	compared	compare	VERB
aiua-10278	136	27	with	with	ADP
aiua-10278	136	28	the	the	DET
aiua-10278	136	29	rate	rate	NOUN
aiua-10278	136	30	in	in	ADP
aiua-10278	136	31	patients	patient	NOUN
aiua-10278	136	32	with	with	ADP
aiua-10278	136	33	pi	pi	NOUN
aiua-10278	136	34	-	-	PUNCT
aiua-10278	136	35	rads	rad	NOUN
aiua-10278	136	36	3	3	NUM
aiua-10278	136	37	-	-	SYM
aiua-10278	136	38	5	5	NUM
aiua-10278	136	39	.	.	PUNCT
aiua-10278	137	1	in	in	ADP
aiua-10278	137	2	addition	addition	NOUN
aiua-10278	137	3	,	,	PUNCT
aiua-10278	137	4	this	this	DET
aiua-10278	137	5	4	4	NUM
aiua-10278	137	6	%	%	NOUN
aiua-10278	137	7	reduction	reduction	NOUN
aiua-10278	137	8	was	be	AUX
aiua-10278	137	9	obtained	obtain	VERB
aiua-10278	137	10	at	at	ADP
aiua-10278	137	11	the	the	DET
aiua-10278	137	12	cost	cost	NOUN
aiua-10278	137	13	of	of	ADP
aiua-10278	137	14	a	a	DET
aiua-10278	137	15	false	false	ADJ
aiua-10278	137	16	negative	negative	ADJ
aiua-10278	137	17	rate	rate	NOUN
aiua-10278	137	18	of	of	ADP
aiua-10278	137	19	3.9	3.9	NUM
aiua-10278	137	20	%	%	NOUN
aiua-10278	137	21	.	.	PUNCT
aiua-10278	138	1	therefore	therefore	ADV
aiua-10278	138	2	,	,	PUNCT
aiua-10278	138	3	in	in	ADP
aiua-10278	138	4	line	line	NOUN
aiua-10278	138	5	with	with	ADP
aiua-10278	138	6	primary	primary	ADJ
aiua-10278	138	7	analysis	analysis	NOUN
aiua-10278	138	8	’	'	PUNCT
aiua-10278	138	9	findings	finding	NOUN
aiua-10278	138	10	,	,	PUNCT
aiua-10278	138	11	patients	patient	NOUN
aiua-10278	138	12	with	with	ADP
aiua-10278	138	13	suspicious	suspicious	ADJ
aiua-10278	138	14	dre	dre	NOUN
aiua-10278	138	15	do	do	AUX
aiua-10278	138	16	not	not	PART
aiua-10278	138	17	benefit	benefit	VERB
aiua-10278	138	18	from	from	ADP
aiua-10278	138	19	mpmri	mpmri	PROPN
aiua-10278	138	20	before	before	ADP
aiua-10278	138	21	pb	pb	PROPN
aiua-10278	138	22	.	.	PUNCT
aiua-10278	139	1	for	for	ADP
aiua-10278	139	2	the	the	DET
aiua-10278	139	3	first	first	ADJ
aiua-10278	139	4	time	time	NOUN
aiua-10278	139	5	,	,	PUNCT
aiua-10278	139	6	we	we	PRON
aiua-10278	139	7	specifically	specifically	ADV
aiua-10278	139	8	report	report	VERB
aiua-10278	139	9	the	the	DET
aiua-10278	139	10	utility	utility	NOUN
aiua-10278	139	11	of	of	ADP
aiua-10278	139	12	mpmri	mpmri	PROPN
aiua-10278	139	13	in	in	ADP
aiua-10278	139	14	patients	patient	NOUN
aiua-10278	139	15	with	with	ADP
aiua-10278	139	16	high	high	ADJ
aiua-10278	139	17	clinical	clinical	ADJ
aiua-10278	139	18	suspicion	suspicion	NOUN
aiua-10278	139	19	of	of	ADP
aiua-10278	139	20	cancer	cancer	NOUN
aiua-10278	139	21	.	.	PUNCT
aiua-10278	140	1	contrary	contrary	ADJ
aiua-10278	140	2	to	to	ADP
aiua-10278	140	3	our	our	PRON
aiua-10278	140	4	hypothesis	hypothesis	NOUN
aiua-10278	140	5	,	,	PUNCT
aiua-10278	140	6	when	when	SCONJ
aiua-10278	140	7	psa	psa	NOUN
aiua-10278	140	8	was	be	AUX
aiua-10278	140	9	>	>	X
aiua-10278	140	10	10	10	NUM
aiua-10278	140	11	ng	ng	PROPN
aiua-10278	140	12	/	/	SYM
aiua-10278	140	13	ml	ml	PROPN
aiua-10278	140	14	and	and	CCONJ
aiua-10278	140	15	psad	psad	VERB
aiua-10278	140	16	>	>	X
aiua-10278	140	17	0.15	0.15	NUM
aiua-10278	140	18	ng	ng	PROPN
aiua-10278	140	19	/	/	SYM
aiua-10278	140	20	ml	ml	PROPN
aiua-10278	140	21	/	/	SYM
aiua-10278	140	22	cc	cc	PROPN
aiua-10278	140	23	,	,	PUNCT
aiua-10278	140	24	mpmri	mpmri	PROPN
aiua-10278	140	25	was	be	AUX
aiua-10278	140	26	still	still	ADV
aiua-10278	140	27	useful	useful	ADJ
aiua-10278	140	28	in	in	ADP
aiua-10278	140	29	discriminating	discriminate	VERB
aiua-10278	140	30	pca	pca	NOUN
aiua-10278	140	31	and	and	CCONJ
aiua-10278	140	32	cspca	cspca	NOUN
aiua-10278	140	33	.	.	PUNCT
aiua-10278	141	1	however	however	ADV
aiua-10278	141	2	,	,	PUNCT
aiua-10278	141	3	according	accord	VERB
aiua-10278	141	4	to	to	ADP
aiua-10278	141	5	our	our	PRON
aiua-10278	141	6	hypothesis	hypothesis	NOUN
aiua-10278	141	7	,	,	PUNCT
aiua-10278	141	8	if	if	SCONJ
aiua-10278	141	9	dre	dre	PROPN
aiua-10278	141	10	is	be	AUX
aiua-10278	141	11	suspicious	suspicious	ADJ
aiua-10278	141	12	,	,	PUNCT
aiua-10278	141	13	mpmri	mpmri	PROPN
aiua-10278	141	14	might	might	AUX
aiua-10278	141	15	no	no	ADV
aiua-10278	141	16	longer	long	ADV
aiua-10278	141	17	be	be	AUX
aiua-10278	141	18	necessary	necessary	ADJ
aiua-10278	141	19	to	to	PART
aiua-10278	141	20	aid	aid	VERB
aiua-10278	141	21	in	in	ADP
aiua-10278	141	22	the	the	DET
aiua-10278	141	23	pb	pb	ADP
aiua-10278	141	24	diagnosis	diagnosis	NOUN
aiua-10278	141	25	of	of	ADP
aiua-10278	141	26	cancer	cancer	NOUN
aiua-10278	141	27	.	.	PUNCT
aiua-10278	142	1	it	it	PRON
aiua-10278	142	2	is	be	AUX
aiua-10278	142	3	true	true	ADJ
aiua-10278	142	4	that	that	SCONJ
aiua-10278	142	5	omitting	omit	VERB
aiua-10278	142	6	mpmri	mpmri	NOUN
aiua-10278	142	7	,	,	PUNCT
aiua-10278	142	8	many	many	ADJ
aiua-10278	142	9	pcas	pca	NOUN
aiua-10278	142	10	of	of	ADP
aiua-10278	142	11	anterior	anterior	ADJ
aiua-10278	142	12	gland	gland	NOUN
aiua-10278	142	13	could	could	AUX
aiua-10278	142	14	be	be	AUX
aiua-10278	142	15	undetected	undetecte	VERB
aiua-10278	142	16	to	to	ADP
aiua-10278	142	17	the	the	DET
aiua-10278	142	18	standard	standard	ADJ
aiua-10278	142	19	trus	trus	NOUN
aiua-10278	142	20	guidedpb	guidedpb	PROPN
aiua-10278	142	21	(	(	PUNCT
aiua-10278	142	22	19	19	NUM
aiua-10278	142	23	)	)	PUNCT
aiua-10278	142	24	,	,	PUNCT
aiua-10278	142	25	but	but	CCONJ
aiua-10278	142	26	several	several	ADJ
aiua-10278	142	27	studies	study	NOUN
aiua-10278	142	28	assessed	assess	VERB
aiua-10278	142	29	the	the	DET
aiua-10278	142	30	importance	importance	NOUN
aiua-10278	142	31	to	to	PART
aiua-10278	142	32	detect	detect	VERB
aiua-10278	142	33	anterior	anterior	ADJ
aiua-10278	142	34	pca	pca	NOUN
aiua-10278	142	35	with	with	ADP
aiua-10278	142	36	discordant	discordant	ADJ
aiua-10278	142	37	findings	finding	NOUN
aiua-10278	142	38	(	(	PUNCT
aiua-10278	142	39	20	20	NUM
aiua-10278	142	40	)	)	PUNCT
aiua-10278	142	41	.	.	PUNCT
aiua-10278	143	1	the	the	DET
aiua-10278	143	2	optimization	optimization	NOUN
aiua-10278	143	3	of	of	ADP
aiua-10278	143	4	the	the	DET
aiua-10278	143	5	trus	trus	NOUN
aiua-10278	143	6	guided	guide	VERB
aiua-10278	143	7	-	-	PUNCT
aiua-10278	143	8	pb	pb	ADP
aiua-10278	143	9	technique	technique	NOUN
aiua-10278	143	10	is	be	AUX
aiua-10278	143	11	,	,	PUNCT
aiua-10278	143	12	anyway	anyway	ADV
aiua-10278	143	13	,	,	PUNCT
aiua-10278	143	14	decisive	decisive	ADJ
aiua-10278	143	15	.	.	PUNCT
aiua-10278	144	1	this	this	DET
aiua-10278	144	2	study	study	NOUN
aiua-10278	144	3	has	have	VERB
aiua-10278	144	4	some	some	DET
aiua-10278	144	5	limitations	limitation	NOUN
aiua-10278	144	6	.	.	PUNCT
aiua-10278	145	1	firstly	firstly	ADV
aiua-10278	145	2	,	,	PUNCT
aiua-10278	145	3	our	our	PRON
aiua-10278	145	4	gold	gold	ADJ
aiua-10278	145	5	standard	standard	NOUN
aiua-10278	145	6	was	be	AUX
aiua-10278	145	7	systematic	systematic	ADJ
aiua-10278	145	8	pb	pb	ADP
aiua-10278	145	9	and	and	CCONJ
aiua-10278	145	10	not	not	PART
aiua-10278	145	11	targeted	target	VERB
aiua-10278	145	12	pb	pb	ADP
aiua-10278	145	13	or	or	CCONJ
aiua-10278	145	14	final	final	ADJ
aiua-10278	145	15	prostatectomy	prostatectomy	NOUN
aiua-10278	145	16	specimens	specimen	NOUN
aiua-10278	145	17	and	and	CCONJ
aiua-10278	145	18	therefore	therefore	ADV
aiua-10278	145	19	some	some	DET
aiua-10278	145	20	men	man	NOUN
aiua-10278	145	21	with	with	ADP
aiua-10278	145	22	negative	negative	ADJ
aiua-10278	145	23	pb	pb	ADP
aiua-10278	145	24	result	result	NOUN
aiua-10278	145	25	may	may	AUX
aiua-10278	145	26	have	have	AUX
aiua-10278	145	27	had	have	VERB
aiua-10278	145	28	pca	pca	PROPN
aiua-10278	145	29	.	.	PUNCT
aiua-10278	146	1	secondly	secondly	ADV
aiua-10278	146	2	,	,	PUNCT
aiua-10278	146	3	mpmri	mpmri	PROPN
aiua-10278	146	4	images	image	NOUN
aiua-10278	146	5	were	be	AUX
aiua-10278	146	6	reviewed	review	VERB
aiua-10278	146	7	by	by	ADP
aiua-10278	146	8	different	different	ADJ
aiua-10278	146	9	radiologists	radiologist	NOUN
aiua-10278	146	10	,	,	PUNCT
aiua-10278	146	11	which	which	PRON
aiua-10278	146	12	may	may	AUX
aiua-10278	146	13	weaken	weaken	VERB
aiua-10278	146	14	internal	internal	ADJ
aiua-10278	146	15	validity	validity	NOUN
aiua-10278	146	16	,	,	PUNCT
aiua-10278	146	17	although	although	SCONJ
aiua-10278	146	18	this	this	DET
aiua-10278	146	19	condition	condition	NOUN
aiua-10278	146	20	could	could	AUX
aiua-10278	146	21	represent	represent	VERB
aiua-10278	146	22	better	well	ADJ
aiua-10278	146	23	every	every	DET
aiua-10278	146	24	day	day	NOUN
aiua-10278	146	25	clinical	clinical	ADJ
aiua-10278	146	26	practice	practice	NOUN
aiua-10278	146	27	.	.	PUNCT
aiua-10278	147	1	conclusions	conclusion	NOUN
aiua-10278	147	2	we	we	PRON
aiua-10278	147	3	think	think	VERB
aiua-10278	147	4	to	to	PART
aiua-10278	147	5	report	report	VERB
aiua-10278	147	6	the	the	DET
aiua-10278	147	7	first	first	ADJ
aiua-10278	147	8	study	study	NOUN
aiua-10278	147	9	to	to	PART
aiua-10278	147	10	evaluate	evaluate	VERB
aiua-10278	147	11	the	the	DET
aiua-10278	147	12	accuracy	accuracy	NOUN
aiua-10278	147	13	of	of	ADP
aiua-10278	147	14	mpmri	mpmri	PROPN
aiua-10278	147	15	in	in	ADP
aiua-10278	147	16	patients	patient	NOUN
aiua-10278	147	17	with	with	ADP
aiua-10278	147	18	different	different	ADJ
aiua-10278	147	19	clinical	clinical	ADJ
aiua-10278	147	20	suspicion	suspicion	NOUN
aiua-10278	147	21	of	of	ADP
aiua-10278	147	22	pca	pca	PROPN
aiua-10278	147	23	.	.	PUNCT
aiua-10278	148	1	pi	pi	NOUN
aiua-10278	148	2	-	-	PUNCT
aiua-10278	148	3	rads	rad	NOUN
aiua-10278	148	4	3	3	NUM
aiua-10278	148	5	-	-	SYM
aiua-10278	148	6	5	5	NUM
aiua-10278	148	7	was	be	AUX
aiua-10278	148	8	predictive	predictive	ADJ
aiua-10278	148	9	of	of	ADP
aiua-10278	148	10	cspca	cspca	NOUN
aiua-10278	148	11	even	even	ADV
aiua-10278	148	12	when	when	SCONJ
aiua-10278	148	13	psa	psa	NOUN
aiua-10278	148	14	was	be	AUX
aiua-10278	148	15	>	>	X
aiua-10278	148	16	10	10	NUM
aiua-10278	148	17	ng	ng	PROPN
aiua-10278	148	18	/	/	SYM
aiua-10278	148	19	ml	ml	PROPN
aiua-10278	148	20	and	and	CCONJ
aiua-10278	148	21	psad	psad	VERB
aiua-10278	148	22	>	>	X
aiua-10278	148	23	0.15	0.15	NUM
aiua-10278	148	24	ng	ng	PROPN
aiua-10278	148	25	/	/	SYM
aiua-10278	148	26	ml	ml	PROPN
aiua-10278	148	27	/	/	SYM
aiua-10278	148	28	cc	cc	NOUN
aiua-10278	148	29	.	.	PROPN
aiua-10278	149	1	therefore	therefore	ADV
aiua-10278	149	2	,	,	PUNCT
aiua-10278	149	3	mpmri	mpmri	PROPN
aiua-10278	149	4	should	should	AUX
aiua-10278	149	5	be	be	AUX
aiua-10278	149	6	performed	perform	VERB
aiua-10278	149	7	also	also	ADV
aiua-10278	149	8	in	in	ADP
aiua-10278	149	9	this	this	DET
aiua-10278	149	10	set	set	NOUN
aiua-10278	149	11	of	of	ADP
aiua-10278	149	12	patients	patient	NOUN
aiua-10278	149	13	with	with	ADP
aiua-10278	149	14	high	high	ADJ
aiua-10278	149	15	clinical	clinical	ADJ
aiua-10278	149	16	suspicion	suspicion	NOUN
aiua-10278	149	17	of	of	ADP
aiua-10278	149	18	cancer	cancer	NOUN
aiua-10278	149	19	.	.	PUNCT
aiua-10278	150	1	in	in	ADP
aiua-10278	150	2	patients	patient	NOUN
aiua-10278	150	3	with	with	ADP
aiua-10278	150	4	suspicious	suspicious	ADJ
aiua-10278	150	5	dre	dre	PROPN
aiua-10278	150	6	,	,	PUNCT
aiua-10278	150	7	mpmri	mpmri	PROPN
aiua-10278	150	8	seems	seem	VERB
aiua-10278	150	9	not	not	PART
aiua-10278	150	10	to	to	PART
aiua-10278	150	11	be	be	AUX
aiua-10278	150	12	significantly	significantly	ADV
aiua-10278	150	13	associated	associate	VERB
aiua-10278	150	14	with	with	ADP
aiua-10278	150	15	cancer	cancer	NOUN
aiua-10278	150	16	and	and	CCONJ
aiua-10278	150	17	it	it	PRON
aiua-10278	150	18	may	may	AUX
aiua-10278	150	19	be	be	AUX
aiua-10278	150	20	avoided	avoid	VERB
aiua-10278	150	21	to	to	PART
aiua-10278	150	22	reduce	reduce	VERB
aiua-10278	150	23	costs	cost	NOUN
aiua-10278	150	24	and	and	CCONJ
aiua-10278	150	25	save	save	VERB
aiua-10278	150	26	time	time	NOUN
aiua-10278	150	27	to	to	PART
aiua-10278	150	28	diagnosis	diagnosis	VERB
aiua-10278	150	29	in	in	ADP
aiua-10278	150	30	this	this	DET
aiua-10278	150	31	particular	particular	ADJ
aiua-10278	150	32	group	group	NOUN
aiua-10278	150	33	of	of	ADP
aiua-10278	150	34	patients	patient	NOUN
aiua-10278	150	35	.	.	PUNCT
aiua-10278	151	1	references	reference	NOUN
aiua-10278	151	2	1	1	NUM
aiua-10278	151	3	.	.	PUNCT
aiua-10278	151	4	center	center	PROPN
aiua-10278	151	5	mm	mm	PROPN
aiua-10278	151	6	,	,	PUNCT
aiua-10278	151	7	jemal	jemal	ADJ
aiua-10278	151	8	a	a	DET
aiua-10278	151	9	,	,	PUNCT
aiua-10278	151	10	lortet	lortet	NOUN
aiua-10278	151	11	-	-	PUNCT
aiua-10278	151	12	tieulent	tieulent	NOUN
aiua-10278	151	13	j	j	PROPN
aiua-10278	151	14	,	,	PUNCT
aiua-10278	151	15	et	et	PROPN
aiua-10278	151	16	al	al	PROPN
aiua-10278	151	17	.	.	PUNCT
aiua-10278	152	1	international	international	ADJ
aiua-10278	152	2	variation	variation	NOUN
aiua-10278	152	3	in	in	ADP
aiua-10278	152	4	prostate	prostate	NOUN
aiua-10278	152	5	cancer	cancer	NOUN
aiua-10278	152	6	incidence	incidence	NOUN
aiua-10278	152	7	and	and	CCONJ
aiua-10278	152	8	mortality	mortality	NOUN
aiua-10278	152	9	rates	rate	NOUN
aiua-10278	152	10	.	.	PUNCT
aiua-10278	153	1	eur	eur	PROPN
aiua-10278	153	2	urol	urol	PROPN
aiua-10278	153	3	.	.	PUNCT
aiua-10278	153	4	2012	2012	NUM
aiua-10278	153	5	;	;	PUNCT
aiua-10278	153	6	61:1079	61:1079	X
aiua-10278	153	7	-	-	SYM
aiua-10278	153	8	92	92	NUM
aiua-10278	153	9	.	.	PUNCT
aiua-10278	154	1	2	2	NUM
aiua-10278	154	2	.	.	X
aiua-10278	154	3	aminsharifi	aminsharifi	PROPN
aiua-10278	154	4	a	a	X
aiua-10278	154	5	,	,	PUNCT
aiua-10278	154	6	howard	howard	PROPN
aiua-10278	154	7	l	l	PROPN
aiua-10278	154	8	,	,	PUNCT
aiua-10278	154	9	wu	wu	PROPN
aiua-10278	154	10	y	y	PROPN
aiua-10278	154	11	,	,	PUNCT
aiua-10278	154	12	et	et	PROPN
aiua-10278	154	13	al	al	PROPN
aiua-10278	154	14	.	.	PROPN
aiua-10278	155	1	prostate	prostate	NOUN
aiua-10278	155	2	specific	specific	ADJ
aiua-10278	155	3	antigen	antigen	ADJ
aiua-10278	155	4	density	density	NOUN
aiua-10278	155	5	as	as	ADP
aiua-10278	155	6	a	a	DET
aiua-10278	155	7	predictor	predictor	NOUN
aiua-10278	155	8	of	of	ADP
aiua-10278	155	9	clinically	clinically	ADV
aiua-10278	155	10	significant	significant	ADJ
aiua-10278	155	11	prostate	prostate	NOUN
aiua-10278	155	12	cancer	cancer	NOUN
aiua-10278	155	13	when	when	SCONJ
aiua-10278	155	14	the	the	DET
aiua-10278	155	15	prostate	prostate	NOUN
aiua-10278	155	16	specific	specific	ADJ
aiua-10278	155	17	antigen	antigen	NOUN
aiua-10278	155	18	is	be	AUX
aiua-10278	155	19	in	in	ADP
aiua-10278	155	20	the	the	DET
aiua-10278	155	21	diagnostic	diagnostic	ADJ
aiua-10278	155	22	gray	gray	ADJ
aiua-10278	155	23	zone	zone	NOUN
aiua-10278	155	24	:	:	PUNCT
aiua-10278	155	25	defining	define	VERB
aiua-10278	155	26	the	the	DET
aiua-10278	155	27	optimum	optimum	ADJ
aiua-10278	155	28	cutoff	cutoff	NOUN
aiua-10278	155	29	point	point	NOUN
aiua-10278	155	30	stratified	stratify	VERB
aiua-10278	155	31	by	by	ADP
aiua-10278	155	32	race	race	NOUN
aiua-10278	155	33	and	and	CCONJ
aiua-10278	155	34	body	body	NOUN
aiua-10278	155	35	mass	mass	PROPN
aiua-10278	155	36	index	index	NOUN
aiua-10278	155	37	.	.	PUNCT
aiua-10278	156	1	j	j	PROPN
aiua-10278	156	2	urol	urol	PROPN
aiua-10278	156	3	.	.	PROPN
aiua-10278	156	4	2018	2018	NUM
aiua-10278	156	5	;	;	PUNCT
aiua-10278	156	6	200:1	200:1	X
aiua-10278	156	7	-	-	SYM
aiua-10278	156	8	9	9	NUM
aiua-10278	156	9	.	.	NOUN
aiua-10278	156	10	3	3	NUM
aiua-10278	156	11	.	.	X
aiua-10278	156	12	galosi	galosi	PROPN
aiua-10278	156	13	ab	ab	PROPN
aiua-10278	156	14	,	,	PUNCT
aiua-10278	156	15	palagonia	palagonia	NOUN
aiua-10278	156	16	e	e	NOUN
aiua-10278	156	17	,	,	PUNCT
aiua-10278	156	18	scarcella	scarcella	PROPN
aiua-10278	156	19	s	s	PART
aiua-10278	156	20	,	,	PUNCT
aiua-10278	156	21	et	et	PROPN
aiua-10278	156	22	al	al	PROPN
aiua-10278	156	23	.	.	PUNCT
aiua-10278	156	24	detection	detection	NOUN
aiua-10278	156	25	limits	limit	NOUN
aiua-10278	156	26	of	of	ADP
aiua-10278	156	27	sigarchivio	sigarchivio	NOUN
aiua-10278	156	28	italiano	italiano	X
aiua-10278	156	29	di	di	PROPN
aiua-10278	156	30	urologia	urologia	PROPN
aiua-10278	156	31	e	e	PROPN
aiua-10278	156	32	andrologia	andrologia	PROPN
aiua-10278	156	33	2022	2022	NUM
aiua-10278	156	34	;	;	PUNCT
aiua-10278	156	35	94	94	NUM
aiua-10278	156	36	,	,	PUNCT
aiua-10278	156	37	1	1	NUM
aiua-10278	156	38	s.	s.	PROPN
aiua-10278	156	39	teixeira	teixeira	PROPN
aiua-10278	156	40	anacleto	anacleto	PROPN
aiua-10278	156	41	,	,	PUNCT
aiua-10278	156	42	j.	j.	PROPN
aiua-10278	156	43	neves	neves	PROPN
aiua-10278	156	44	alberto	alberto	PROPN
aiua-10278	156	45	,	,	PUNCT
aiua-10278	156	46	e.	e.	PROPN
aiua-10278	156	47	carvalho	carvalho	PROPN
aiua-10278	156	48	dias	dias	PROPN
aiua-10278	156	49	,	,	PUNCT
aiua-10278	156	50	p.	p.	PROPN
aiua-10278	156	51	sousa	sousa	PROPN
aiua-10278	156	52	passos	passos	PROPN
aiua-10278	156	53	,	,	PUNCT
aiua-10278	156	54	m.	m.	PROPN
aiua-10278	156	55	cerqueira	cerqueira	PROPN
aiua-10278	156	56	alves	alve	VERB
aiua-10278	156	57	36	36	NUM
aiua-10278	156	58	nificant	nificant	ADJ
aiua-10278	156	59	prostate	prostate	NOUN
aiua-10278	156	60	cancer	cancer	NOUN
aiua-10278	156	61	using	use	VERB
aiua-10278	156	62	multiparametric	multiparametric	ADJ
aiua-10278	156	63	mr	mr	PROPN
aiua-10278	156	64	and	and	CCONJ
aiua-10278	156	65	digital	digital	ADJ
aiua-10278	156	66	rectal	rectal	ADJ
aiua-10278	156	67	examination	examination	NOUN
aiua-10278	156	68	in	in	ADP
aiua-10278	156	69	men	man	NOUN
aiua-10278	156	70	with	with	ADP
aiua-10278	156	71	low	low	ADJ
aiua-10278	156	72	serum	serum	NOUN
aiua-10278	156	73	psa	psa	NOUN
aiua-10278	156	74	:	:	PUNCT
aiua-10278	156	75	up	up	ADP
aiua-10278	156	76	-	-	PUNCT
aiua-10278	156	77	date	date	NOUN
aiua-10278	156	78	of	of	ADP
aiua-10278	156	79	the	the	DET
aiua-10278	156	80	italian	italian	ADJ
aiua-10278	156	81	society	society	NOUN
aiua-10278	156	82	of	of	ADP
aiua-10278	156	83	integrated	integrate	VERB
aiua-10278	156	84	diagnostic	diagnostic	NOUN
aiua-10278	156	85	in	in	ADP
aiua-10278	156	86	urology	urology	NOUN
aiua-10278	156	87	.	.	PUNCT
aiua-10278	157	1	arch	arch	ADJ
aiua-10278	157	2	ital	ital	PROPN
aiua-10278	157	3	urol	urol	PROPN
aiua-10278	157	4	androl	androl	PROPN
aiua-10278	157	5	.	.	PROPN
aiua-10278	157	6	2021	2021	NUM
aiua-10278	157	7	;	;	PUNCT
aiua-10278	157	8	93:92	93:92	NUM
aiua-10278	157	9	-	-	SYM
aiua-10278	157	10	100	100	NUM
aiua-10278	157	11	.	.	PUNCT
aiua-10278	158	1	4	4	X
aiua-10278	158	2	.	.	X
aiua-10278	158	3	rabbani	rabbani	PROPN
aiua-10278	158	4	f	f	PROPN
aiua-10278	158	5	,	,	PUNCT
aiua-10278	158	6	stroumbakis	stroumbakis	PROPN
aiua-10278	158	7	n	n	CCONJ
aiua-10278	158	8	,	,	PUNCT
aiua-10278	158	9	kava	kava	PROPN
aiua-10278	158	10	br	br	PROPN
aiua-10278	158	11	,	,	PUNCT
aiua-10278	158	12	et	et	PROPN
aiua-10278	158	13	al	al	PROPN
aiua-10278	158	14	.	.	PROPN
aiua-10278	158	15	incidence	incidence	NOUN
aiua-10278	158	16	and	and	CCONJ
aiua-10278	158	17	clinical	clinical	ADJ
aiua-10278	158	18	significance	significance	NOUN
aiua-10278	158	19	of	of	ADP
aiua-10278	158	20	false	false	ADJ
aiua-10278	158	21	-	-	PUNCT
aiua-10278	158	22	negative	negative	ADJ
aiua-10278	158	23	sextant	sextant	ADJ
aiua-10278	158	24	prostate	prostate	NOUN
aiua-10278	158	25	biopsies	biopsy	NOUN
aiua-10278	158	26	.	.	PUNCT
aiua-10278	159	1	j	j	PROPN
aiua-10278	159	2	urol	urol	PROPN
aiua-10278	159	3	.	.	PUNCT
aiua-10278	160	1	1998	1998	NUM
aiua-10278	160	2	;	;	PUNCT
aiua-10278	160	3	159:1247	159:1247	NUM
aiua-10278	160	4	-	-	SYM
aiua-10278	160	5	50	50	NUM
aiua-10278	160	6	.	.	NOUN
aiua-10278	161	1	5	5	NUM
aiua-10278	161	2	.	.	X
aiua-10278	161	3	grenabo	grenabo	PROPN
aiua-10278	161	4	bergdahl	bergdahl	PROPN
aiua-10278	161	5	a	a	PRON
aiua-10278	161	6	,	,	PUNCT
aiua-10278	161	7	wilderang	wilderang	PROPN
aiua-10278	161	8	u	u	PROPN
aiua-10278	161	9	,	,	PUNCT
aiua-10278	161	10	aus	aus	PROPN
aiua-10278	161	11	g	g	PROPN
aiua-10278	161	12	,	,	PUNCT
aiua-10278	161	13	et	et	PROPN
aiua-10278	161	14	al	al	PROPN
aiua-10278	161	15	.	.	PUNCT
aiua-10278	162	1	role	role	NOUN
aiua-10278	162	2	of	of	ADP
aiua-10278	162	3	magnetic	magnetic	ADJ
aiua-10278	162	4	resonance	resonance	NOUN
aiua-10278	162	5	imaging	imaging	NOUN
aiua-10278	162	6	in	in	ADP
aiua-10278	162	7	prostate	prostate	NOUN
aiua-10278	162	8	cancer	cancer	NOUN
aiua-10278	162	9	screening	screening	NOUN
aiua-10278	162	10	:	:	PUNCT
aiua-10278	162	11	a	a	DET
aiua-10278	162	12	pilot	pilot	NOUN
aiua-10278	162	13	study	study	NOUN
aiua-10278	162	14	within	within	ADP
aiua-10278	162	15	the	the	DET
aiua-10278	162	16	goteborg	goteborg	NOUN
aiua-10278	162	17	randomised	randomise	VERB
aiua-10278	162	18	screening	screening	NOUN
aiua-10278	162	19	trial	trial	NOUN
aiua-10278	162	20	.	.	PUNCT
aiua-10278	163	1	eur	eur	PROPN
aiua-10278	163	2	urol	urol	PROPN
aiua-10278	163	3	.	.	PUNCT
aiua-10278	164	1	2016	2016	NUM
aiua-10278	164	2	;	;	PUNCT
aiua-10278	164	3	70:566	70:566	NUM
aiua-10278	164	4	-	-	SYM
aiua-10278	164	5	73	73	NUM
aiua-10278	164	6	.	.	PUNCT
aiua-10278	165	1	6	6	NUM
aiua-10278	165	2	.	.	X
aiua-10278	165	3	pokorny	pokorny	VERB
aiua-10278	165	4	mr	mr	PROPN
aiua-10278	165	5	,	,	PUNCT
aiua-10278	165	6	de	de	X
aiua-10278	165	7	rooij	rooij	NOUN
aiua-10278	165	8	m	m	PROPN
aiua-10278	165	9	,	,	PUNCT
aiua-10278	165	10	duncan	duncan	PROPN
aiua-10278	165	11	e	e	NOUN
aiua-10278	165	12	,	,	PUNCT
aiua-10278	165	13	et	et	PROPN
aiua-10278	165	14	al	al	PROPN
aiua-10278	165	15	.	.	PROPN
aiua-10278	165	16	prospective	prospective	ADJ
aiua-10278	165	17	study	study	NOUN
aiua-10278	165	18	of	of	ADP
aiua-10278	165	19	diagnostic	diagnostic	ADJ
aiua-10278	165	20	accuracy	accuracy	NOUN
aiua-10278	165	21	comparing	compare	VERB
aiua-10278	165	22	prostate	prostate	NOUN
aiua-10278	165	23	cancer	cancer	NOUN
aiua-10278	165	24	detection	detection	NOUN
aiua-10278	165	25	by	by	ADP
aiua-10278	165	26	transrectal	transrectal	ADJ
aiua-10278	165	27	ultrasound	ultrasound	NOUN
aiua-10278	165	28	-	-	PUNCT
aiua-10278	165	29	guided	guide	VERB
aiua-10278	165	30	biopsy	biopsy	NOUN
aiua-10278	165	31	versus	versus	ADP
aiua-10278	165	32	magnetic	magnetic	ADJ
aiua-10278	165	33	resonance	resonance	NOUN
aiua-10278	165	34	(	(	PUNCT
aiua-10278	165	35	mr	mr	PROPN
aiua-10278	165	36	)	)	PUNCT
aiua-10278	165	37	imaging	imaging	NOUN
aiua-10278	165	38	with	with	ADP
aiua-10278	165	39	subsequent	subsequent	ADJ
aiua-10278	165	40	mr	mr	PROPN
aiua-10278	165	41	-	-	PUNCT
aiua-10278	165	42	guided	guide	VERB
aiua-10278	165	43	biopsy	biopsy	NOUN
aiua-10278	165	44	in	in	ADP
aiua-10278	165	45	men	man	NOUN
aiua-10278	165	46	without	without	ADP
aiua-10278	165	47	previous	previous	ADJ
aiua-10278	165	48	prostate	prostate	NOUN
aiua-10278	165	49	biopsies	biopsy	NOUN
aiua-10278	165	50	.	.	PUNCT
aiua-10278	166	1	eur	eur	PROPN
aiua-10278	166	2	urol	urol	PROPN
aiua-10278	166	3	.	.	PUNCT
aiua-10278	166	4	2014	2014	NUM
aiua-10278	166	5	;	;	PUNCT
aiua-10278	166	6	66:22	66:22	NUM
aiua-10278	166	7	-	-	SYM
aiua-10278	166	8	9	9	NUM
aiua-10278	166	9	.	.	NOUN
aiua-10278	166	10	7	7	X
aiua-10278	166	11	.	.	X
aiua-10278	166	12	brizmohun	brizmohun	PROPN
aiua-10278	166	13	appayya	appayya	PROPN
aiua-10278	166	14	m	m	PROPN
aiua-10278	166	15	,	,	PUNCT
aiua-10278	166	16	sidhu	sidhu	PROPN
aiua-10278	166	17	hs	hs	PROPN
aiua-10278	166	18	,	,	PUNCT
aiua-10278	166	19	dikaios	dikaio	NOUN
aiua-10278	166	20	n	n	CCONJ
aiua-10278	166	21	,	,	PUNCT
aiua-10278	166	22	et	et	PROPN
aiua-10278	166	23	al	al	PROPN
aiua-10278	166	24	.	.	PROPN
aiua-10278	167	1	characterizing	characterize	VERB
aiua-10278	167	2	indeterminate	indeterminate	NOUN
aiua-10278	167	3	(	(	PUNCT
aiua-10278	167	4	likert	likert	NOUN
aiua-10278	167	5	-	-	NOUN
aiua-10278	167	6	score	score	NOUN
aiua-10278	167	7	3/5	3/5	NUM
aiua-10278	167	8	)	)	PUNCT
aiua-10278	167	9	peripheral	peripheral	ADJ
aiua-10278	167	10	zone	zone	NOUN
aiua-10278	167	11	prostate	prostate	NOUN
aiua-10278	167	12	lesions	lesion	NOUN
aiua-10278	167	13	with	with	ADP
aiua-10278	167	14	psa	psa	NOUN
aiua-10278	167	15	density	density	NOUN
aiua-10278	167	16	,	,	PUNCT
aiua-10278	167	17	pi	pi	NOUN
aiua-10278	167	18	-	-	PUNCT
aiua-10278	167	19	rads	rad	NOUN
aiua-10278	167	20	scoring	scoring	NOUN
aiua-10278	167	21	and	and	CCONJ
aiua-10278	167	22	qualitative	qualitative	ADJ
aiua-10278	167	23	descriptors	descriptor	NOUN
aiua-10278	167	24	on	on	ADP
aiua-10278	167	25	multiparametric	multiparametric	ADJ
aiua-10278	167	26	mri	mri	NOUN
aiua-10278	167	27	.	.	PUNCT
aiua-10278	168	1	br	br	PROPN
aiua-10278	168	2	j	j	PROPN
aiua-10278	168	3	radiol	radiol	PROPN
aiua-10278	168	4	.	.	PUNCT
aiua-10278	169	1	2018	2018	NUM
aiua-10278	169	2	;	;	PUNCT
aiua-10278	169	3	91:20170645	91:20170645	NUM
aiua-10278	169	4	.	.	X
aiua-10278	169	5	8	8	NUM
aiua-10278	169	6	.	.	PUNCT
aiua-10278	170	1	barnett	barnett	PROPN
aiua-10278	170	2	cl	cl	PROPN
aiua-10278	170	3	,	,	PUNCT
aiua-10278	170	4	davenport	davenport	PROPN
aiua-10278	170	5	ms	ms	PROPN
aiua-10278	170	6	,	,	PUNCT
aiua-10278	170	7	montgomery	montgomery	PROPN
aiua-10278	170	8	js	js	PROPN
aiua-10278	170	9	,	,	PUNCT
aiua-10278	170	10	et	et	PROPN
aiua-10278	170	11	al	al	PROPN
aiua-10278	170	12	.	.	PUNCT
aiua-10278	170	13	cost	cost	NOUN
aiua-10278	170	14	-	-	PUNCT
aiua-10278	170	15	effectiveness	effectiveness	NOUN
aiua-10278	170	16	of	of	ADP
aiua-10278	170	17	magnetic	magnetic	ADJ
aiua-10278	170	18	resonance	resonance	NOUN
aiua-10278	170	19	imaging	imaging	NOUN
aiua-10278	170	20	and	and	CCONJ
aiua-10278	170	21	targeted	target	VERB
aiua-10278	170	22	fusion	fusion	NOUN
aiua-10278	170	23	biopsy	biopsy	NOUN
aiua-10278	170	24	for	for	ADP
aiua-10278	170	25	early	early	ADJ
aiua-10278	170	26	detection	detection	NOUN
aiua-10278	170	27	of	of	ADP
aiua-10278	170	28	prostate	prostate	NOUN
aiua-10278	170	29	cancer	cancer	NOUN
aiua-10278	170	30	.	.	PUNCT
aiua-10278	171	1	bju	bju	NOUN
aiua-10278	171	2	int	int	PROPN
aiua-10278	171	3	.	.	PUNCT
aiua-10278	172	1	2018	2018	NUM
aiua-10278	172	2	;	;	PUNCT
aiua-10278	172	3	122:50	122:50	NUM
aiua-10278	172	4	-	-	SYM
aiua-10278	172	5	8	8	NUM
aiua-10278	172	6	.	.	NOUN
aiua-10278	173	1	9	9	NUM
aiua-10278	173	2	.	.	X
aiua-10278	174	1	radtke	radtke	PROPN
aiua-10278	174	2	jp	jp	PROPN
aiua-10278	174	3	,	,	PUNCT
aiua-10278	174	4	wiesenfarth	wiesenfarth	PROPN
aiua-10278	174	5	m	m	PROPN
aiua-10278	174	6	,	,	PUNCT
aiua-10278	174	7	kesch	kesch	PROPN
aiua-10278	174	8	c	c	NOUN
aiua-10278	174	9	,	,	PUNCT
aiua-10278	174	10	et	et	PROPN
aiua-10278	174	11	al	al	PROPN
aiua-10278	174	12	.	.	PROPN
aiua-10278	175	1	combined	combine	VERB
aiua-10278	175	2	clinical	clinical	ADJ
aiua-10278	175	3	parameters	parameter	NOUN
aiua-10278	175	4	and	and	CCONJ
aiua-10278	175	5	multiparametric	multiparametric	ADJ
aiua-10278	175	6	magnetic	magnetic	ADJ
aiua-10278	175	7	resonance	resonance	NOUN
aiua-10278	175	8	imaging	imaging	NOUN
aiua-10278	175	9	for	for	ADP
aiua-10278	175	10	advanced	advanced	ADJ
aiua-10278	175	11	risk	risk	NOUN
aiua-10278	175	12	modeling	modeling	NOUN
aiua-10278	175	13	of	of	ADP
aiua-10278	175	14	prostate	prostate	NOUN
aiua-10278	175	15	cancer	cancer	NOUN
aiua-10278	175	16	-	-	PUNCT
aiua-10278	175	17	patient	patient	NOUN
aiua-10278	175	18	-	-	PUNCT
aiua-10278	175	19	tailored	tailor	VERB
aiua-10278	175	20	risk	risk	NOUN
aiua-10278	175	21	stratification	stratification	NOUN
aiua-10278	175	22	can	can	AUX
aiua-10278	175	23	reduce	reduce	VERB
aiua-10278	175	24	unnecessary	unnecessary	ADJ
aiua-10278	175	25	biopsies	biopsy	NOUN
aiua-10278	175	26	.	.	PUNCT
aiua-10278	176	1	eur	eur	PROPN
aiua-10278	176	2	urol	urol	PROPN
aiua-10278	176	3	.	.	PROPN
aiua-10278	176	4	2017	2017	NUM
aiua-10278	176	5	;	;	PUNCT
aiua-10278	176	6	72:888	72:888	NUM
aiua-10278	176	7	-	-	SYM
aiua-10278	176	8	96	96	NUM
aiua-10278	176	9	.	.	PUNCT
aiua-10278	177	1	10	10	NUM
aiua-10278	177	2	.	.	X
aiua-10278	177	3	schroder	schroder	PROPN
aiua-10278	177	4	fh	fh	PROPN
aiua-10278	177	5	,	,	PUNCT
aiua-10278	177	6	hugosson	hugosson	PROPN
aiua-10278	177	7	j	j	PROPN
aiua-10278	177	8	,	,	PUNCT
aiua-10278	177	9	roobol	roobol	PROPN
aiua-10278	177	10	mj	mj	PROPN
aiua-10278	177	11	,	,	PUNCT
aiua-10278	177	12	et	et	PROPN
aiua-10278	177	13	al	al	PROPN
aiua-10278	177	14	.	.	PUNCT
aiua-10278	178	1	screening	screening	NOUN
aiua-10278	178	2	and	and	CCONJ
aiua-10278	178	3	prostate	prostate	NOUN
aiua-10278	178	4	cancer	cancer	NOUN
aiua-10278	178	5	mortality	mortality	NOUN
aiua-10278	178	6	:	:	PUNCT
aiua-10278	178	7	results	result	NOUN
aiua-10278	178	8	of	of	ADP
aiua-10278	178	9	the	the	DET
aiua-10278	178	10	european	european	ADJ
aiua-10278	178	11	randomised	randomised	ADJ
aiua-10278	178	12	study	study	NOUN
aiua-10278	178	13	of	of	ADP
aiua-10278	178	14	screening	screen	VERB
aiua-10278	178	15	for	for	ADP
aiua-10278	178	16	prostate	prostate	NOUN
aiua-10278	178	17	cancer	cancer	NOUN
aiua-10278	178	18	(	(	PUNCT
aiua-10278	178	19	erspc	erspc	PROPN
aiua-10278	178	20	)	)	PUNCT
aiua-10278	178	21	at	at	ADP
aiua-10278	178	22	13	13	NUM
aiua-10278	178	23	years	year	NOUN
aiua-10278	178	24	of	of	ADP
aiua-10278	178	25	follow	follow	NOUN
aiua-10278	178	26	-	-	PUNCT
aiua-10278	178	27	up	up	NOUN
aiua-10278	178	28	.	.	PUNCT
aiua-10278	179	1	lancet	lancet	PROPN
aiua-10278	179	2	(	(	PUNCT
aiua-10278	179	3	london	london	PROPN
aiua-10278	179	4	,	,	PUNCT
aiua-10278	179	5	england	england	PROPN
aiua-10278	179	6	)	)	PUNCT
aiua-10278	179	7	.	.	PUNCT
aiua-10278	180	1	2014	2014	NUM
aiua-10278	180	2	;	;	PUNCT
aiua-10278	180	3	384:2027	384:2027	NUM
aiua-10278	180	4	-	-	SYM
aiua-10278	180	5	35	35	NUM
aiua-10278	180	6	.	.	PUNCT
aiua-10278	181	1	11	11	NUM
aiua-10278	181	2	.	.	PUNCT
aiua-10278	182	1	meng	meng	PROPN
aiua-10278	182	2	x	x	PROPN
aiua-10278	182	3	,	,	PUNCT
aiua-10278	182	4	rosenkrantz	rosenkrantz	PROPN
aiua-10278	182	5	ab	ab	PROPN
aiua-10278	182	6	,	,	PUNCT
aiua-10278	182	7	mendhiratta	mendhiratta	PROPN
aiua-10278	182	8	n	n	CCONJ
aiua-10278	182	9	,	,	PUNCT
aiua-10278	182	10	et	et	PROPN
aiua-10278	182	11	al	al	PROPN
aiua-10278	182	12	.	.	PROPN
aiua-10278	182	13	relationship	relationship	NOUN
aiua-10278	182	14	between	between	ADP
aiua-10278	182	15	prebiopsy	prebiopsy	PROPN
aiua-10278	182	16	multiparametric	multiparametric	PROPN
aiua-10278	182	17	magnetic	magnetic	ADJ
aiua-10278	182	18	resonance	resonance	NOUN
aiua-10278	182	19	imaging	imaging	NOUN
aiua-10278	182	20	(	(	PUNCT
aiua-10278	182	21	mri	mri	NOUN
aiua-10278	182	22	)	)	PUNCT
aiua-10278	182	23	,	,	PUNCT
aiua-10278	182	24	biopsy	biopsy	NOUN
aiua-10278	182	25	indication	indication	NOUN
aiua-10278	182	26	,	,	PUNCT
aiua-10278	182	27	and	and	CCONJ
aiua-10278	182	28	mri	mri	NOUN
aiua-10278	182	29	-	-	PUNCT
aiua-10278	182	30	ultrasound	ultrasound	NOUN
aiua-10278	182	31	fusion	fusion	NOUN
aiua-10278	182	32	-	-	PUNCT
aiua-10278	182	33	targeted	target	VERB
aiua-10278	182	34	prostate	prostate	NOUN
aiua-10278	182	35	biopsy	biopsy	NOUN
aiua-10278	182	36	outcomes	outcome	NOUN
aiua-10278	182	37	.	.	PUNCT
aiua-10278	183	1	eur	eur	PROPN
aiua-10278	183	2	urol	urol	PROPN
aiua-10278	183	3	.	.	PUNCT
aiua-10278	183	4	2016	2016	NUM
aiua-10278	183	5	;	;	PUNCT
aiua-10278	183	6	69:512	69:512	NUM
aiua-10278	183	7	-	-	SYM
aiua-10278	183	8	7	7	NUM
aiua-10278	183	9	.	.	NOUN
aiua-10278	183	10	12	12	NUM
aiua-10278	183	11	.	.	PUNCT
aiua-10278	184	1	stanzione	stanzione	NOUN
aiua-10278	184	2	a	a	PRON
aiua-10278	184	3	,	,	PUNCT
aiua-10278	184	4	creta	creta	NOUN
aiua-10278	184	5	m	m	PROPN
aiua-10278	184	6	,	,	PUNCT
aiua-10278	184	7	imbriaco	imbriaco	PROPN
aiua-10278	184	8	m	m	PROPN
aiua-10278	184	9	,	,	PUNCT
aiua-10278	184	10	et	et	PROPN
aiua-10278	184	11	al	al	PROPN
aiua-10278	184	12	.	.	PROPN
aiua-10278	184	13	attitudes	attitude	NOUN
aiua-10278	184	14	and	and	CCONJ
aiua-10278	184	15	perceptions	perception	NOUN
aiua-10278	184	16	towards	towards	ADP
aiua-10278	184	17	multiparametric	multiparametric	ADJ
aiua-10278	184	18	magnetic	magnetic	ADJ
aiua-10278	184	19	resonance	resonance	NOUN
aiua-10278	184	20	imaging	imaging	NOUN
aiua-10278	184	21	of	of	ADP
aiua-10278	184	22	the	the	DET
aiua-10278	184	23	prostate	prostate	NOUN
aiua-10278	184	24	:	:	PUNCT
aiua-10278	184	25	a	a	DET
aiua-10278	184	26	national	national	ADJ
aiua-10278	184	27	survey	survey	NOUN
aiua-10278	184	28	among	among	ADP
aiua-10278	184	29	italian	italian	ADJ
aiua-10278	184	30	urologists	urologist	NOUN
aiua-10278	184	31	.	.	PUNCT
aiua-10278	185	1	arch	arch	ADJ
aiua-10278	185	2	ital	ital	PROPN
aiua-10278	185	3	urol	urol	PROPN
aiua-10278	185	4	androl	androl	PROPN
aiua-10278	185	5	.	.	PUNCT
aiua-10278	185	6	2020	2020	NUM
aiua-10278	185	7	;	;	PUNCT
aiua-10278	185	8	92:291	92:291	NUM
aiua-10278	185	9	-	-	SYM
aiua-10278	185	10	296	296	NUM
aiua-10278	185	11	.	.	PUNCT
aiua-10278	185	12	13	13	NUM
aiua-10278	185	13	.	.	PUNCT
aiua-10278	186	1	panebianco	panebianco	PROPN
aiua-10278	186	2	v	v	NOUN
aiua-10278	186	3	,	,	PUNCT
aiua-10278	186	4	barchetti	barchetti	NOUN
aiua-10278	186	5	g	g	NOUN
aiua-10278	186	6	,	,	PUNCT
aiua-10278	186	7	simone	simone	NOUN
aiua-10278	186	8	g	g	NOUN
aiua-10278	186	9	,	,	PUNCT
aiua-10278	186	10	,	,	PUNCT
aiua-10278	186	11	et	et	PROPN
aiua-10278	186	12	al	al	PROPN
aiua-10278	186	13	.	.	PROPN
aiua-10278	187	1	negative	negative	ADJ
aiua-10278	187	2	multiparametric	multiparametric	ADJ
aiua-10278	187	3	magnetic	magnetic	ADJ
aiua-10278	187	4	resonance	resonance	NOUN
aiua-10278	187	5	imaging	imaging	NOUN
aiua-10278	187	6	for	for	ADP
aiua-10278	187	7	prostate	prostate	NOUN
aiua-10278	187	8	cancer	cancer	NOUN
aiua-10278	187	9	:	:	PUNCT
aiua-10278	187	10	what	what	PRON
aiua-10278	187	11	’s	’	VERB
aiua-10278	187	12	next	next	ADJ
aiua-10278	187	13	?	?	PUNCT
aiua-10278	188	1	eur	eur	PROPN
aiua-10278	188	2	urol	urol	NOUN
aiua-10278	188	3	.	.	PUNCT
aiua-10278	188	4	2018	2018	NUM
aiua-10278	188	5	;	;	PUNCT
aiua-10278	188	6	74:48	74:48	NUM
aiua-10278	188	7	-	-	SYM
aiua-10278	188	8	54	54	NUM
aiua-10278	188	9	.	.	PUNCT
aiua-10278	189	1	14	14	NUM
aiua-10278	189	2	.	.	PUNCT
aiua-10278	190	1	mottet	mottet	PROPN
aiua-10278	190	2	n	n	CCONJ
aiua-10278	190	3	,	,	PUNCT
aiua-10278	190	4	cornford	cornford	PROPN
aiua-10278	190	5	p	p	X
aiua-10278	190	6	,	,	PUNCT
aiua-10278	190	7	van	van	PROPN
aiua-10278	190	8	den	den	PROPN
aiua-10278	190	9	bergh	bergh	PROPN
aiua-10278	190	10	rcn	rcn	PROPN
aiua-10278	190	11	,	,	PUNCT
aiua-10278	190	12	et	et	PROPN
aiua-10278	190	13	al	al	PROPN
aiua-10278	190	14	.	.	PUNCT
aiua-10278	191	1	eau	eau	PROPN
aiua-10278	191	2	-	-	PUNCT
aiua-10278	191	3	eanmestro	eanmestro	VERB
aiua-10278	191	4	-	-	PUNCT
aiua-10278	191	5	esur	esur	ADJ
aiua-10278	191	6	-	-	PUNCT
aiua-10278	191	7	isup	isup	NOUN
aiua-10278	191	8	-	-	PUNCT
aiua-10278	191	9	siog	siog	NOUN
aiua-10278	191	10	guidelines	guideline	NOUN
aiua-10278	191	11	on	on	ADP
aiua-10278	191	12	prostate	prostate	NOUN
aiua-10278	191	13	cancer	cancer	NOUN
aiua-10278	191	14	.	.	PUNCT
aiua-10278	192	1	https://	https://	NOUN
aiua-10278	192	2	uroweb.org/wp-content/uploads/eau-eanm-estro_esur_isup	uroweb.org/wp-content/uploads/eau-eanm-estro_esur_isup	NOUN
aiua-10278	192	3	_	_	PUNCT
aiua-10278	192	4	siog-guidelines-on-prostate-cancer-2021.pdf	siog-guidelines-on-prostate-cancer-2021.pdf	NOUN
aiua-10278	192	5	15	15	NUM
aiua-10278	192	6	.	.	PUNCT
aiua-10278	193	1	weinreb	weinreb	PROPN
aiua-10278	193	2	jc	jc	PROPN
aiua-10278	193	3	,	,	PUNCT
aiua-10278	193	4	barentsz	barentsz	VERB
aiua-10278	193	5	jo	jo	PROPN
aiua-10278	193	6	,	,	PUNCT
aiua-10278	193	7	choyke	choyke	PROPN
aiua-10278	193	8	pl	pl	PROPN
aiua-10278	193	9	,	,	PUNCT
aiua-10278	193	10	et	et	PROPN
aiua-10278	193	11	al	al	PROPN
aiua-10278	193	12	.	.	PROPN
aiua-10278	194	1	pi	pi	NOUN
aiua-10278	194	2	-	-	PUNCT
aiua-10278	194	3	rads	rad	NOUN
aiua-10278	194	4	prostate	prostate	NOUN
aiua-10278	194	5	imaging	imaging	NOUN
aiua-10278	194	6	reporting	reporting	NOUN
aiua-10278	194	7	and	and	CCONJ
aiua-10278	194	8	data	datum	NOUN
aiua-10278	194	9	system	system	NOUN
aiua-10278	194	10	:	:	PUNCT
aiua-10278	194	11	2015	2015	NUM
aiua-10278	194	12	,	,	PUNCT
aiua-10278	194	13	version	version	NOUN
aiua-10278	194	14	2	2	NUM
aiua-10278	194	15	.	.	PUNCT
aiua-10278	194	16	eur	eur	PROPN
aiua-10278	194	17	urol	urol	PROPN
aiua-10278	194	18	.	.	PUNCT
aiua-10278	194	19	2016	2016	NUM
aiua-10278	194	20	;	;	PUNCT
aiua-10278	194	21	69:16	69:16	NUM
aiua-10278	194	22	-	-	SYM
aiua-10278	194	23	40	40	NUM
aiua-10278	194	24	.	.	PUNCT
aiua-10278	195	1	16	16	NUM
aiua-10278	195	2	.	.	PUNCT
aiua-10278	196	1	washino	washino	PROPN
aiua-10278	196	2	s	s	PROPN
aiua-10278	196	3	,	,	PUNCT
aiua-10278	196	4	okochi	okochi	PROPN
aiua-10278	196	5	t	t	PROPN
aiua-10278	196	6	,	,	PUNCT
aiua-10278	196	7	saito	saito	PROPN
aiua-10278	196	8	k	k	PROPN
aiua-10278	196	9	,	,	PUNCT
aiua-10278	196	10	et	et	PROPN
aiua-10278	196	11	al	al	PROPN
aiua-10278	196	12	.	.	PROPN
aiua-10278	196	13	combination	combination	NOUN
aiua-10278	196	14	of	of	ADP
aiua-10278	196	15	prostate	prostate	NOUN
aiua-10278	196	16	imaging	imaging	NOUN
aiua-10278	196	17	reporting	reporting	NOUN
aiua-10278	196	18	and	and	CCONJ
aiua-10278	196	19	data	datum	NOUN
aiua-10278	196	20	system	system	NOUN
aiua-10278	196	21	(	(	PUNCT
aiua-10278	196	22	pi	pi	NOUN
aiua-10278	196	23	-	-	PUNCT
aiua-10278	196	24	rads	rad	NOUN
aiua-10278	196	25	)	)	PUNCT
aiua-10278	196	26	score	score	NOUN
aiua-10278	196	27	and	and	CCONJ
aiua-10278	196	28	prostatespecific	prostatespecific	VERB
aiua-10278	196	29	antigen	antigen	NOUN
aiua-10278	196	30	(	(	PUNCT
aiua-10278	196	31	psa	psa	NOUN
aiua-10278	196	32	)	)	PUNCT
aiua-10278	196	33	density	density	NOUN
aiua-10278	196	34	predicts	predict	NOUN
aiua-10278	196	35	biopsy	biopsy	VERB
aiua-10278	196	36	outcome	outcome	NOUN
aiua-10278	196	37	in	in	ADP
aiua-10278	196	38	prostate	prostate	NOUN
aiua-10278	196	39	biopsy	biopsy	NOUN
aiua-10278	196	40	naive	naive	ADJ
aiua-10278	196	41	patients	patient	NOUN
aiua-10278	196	42	.	.	PUNCT
aiua-10278	197	1	bju	bju	NOUN
aiua-10278	197	2	int	int	PROPN
aiua-10278	197	3	.	.	PUNCT
aiua-10278	198	1	2017	2017	NUM
aiua-10278	198	2	;	;	PUNCT
aiua-10278	198	3	119:225	119:225	ADJ
aiua-10278	198	4	-	-	SYM
aiua-10278	198	5	33	33	NUM
aiua-10278	198	6	.	.	PUNCT
aiua-10278	198	7	17	17	NUM
aiua-10278	198	8	.	.	PUNCT
aiua-10278	199	1	ahmed	ahmed	PROPN
aiua-10278	199	2	hu	hu	PROPN
aiua-10278	199	3	,	,	PUNCT
aiua-10278	199	4	el	el	PROPN
aiua-10278	199	5	-	-	PUNCT
aiua-10278	199	6	shater	shater	NOUN
aiua-10278	199	7	bosaily	bosaily	ADV
aiua-10278	199	8	a	a	DET
aiua-10278	199	9	,	,	PUNCT
aiua-10278	199	10	brown	brown	ADJ
aiua-10278	199	11	lc	lc	PROPN
aiua-10278	199	12	,	,	PUNCT
aiua-10278	199	13	et	et	PROPN
aiua-10278	199	14	al	al	PROPN
aiua-10278	199	15	.	.	PUNCT
aiua-10278	200	1	diagnostic	diagnostic	ADJ
aiua-10278	200	2	accuracy	accuracy	NOUN
aiua-10278	200	3	of	of	ADP
aiua-10278	200	4	multi	multi	ADJ
aiua-10278	200	5	-	-	ADJ
aiua-10278	200	6	parametric	parametric	ADJ
aiua-10278	200	7	mri	mri	NOUN
aiua-10278	200	8	and	and	CCONJ
aiua-10278	200	9	trus	trus	NOUN
aiua-10278	200	10	biopsy	biopsy	NOUN
aiua-10278	200	11	in	in	ADP
aiua-10278	200	12	prostate	prostate	NOUN
aiua-10278	200	13	cancer	cancer	NOUN
aiua-10278	200	14	(	(	PUNCT
aiua-10278	200	15	promis	promis	PROPN
aiua-10278	200	16	):	):	PUNCT
aiua-10278	200	17	a	a	DET
aiua-10278	200	18	paired	pair	VERB
aiua-10278	200	19	validating	validate	VERB
aiua-10278	200	20	confirmatory	confirmatory	ADJ
aiua-10278	200	21	study	study	NOUN
aiua-10278	200	22	.	.	PUNCT
aiua-10278	201	1	lancet	lancet	PROPN
aiua-10278	201	2	(	(	PUNCT
aiua-10278	201	3	london	london	PROPN
aiua-10278	201	4	,	,	PUNCT
aiua-10278	201	5	england	england	PROPN
aiua-10278	201	6	)	)	PUNCT
aiua-10278	201	7	.	.	PUNCT
aiua-10278	202	1	2017	2017	NUM
aiua-10278	202	2	;	;	PUNCT
aiua-10278	202	3	389:815	389:815	NOUN
aiua-10278	202	4	-	-	SYM
aiua-10278	202	5	22	22	NUM
aiua-10278	202	6	.	.	PUNCT
aiua-10278	202	7	18	18	NUM
aiua-10278	202	8	.	.	PUNCT
aiua-10278	202	9	cormio	cormio	NOUN
aiua-10278	202	10	l	l	PROPN
aiua-10278	202	11	,	,	PUNCT
aiua-10278	202	12	cindolo	cindolo	PROPN
aiua-10278	202	13	l	l	PROPN
aiua-10278	202	14	,	,	PUNCT
aiua-10278	202	15	troiano	troiano	PROPN
aiua-10278	202	16	f	f	AUX
aiua-10278	202	17	,	,	PUNCT
aiua-10278	202	18	et	et	PROPN
aiua-10278	202	19	al	al	PROPN
aiua-10278	202	20	.	.	PROPN
aiua-10278	202	21	development	development	PROPN
aiua-10278	202	22	and	and	CCONJ
aiua-10278	202	23	internal	internal	ADJ
aiua-10278	202	24	validation	validation	NOUN
aiua-10278	202	25	of	of	ADP
aiua-10278	202	26	novel	novel	NOUN
aiua-10278	202	27	nomograms	nomogram	NOUN
aiua-10278	202	28	based	base	VERB
aiua-10278	202	29	on	on	ADP
aiua-10278	202	30	benign	benign	ADJ
aiua-10278	202	31	prostatic	prostatic	ADJ
aiua-10278	202	32	obstructionrelated	obstructionrelate	VERB
aiua-10278	202	33	parameters	parameter	NOUN
aiua-10278	202	34	to	to	PART
aiua-10278	202	35	predict	predict	VERB
aiua-10278	202	36	the	the	DET
aiua-10278	202	37	risk	risk	NOUN
aiua-10278	202	38	of	of	ADP
aiua-10278	202	39	prostate	prostate	NOUN
aiua-10278	202	40	cancer	cancer	NOUN
aiua-10278	202	41	at	at	ADP
aiua-10278	202	42	first	first	ADJ
aiua-10278	202	43	prostate	prostate	NOUN
aiua-10278	202	44	biopsy	biopsy	NOUN
aiua-10278	202	45	.	.	PUNCT
aiua-10278	203	1	front	front	ADJ
aiua-10278	203	2	oncol	oncol	ADJ
aiua-10278	203	3	.	.	PUNCT
aiua-10278	204	1	2018	2018	NUM
aiua-10278	204	2	;	;	PUNCT
aiua-10278	205	1	8:438	8:438	X
aiua-10278	205	2	.	.	PROPN
aiua-10278	206	1	19	19	NUM
aiua-10278	206	2	.	.	PUNCT
aiua-10278	207	1	komai	komai	PROPN
aiua-10278	207	2	y	y	PROPN
aiua-10278	207	3	,	,	PUNCT
aiua-10278	207	4	numao	numao	PROPN
aiua-10278	207	5	n	n	CCONJ
aiua-10278	207	6	,	,	PUNCT
aiua-10278	207	7	yoshida	yoshida	PROPN
aiua-10278	207	8	s	s	PROPN
aiua-10278	207	9	,	,	PUNCT
aiua-10278	207	10	et	et	PROPN
aiua-10278	207	11	al	al	PROPN
aiua-10278	207	12	.	.	PROPN
aiua-10278	207	13	high	high	ADJ
aiua-10278	207	14	diagnostic	diagnostic	ADJ
aiua-10278	207	15	ability	ability	NOUN
aiua-10278	207	16	of	of	ADP
aiua-10278	207	17	multiparametric	multiparametric	ADJ
aiua-10278	207	18	magnetic	magnetic	ADJ
aiua-10278	207	19	resonance	resonance	NOUN
aiua-10278	207	20	imaging	imaging	NOUN
aiua-10278	207	21	to	to	PART
aiua-10278	207	22	detect	detect	VERB
aiua-10278	207	23	anterior	anterior	ADJ
aiua-10278	207	24	prostate	prostate	NOUN
aiua-10278	207	25	cancer	cancer	NOUN
aiua-10278	207	26	missed	miss	VERB
aiua-10278	207	27	by	by	ADP
aiua-10278	207	28	transrectal	transrectal	ADJ
aiua-10278	207	29	12	12	NUM
aiua-10278	207	30	-	-	PUNCT
aiua-10278	207	31	core	core	NOUN
aiua-10278	207	32	biopsy	biopsy	NOUN
aiua-10278	207	33	.	.	PUNCT
aiua-10278	208	1	j	j	PROPN
aiua-10278	208	2	urol	urol	PROPN
aiua-10278	208	3	.	.	PUNCT
aiua-10278	209	1	2013	2013	NUM
aiua-10278	209	2	;	;	PUNCT
aiua-10278	209	3	190:867	190:867	NUM
aiua-10278	209	4	-	-	SYM
aiua-10278	209	5	73	73	NUM
aiua-10278	209	6	.	.	PUNCT
aiua-10278	210	1	20	20	NUM
aiua-10278	210	2	.	.	PUNCT
aiua-10278	211	1	ekin	ekin	PROPN
aiua-10278	211	2	rg	rg	PROPN
aiua-10278	211	3	,	,	PUNCT
aiua-10278	211	4	zorlu	zorlu	PROPN
aiua-10278	211	5	f	f	PROPN
aiua-10278	211	6	,	,	PUNCT
aiua-10278	211	7	akarken	akarken	VERB
aiua-10278	211	8	i	i	PROPN
aiua-10278	211	9	,	,	PUNCT
aiua-10278	211	10	et	et	PROPN
aiua-10278	211	11	al	al	PROPN
aiua-10278	211	12	.	.	PROPN
aiua-10278	211	13	anterior	anterior	ADJ
aiua-10278	211	14	apical	apical	ADJ
aiua-10278	211	15	cores	core	NOUN
aiua-10278	211	16	in	in	ADP
aiua-10278	211	17	the	the	DET
aiua-10278	211	18	initial	initial	ADJ
aiua-10278	211	19	prostate	prostate	NOUN
aiua-10278	211	20	biopsy	biopsy	NOUN
aiua-10278	211	21	does	do	AUX
aiua-10278	211	22	not	not	PART
aiua-10278	211	23	increase	increase	VERB
aiua-10278	211	24	detection	detection	NOUN
aiua-10278	211	25	of	of	ADP
aiua-10278	211	26	significant	significant	ADJ
aiua-10278	211	27	prostate	prostate	NOUN
aiua-10278	211	28	cancer	cancer	NOUN
aiua-10278	211	29	.	.	PUNCT
aiua-10278	212	1	urol	urol	PROPN
aiua-10278	212	2	j.	j.	PROPN
aiua-10278	212	3	2015	2015	NUM
aiua-10278	212	4	;	;	PUNCT
aiua-10278	212	5	12:2084	12:2084	NUM
aiua-10278	212	6	-	-	SYM
aiua-10278	212	7	9	9	NUM
aiua-10278	212	8	.	.	PUNCT
aiua-10278	213	1	correspondence	correspondence	NOUN
aiua-10278	213	2	sara	sara	PROPN
aiua-10278	213	3	teixeira	teixeira	PROPN
aiua-10278	213	4	anacleto	anacleto	PROPN
aiua-10278	213	5	,	,	PUNCT
aiua-10278	213	6	md	md	PROPN
aiua-10278	213	7	(	(	PUNCT
aiua-10278	213	8	corresponding	correspond	VERB
aiua-10278	213	9	author	author	NOUN
aiua-10278	213	10	)	)	PUNCT
aiua-10278	214	1	sara.anacleto241@gmail.com	sara.anacleto241@gmail.com	PROPN
aiua-10278	214	2	emanuel	emanuel	PROPN
aiua-10278	214	3	carvalho	carvalho	PROPN
aiua-10278	214	4	dias	dias	PROPN
aiua-10278	214	5	,	,	PUNCT
aiua-10278	214	6	md	md	PROPN
aiua-10278	214	7	emanueldias@med.uminho.pt	emanueldias@med.uminho.pt	PROPN
aiua-10278	214	8	department	department	PROPN
aiua-10278	214	9	of	of	ADP
aiua-10278	214	10	urology	urology	NOUN
aiua-10278	214	11	,	,	PUNCT
aiua-10278	214	12	hospital	hospital	NOUN
aiua-10278	214	13	of	of	ADP
aiua-10278	214	14	braga	braga	NOUN
aiua-10278	214	15	,	,	PUNCT
aiua-10278	214	16	braga	braga	NOUN
aiua-10278	214	17	(	(	PUNCT
aiua-10278	214	18	portugal	portugal	PROPN
aiua-10278	214	19	)	)	PUNCT
aiua-10278	214	20	joana	joana	PROPN
aiua-10278	214	21	neves	neves	PROPN
aiua-10278	214	22	alberto	alberto	PROPN
aiua-10278	214	23	,	,	PUNCT
aiua-10278	214	24	md	md	PROPN
aiua-10278	214	25	joana.alberto26@gmail.com	joana.alberto26@gmail.com	PROPN
aiua-10278	214	26	mário	mário	PROPN
aiua-10278	214	27	cerqueira	cerqueira	PROPN
aiua-10278	214	28	alves	alves	PROPN
aiua-10278	214	29	,	,	PUNCT
aiua-10278	214	30	md	md	PROPN
aiua-10278	214	31	mario.alves@hb.min-saude.pt	mario.alves@hb.min-saude.pt	PROPN
aiua-10278	214	32	life	life	PROPN
aiua-10278	214	33	and	and	CCONJ
aiua-10278	214	34	health	health	PROPN
aiua-10278	214	35	sciences	sciences	PROPN
aiua-10278	214	36	research	research	PROPN
aiua-10278	214	37	institute	institute	PROPN
aiua-10278	214	38	(	(	PUNCT
aiua-10278	214	39	icvs	icvs	NOUN
aiua-10278	214	40	)	)	PUNCT
aiua-10278	214	41	,	,	PUNCT
aiua-10278	214	42	school	school	NOUN
aiua-10278	214	43	of	of	ADP
aiua-10278	214	44	medicine	medicine	NOUN
aiua-10278	214	45	,	,	PUNCT
aiua-10278	214	46	university	university	NOUN
aiua-10278	214	47	of	of	ADP
aiua-10278	214	48	minho	minho	PROPN
aiua-10278	214	49	,	,	PUNCT
aiua-10278	214	50	4710	4710	NUM
aiua-10278	214	51	-	-	SYM
aiua-10278	214	52	057	057	NUM
aiua-10278	214	53	,	,	PUNCT
aiua-10278	214	54	braga	braga	NOUN
aiua-10278	214	55	(	(	PUNCT
aiua-10278	214	56	portugal	portugal	PROPN
aiua-10278	214	57	)	)	PUNCT
aiua-10278	214	58	pedro	pedro	PROPN
aiua-10278	214	59	sousa	sousa	PROPN
aiua-10278	214	60	passos	passos	PROPN
aiua-10278	214	61	,	,	PUNCT
aiua-10278	214	62	md	md	PROPN
aiua-10278	214	63	pedrosousapassos@gmail.com	pedrosousapassos@gmail.com	PROPN
aiua-10278	214	64	department	department	PROPN
aiua-10278	214	65	of	of	ADP
aiua-10278	214	66	urology	urology	NOUN
aiua-10278	214	67	,	,	PUNCT
aiua-10278	214	68	hospital	hospital	NOUN
aiua-10278	214	69	da	da	PROPN
aiua-10278	214	70	senhora	senhora	PROPN
aiua-10278	214	71	da	da	PROPN
aiua-10278	214	72	oliveira	oliveira	PROPN
aiua-10278	214	73	,	,	PUNCT
aiua-10278	214	74	guimarães	guimarães	PROPN
aiua-10278	214	75	(	(	PUNCT
aiua-10278	214	76	portugal	portugal	PROPN
aiua-10278	214	77	)	)	PUNCT